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Abstract

Abstract
The deterioration of lipids by oxygen, termed peroxidation, is a constitutive process in
living systems. Enzymatic peroxidation is required for some forms of cell signalling,
but the non-enzymatic peroxidation of polyunsaturated fatty acids (PUFA) produces
numerous toxic and mutagenic products associated with pathology and aging.
Phospholipids containing PUFA are common in mammalian membranes, but an inverse
relationship has been found between membrane susceptibility to peroxidation and
maximal lifespan (MLS). Past studies of peroxidation have focused on the PUFA
content of phospholipids, but other elements of phospholipid composition including
class and saturated fatty acid (SFA) or monounsaturated fatty acid (MUFA) content
may also influence peroxidation. This thesis presents three studies investigating the
relationship between phospholipid composition and peroxidation.
In the first study, published data was analysed to examine the relationship
between dietary fatty acids and the PUFA composition of cardiolipin and other classes
of mitochondrial phospholipids. The composition of heart cardiolipin is commonly
viewed as being strongly regulated due to its high levels of linoleic acid (18:2n-6), but
the analysis showed that the percentage of 18:2n-6 in cardiolipin of heart conformed to
dietary availability from 2–20% of total dietary fatty acids and was thereafter regulated.
The percentage of 18:2n-6 in liver cardiolipin was lower than in heart, and was
regulated across the dietary range examined. When both 18:2n-6 and docosahexaenoic
acid (22:6n-3) were present in the diet, 22:6n-3 was incorporated into cardiolipin of
heart and liver at the expense of 18:2n-6. The content of 22:6n-3 present in
phosphatidylcholine and phosphatidylethanolamine also conformed to dietary levels,
but not at the expense of 18:2n-6. This study suggests that dietary 22:6n-3 may increase
the susceptibility of cardiolipin and other mitochondrial classes to peroxidation, and
may therefore alter mitochondrial function.
In the second study, in vitro assays of iron-mediated peroxidation were used to
investigate the effect of phospholipid composition on iron-mediated, non-enzymatic
peroxidation. The influence of phospholipid class was examined for phospholipids of
the cardiolipin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol
and phosphatidic acid classes that were matched for 18:2n-6 content. Iron-initiated
peroxidation of these phospholipids was tested in diffuse solution and in liposomes.
ii

Abstract

Cardiolipin and phosphatidic acid were found to peroxidise more readily than other
classes in diffuse solution, but not in liposomes. Differences in peroxidation between
classes were found to be related to head group charges in diffuse solution but head
group sizes in liposomes. Following this work, in vitro assays of peroxidation were used
to investigate whether phospholipids composed of SFA and MUFA influence the rates
and phases of peroxidation. Phospholipids containing no PUFA, termed nonperoxidisable phospholipids (non-PPLs), were found to have an antioxidant-like effect
that extended the duration of the lag phase of peroxidation several-fold through a weak
inhibitory effect on rate of peroxidation during the lag phase. Non-PPLs are common in
cellular membranes, suggesting that this antioxidant-like activity may be a widespread
mechanism that augments traditional antioxidant defences to delay peroxidation.
In the third study, shotgun lipidomics was used to examine the phospholipid
composition and peroxidation index of skeletal muscle, liver, and brain from mice (Mus
musculus, MLS of 4 years), pigs (Sus scrofa, MLS of 27 years), and humans (Homo
sapiens, MLS of 122 years). A comparison of mitochondrial membranes found a higher
percentage of 22:6n-3 and a higher peroxidation index for each tissue in mice than
humans. In comparison to mice, the mitochondrial membranes of humans contained a
lower percentage of PUFA and a higher percentage of non-PPLs. The mitochondrial
membranes of pigs shared characteristics of both mice and humans, supporting earlier
findings that membrane composition is associated with lifespan. A second investigation
of the importance of membrane composition to lifespan examined whether humans
prevent peroxidation by excluding highly peroxidisable PUFA from their mitochondrial
membranes. This exclusion has been suggested to be an evolutionary adaptation to
extend longevity that is unique in humans. An intra-species comparison found few
significant differences in the distributions of phospholipid classes, molecular
phospholipids within classes, fatty acid composition, and the peroxidation index
between the mitochondrial and microsomal membranes of humans, mice or pigs. This
study is one of the most in-depth lipidomics analysis of human tissue to date, and
suggests that human longevity may be related to a decrease in the susceptibility of all
cellular membrane phospholipids to peroxidation.
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Chapter One
Preamble

1.1

Peroxidation and membrane composition

“We must answer the question, what is it that which, in natural objects, makes them
easily destroyed?”
Aristotle, On the Length and Shortness of Life, paragraph 2 [1].

1.1.1 Peroxidation
Oxidative damage is a process that all aerobic organisms must accommodate in order to
survive. Peroxidation is a form of oxidative modification that primarily affects the
polyunsaturated fatty acids (PUFA) present in membrane and storage lipids. Many of
the products of peroxidation are volatile, toxic and mutagenic [2-5] and while cells have
adapted to make use of some of these products in enzymatically-controlled cell
signalling pathways [6-9], the majority of products formed during peroxidation are due
to non-enzymatic peroxidation [4]. Non-enzymatic peroxidation is commonly initiated
by reactive oxygen species (ROS), reactive nitrogen species, and reactive chlorine
species in a self-propagating reaction that produces multiple types of ROS [5, 10, 11].
This propagation may be problematic to cell function as it has the potential to greatly
increase the oxidative stress placed on cells [11-14]. It is unsurprising, then, that
peroxidation and its products are associated with numerous pathologies [3] and have
been identified as a possible cause of aging [12]. The ROS produced by peroxidation
may affect numerous components of cellular membranes including proteins, lipophilic
antioxidants, and lipids. The major factor identified as determining membrane
vulnerability to peroxidation is the PUFA content of membrane phospholipids, but
phospholipid class and content of saturated fatty acids (SFA) and monounsaturated fatty
acids (MUFA) have also been suggested to influence peroxidation [15, 16]. The general
aim of this thesis was to examine the relationships between membrane phospholipid
composition and peroxidation.
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1.1.2 Membrane phospholipid composition and peroxidation
Phospholipids are commonly composed of a class-defining head group, a glycerol
backbone, and two fatty acids. Exceptions to this common structure include
sphingomyelins with only one fatty acid, and cardiolipin (CL) with up to four fatty
acids. Mammalian phospholipids are composed of SFA, MUFA and PUFA, with the
distribution of these fatty acids differing between animal species, tissues, and classes of
phospholipid [17-20]. The vulnerability of membrane phospholipids to peroxidation
may be influenced by class [15] and proximity to sources of ROS production within a
cell [12], but is primarily determined by fatty acid composition [5, 21-23]. Due to the
abstraction energies required to initiate peroxidation, the vulnerability of membranes to
peroxidation is principally determined by the percentage of PUFA present in membrane
phospholipids, and the degree of unsaturation of PUFA [21]. Despite the risk posed by
peroxidation, however, phospholipids containing PUFA are common in the majority of
eukaryote membranes [24]. Between 40–80% of mammalian phospholipids contain a
PUFA [18], and CL, a phospholipid class found primarily in mitochondria, appears to
require a high PUFA content in order to interact with mitochondrial proteins of the
electron transport chain (ETC) [25, 26]. It therefore appears that the incorporation of
PUFA into membrane phospholipids is common, and is likely to be a trade-off between
the associated risks and benefits.
Membrane phospholipid composition has been the subject of numerous studies
including the influence of diet on membrane composition (e.g. [27, 28]), differences in
membrane composition between animal species (reviewed in [14, 29]) and cellular
organelles [17], and mechanistic studies showing how phospholipid properties may
influence peroxidation and biological processes such as apoptosis [15, 30, 31]. A great
deal still remains to be discovered regarding the biological importance of membrane
composition and peroxidation. For example, although PUFA content may be the
primary factor determining peroxidation, phospholipid class may also affect
peroxidation [15, 30]. In addition, while non-peroxidisable phospholipids (non-PPLs)
containing only saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA)
are not generally considered to influence peroxidation, non-PPLs may delay the onset of
peroxidation [16]. Despite the importance of membrane composition and peroxidation
to cellular health, relatively little is known regarding how PUFA and non-PPLs are
distributed across phospholipid classes and whether this distribution differs between
animal species or tissues. This distribution may be of particular importance as the
2
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susceptibility of membrane phospholipids to peroxidation is inversely related to species
longevity.

1.1.3 Peroxidation of membrane PUFA: A possible cause of aging?
The ‘Free Radical Theory of Aging’ [32, 33] proposes that ROS cause aging by
irreversibly damaging cellular components, and peroxidation has been identified as a
likely source of such ROS due to its self-propagating nature [12, 14]. Much of the work
supporting the importance of membrane fatty acid composition and longevity comes
from comparative animal studies that have established a strong and inverse correlation
between membrane susceptibility to peroxidation and longevity. This relationship is
best characterised for mammal muscle and liver [14, 34-36], but similar relationships
have also been found for birds [12], molluscs [37], bees [38], and strains of
Caenorhabditis elegans [39]. The relationship between membrane composition and
aging caused by non-enzymatic lipid peroxidation was first proposed by Pamploma et
al. under the name “Homeoviscous-Longevity” theory of aging [35] and formalised
within the “Membrane Pacemaker Theory Of Aging” by Hulbert in 2005 [13]. This
theory proposes that membrane composition and susceptibility to peroxidation is a key
component of aging, but work in this area has been primarily based on fatty acid
composition rather than phospholipid class or composition of molecular phospholipids.
In recent years, advances in mass spectrometry have opened up new avenues of
investigation into membrane phospholipid composition and longevity, but use of such
technology has been limited to a small number of studies [40-42].

1.2

Thesis outline

Over 84 000 research articles have been published on the topic of peroxidation, with
50% of these published in the last decade (Web of Science). Many of these articles have
focused on the chemistry of peroxidation and its complex product formation (reviewed
in [4, 10, 43]), while others have focused on the presence of these products across a
range of pathologies (reviewed in [3]). This thesis builds on this extensive body of work
by examining the importance of phospholipid composition to peroxidation in three
studies.
The first study was an analysis of all published in vivo dietary interventions that
examined the influence of dietary PUFA on the fatty acid composition of cardiolipin
3
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and other mitochondrial phospholipids. The results of these feeding trials are discussed
in terms of recent reports of cardiolipin’s role in ATP production and apoptosis in an
attempt to understand the physiological relevance of changes in membrane composition.
This work is presented in Chapter Three.
The second study examined in vitro iron-mediated peroxidation in liposomes of
known membrane composition. This work investigated if phospholipid properties other
than PUFA content influenced peroxidation. Chapter Four examined the influence of
phospholipid head group on peroxidation independently of fatty acid content, and if the
cardiolipin class of phospholipids is particularly susceptible to peroxidation compared
to other phospholipid classes. This study used purified synthetic phospholipids to
investigate the importance of phospholipid class to peroxidation independently of
phospholipid associations with proteins, lipophilic antioxidants, and other membrane
molecules that may influence peroxidation. In Chapter Five multiple measures of
peroxidation were used to determine whether phospholipids containing only SFA and
MUFA influence the onset of peroxidation by exerting an antioxidant-like effect. Such
phospholipids are generally not thought to influence peroxidation, but are very common
in membranes and have been suggested to delay the onset of peroxidation [16].
In the third study, a comparison of membrane composition of three mammal
species with very different maximal lifespans (MLS) was conducted. The animal
species examined were mice (Mus musculus, MLS of 4 years), pigs (Sus scrofa, MLs of
27 years) and humans (Homo sapiens, MLS of 122 years). Mice and pigs have typical
lifespans for their body masses, but humans are exceptionally long-lived in comparison
to other mammals with similar body masses (AnAge Database [44]). The reason for this
longevity may be related to human membrane composition, but relatively little data for
humans is available in the literature. Shotgun lipidomics was used to determine the
molecular phospholipid composition of membranes from skeletal muscle, liver and
brain. In Chapter Six, the differences in the membrane composition and susceptibility to
peroxidation of mitochondria were compared between the three species. Chapter Seven
continued this examination by testing the suggestion by Hulbert (2010) [45] that
humans have a unique ability to decrease the susceptibility of their mitochondrial
membranes peroxidation when compared to other cellular membranes. It was suggested
that such an ability may prevent oxidative stress and therefore extend longevity. A
major strength of these chapters was the use of human tissues, which is rarely included
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in comparative studies. In addition, the use of shotgun lipidomics allowed a more
detailed lipidomics analysis of membranes than previously possible.
The outline of this thesis is presented in Figure 1.1. Due to the different methods
used in each study, separate introduction and method sections are provided for each
chapter. A combined Bibliography is provided for all chapters.

Chapter One: Preamble
Chapter Two: General literature review

Study one: Dietary PUFA and cardiolipin composition
Chapter Three: Dietary docosahexaenoic acid incorporates
into cardiolipin at the expense of linoleic acid: a review of
published datasets

Study two: In vitro phospholipid peroxidation
Chapter Four: Examining the influence of phospholipid
class on phospholipid susceptibility to peroxidation
Chapter Five: An antioxidant-like action for nonperoxidisable phospholipids using ferrous iron as a
peroxidation initiator

Study three: Peroxidation and its role in aging
Chapter Six: A lipidomics analysis of mitochondrial
phospholipids from mammals with very different maximal
lifespans
Chapter Seven: Is human longevity due to a unique ability
to limit the peroxidation of mitochondrial membranes?

Chapter Eight: Conclusions and outlook

Figure 1.1. Thesis outline.
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1.3

Aims and research questions

The overall aim of this thesis was to investigate the relationship between membrane
composition and peroxidation with relevance to the aging process. The specific research
questions addressed in this thesis are:
 How do dietary MUFA and PUFA influence the fatty acid composition of
cardiolipin and other major classes of mitochondrial phospholipids in
mammals?
 Do

cardiolipin

and

other

phospholipid

classes

affect

peroxidation

independently of PUFA composition?
 Do phospholipids composed of only SFA or MUFA influence the rates and lag
phase of peroxidation of phospholipids containing PUFA through an
antioxidant-like action?
 Are mitochondrial phospholipids less susceptible to peroxidation in humans
than in mice or pigs?
 Are human mitochondria less susceptible to peroxidation than other human
cellular membranes?
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Chapter Two
General literature review

2.1

Overview

This chapter provides an overarching review of the literature relevant to this thesis.
More specific literature reviews are provided within the introduction sections of each
chapter. This chapter includes a discussion of cellular membranes and the role of
phospholipids (2.2), phospholipid structure and regulation in membranes (2.3), the
mechanisms and measurement of peroxidation of membrane lipids (2.4), the association
between membrane composition and aging (2.5), and a brief conclusion (2.6).

2.2

Cellular membranes

Cellular membranes are ubiquitous structures in cells that are thin (6–8 nm),
semi-permeable structures that define cell boundaries. Numerous interactions take place
within and across cell membranes including the movement of molecules during
signalling and transport, the formation of enzymes complexes to localise enzymatic
reactions, and a great many anabolic and catabolic processes [46, 47]. In addition to the
plasma membranes that define a cell’s boundary, eukaryotes also have membranebound organelles that increase metabolic efficiency by compartmentalizing catabolic
and anabolic functions [48]. Cellular membranes are complex structures composed of a
diverse mixture of lipids, proteins, and carbohydrates, and this composition may differ
between species, between tissues within a species, and even between organelles within a
cell [17, 49-51]. The current model used to describe the interactions of the components
in membranes is a modified form of the “Fluid-Mosaic Model” originally proposed by
Singer and Nicolson in 1972 [49]. In this model, phospholipids form a
thermodynamically stable, fluid and semi-permeable bilayer to which membrane
proteins are associated by strong hydrophobic interactions (integral proteins), weaker
hydrophilic bonds (peripheral proteins) [49], or through interactions that do not interfere
with the intrinsic structure of cell membranes (membrane-associated proteins) [52]
(Figure 2.1). The “Fluid-Mosaic Model” has been reviewed many times, and recent
work in the area [46, 47, 53] supports the original “Fluid-Mosaic Model” with the
7
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amendments that phospholipids are not organised randomly but rather as curved micro
domains of varying fluidity including relatively viscous ‘rafts’ [54], that proteins are far
more common within the bilayer than suggested in the original work [47, 53], and that
these proteins may form aggregates with restricted lateral mobility [46].

-

Figure 2.1. Diagram of protein interactions with the phospholipid bilayer. Proteins are in red;
phospholipids in the bilayer are blue. Based on Goni et al. 2014 [47].

The phospholipid bilayer is a fundamental component of the cell membrane, and
the phospholipids that comprise this bilayer account for 15–45% of the weight of
biological membranes, with the remaining weight primarily proteins [17, 51]. As the
average phospholipid molecule is much lighter than the average protein molecule, it has
been estimated that cellular membranes contain 10–100 phospholipids per protein,
making phospholipids the most numerous component of cellular membranes [50, 55]. In
comparison to phospholipids, other lipid components of membranes such as
sphingolipids, glycolipids and cholesterols are far less abundant [17]. In addition to
forming the bilayer structure, phospholipids also have important roles in membranes as
allosteric effectors of proteins [25, 56-58], substrates for enzymes during signalling
cascades [8, 59-63], and in influencing key membrane properties including curvature
[20], fluidity [64], and susceptibility to peroxidation [5, 22]. The peroxidation of
phospholipids may disrupt the bilayer structure and permeability [65, 66] and damage
membrane proteins [4, 5, 12], and the relative susceptibility of membrane phospholipids
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to peroxidation is the focus of this thesis. This susceptibility is primarily determined by
phospholipid fatty composition.

2.3

Phospholipids

2.3.1 Phospholipid structure
Phospholipids, which include all glycerophospholipids and some sphingosines, are
composed of a polar head group joined by a phosphodiester linkage to a hydrophobic
moiety. Due to this structure, phospholipids are amphipathic and self-orientate in
aqueous media with head groups towards the aqueous plane and hydrophobic moieties
away from the aqueous plane. This orientation forms a stable micelle or bilayer.
Glycerophospholipids are composed of a head group joined by a phosphodiester link to
the sn-3 position of a glycerol backbone and acyl chains at the sn-1 and sn-2 positions
of the glycerol. An example of a common glycerol phospholipid is shown in Figure 2.2.
In comparison, sphingomyelin phospholipids have a hydrophilic head group joined to a
sphingosine backbone by a phosphodiester, and a single fatty acid joined to the
backbone. As glycerophospholipids are the most common component of cell
membranes and are the primary substrate of peroxidation, the subsequent use of
‘phospholipids’ in this thesis will refer to glycerolphospholipids only.

Figure 2.2. A typical mammalian phospholipid composed of a glycerol backbone with a
phosphate-linked head group at the sn-3 position and hydrophobic acyl chains at the sn-1 and
sn-2 positions.
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2.3.2 Head groups
Phospholipids are classified according to the structure of the phosphate-ester head group
present at the sn-3 position of the glycerol backbone. The structure of these phosphateester head groups determine the ionization constants, net charges, and relative shape of
phospholipids [24]. The seven classes of glycerophospholipid that have been identified
in

mammals

are

phosphatidylserine

phosphatidylcholine
(PS),

(PC),

phosphatidylglycerol

phosphatidylethanolamine
(PG),

phosphatidic

acid

(PE),
(PA),

phosphatidylinositol (PI), and di-phosphatidylglycerol which is more commonly known
as cardiolipin (CL). The structures of these seven head groups are presented in Figure
2.3.

Figure 2.3. Structure of glycerophospholipid head groups.
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2.3.3 Types of bonds between the glycerol and fatty acids
The sn-2 position of a phospholipid glycerol is typically occupied by an ester-linked
fatty acid, but the sn-1 position of the glycerol may be unoccupied, making a
lyso-phospholipid, or occupied by an ester-linked acyl chain, a vinyl ether-linked acyl
chain (commonly termed a plasmalogen), or an alkyl ether [67]. The structures of these
three bonding motifs are shown in Figure 2.4. The purpose of these different types of
fatty acid bonding motifs is unclear, but plasmalogen deficiencies have been reported in
a number of developmental disorders [68], and it has been suggested that plasmalogens
and alkyl ethers are important in membrane fusion events and as sacrificial molecules
that prevent the propagation of peroxidation [67-69].

Figure 2.4. The structure of ester, alkyl ether and plasmalogen bonding motifs at the sn-1
position of a phospholipid’s glycerol backbone. Differences in structures are highlighted in red.

2.3.4 Fatty acids
Fatty acids are long-chain carboxylic acids. Mammalian fatty acids are grouped into
three structural categories based on the number of carbon-carbon bonds present [70].
The categories are: saturated fatty acids (SFA) that contain no double bonds,
monounsaturated fatty acids (MUFA) that contain a single double bond, and
polyunsaturated fatty acids (PUFA) that contain two or more double bonds. These
double bonds are predominately in the cis (Z) configuration in mammalian tissues [71].
11
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Isomers of MUFA and PUFA can be further classified by the position of the first double
bond between carbons from the methyl end of the fatty acid chains [70]. This is termed
the ‘n’ or omega position. Most MUFA are n-9 in structure, with the double bond
beginning at the 9th carbon in from the methyl end of the acyl chain, while some are n-7
with the double bond beginning at the 7th carbon from the methyl end of the acyl chain.
PUFA are most commonly n-6 or n-3, with the notable exception of mead acid which is
an n-9 PUFA. Fatty acids can be abbreviated using the omega abbreviation system
proposed by Holman (1964) [72] as the number of carbons: number of double bonds
and the position of the ‘n’ double bond. The structures of 18-carbon long SFA, n-9
MUFA, n-6 PUFA and n-3 PUFA are presented in Figure 2.5. Examples of the names,
structures, and abbreviations of common mammalian fatty acids are listed in Table 2.1.

Figure 2.5. Structure of a saturated fatty acid (SFA), an omega-9 monounsaturated (n-9 MUFA),
an omega-3 polyunsaturated fatty acid (n-3 PUFA) and an omega-6 polyunsaturated fatty acid
(n-6 PUFA). All fatty acids shown are 18 carbons long.
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Table 2.1. Common mammalian fatty acids
Trivial names

Systematic name

Carbons:
Double bonds

Class

Saturated
Myristic acid
Palmitic acid
Stearic acid

Tetradecanoic acid
Hexadecanoic acid
Octadecanoic acid

14:0
16:0
18:0

–
–
–

Monounsaturated
Vaccenic acid
Oleic acid

11–Octadecenoic acid
9–Octadecenoic acid

18:1
18:1

n-7
n-9

Polyunsaturated
Linoleic acid
α–Linolenic acid
Arachidonic acid
Clupanodonic acid
Cervonic acid

9,12–Octadecadienoic acid
9,12,15–Octadecatrienoic acid
5,8,11,14–Eicosatetraenoic acid
7,10,13,16,19–Docosapentaenoic acid
4,7,10,13,16,19–Docosahexaenoic acid

18:2
18:3
20:4
22:5
22:6

n-6
n-3
n-6
n-3
n-3

The introduction of a double bond into a fatty acid can affect a number of
phospholipid properties including melting point [64]. Phospholipid melting points
increase with fatty acid length but are decreased by the presence of double bonds, with
double bonds having the greatest effect when present in the middle of the chain [24, 64].
For example, lyso-PC 18:0 has a melting point of 55 ºC, lyso-PC 18:1n-6 has a melting
temperature of 10 ºC, and lyso-PC 18:1n-9 has a melting temperature of –20 ºC [64].
The presence of MUFA and PUFA in membranes may therefore greatly increases
membrane fluidity.
The number and position of double bonds in the fatty acid chain is also the
primary factor determining phospholipid susceptibility to hydrogen abstraction which
may initiate peroxidation [5, 22, 73]. A SFA has no double bonds between carbons and
can be considered to be a series of linked methylene groups with electrochemical
reduction potentials of 1.90 V at the C–H bonds. The introduction of a single double
bond produces a MUFA with two allylic methylene that have a C–H bond reduction
potential of 0.96 V, and the introduction of multiple double bonds on alternative
carbons produces a PUFA with bis-allylic methylene that have a reduction potential of
only 0.60 V [73]. As a consequence of their lower reduction potential, the hydrogen in
bis-allylic methylene groups are more likely to be abstracted than those in methylene or
allylic methylene [11]. Due to their structure, SFA contain only methylene groups,
MUFA contain two allylic methylene groups, and PUFA contain multiple allylic
methylene groups and at least one bis-allylic methylene group depending on the degree
13
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of polyunsaturation. For example, 18:2n-6 contains only one bis-allylic methylene while
18:3n-3 contains two, 20:4n-6 contains four, and 22:6n-3 contains five. Examples of a
methylene group, allylic methylene group, and bis-allylic methylene group are
illustrated in Figure 2.6.

Figure 2.6. Structure of methylene, allylic methylene, and bis-allylic methylene groups. Red
circles highlight the relevant methylene.

2.3.5 Nomenclature
Phospholipids have complex systematic names, and a number of ways to abbreviate
these names have been proposed. This thesis follows the nomenclature for phospholipid
abbreviation established by Liebish et al in 2013 [74]. Using this nomenclature,
phospholipids are identified by abbreviation of phospholipid class (e.g. PC) and the
number of carbon: number of double bonds of fatty acids present (e.g. 16:0, 22:6). Fatty
acids are separated by a “/” when sn-position is known (sn-1/sn-2) or a “_” when sn
position is not known (Lyso species can be indicated with either an “L” preceding the
class or with a 0:0 indicating the empty sn position. Bond types other than esters are
indicated with a “P” for plasmalogen or an “O” for alkyl ether in front of the fatty acid.
For example, lyso-phosphatidylcholine (LPC) composed of palmitic acid (16:0)
has a systematic name of 1–hexadecanoyl–sn–glycero-3–phosphocholine and is
abbreviated as LPC 16:0. Phosphatidylcholine (PC) containing a palmitic acid (16:0)
and an oleic acid (18:1) has the systematic name 1–hexadecanoyl–2–(9-octadecenoyl) –
sn–glycero–3–phosphocholine, and is abbreviated to PC 16:0_18:1 when sn position is
unknown or PC 16:0/18:1 if sn position has been confirmed. Phosphatidylethanolamine
(PE) with a plasmalogen-linked stearic acid (P–18:0) at the sn-1 position and a
docosahexaenoic acid (22:6n-3) at the sn-2 position has the systematic name
1–(1–octadecenyl)–2–(4,7,10,13,16,19–docosahexaenoyl)–sn-glycero–3–phosphorethanolamine and is abbreviated as PE P–18:0/22:6.
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2.3.6 Phospholipid composition influences membrane structure
The class and fatty acid composition of phospholipid properties may affect both their
position within a membrane and the shape of the membrane itself. Phospholipids with
head groups that are wider than their fatty acid moiety, such as lyso-phospholipids, have
large positive curvatures and tend to form micelles in the hexagonal I (HI) phase [75].
Phospholipids with head groups that are narrow relative to their fatty acid moiety, such
as non-lyso molecular species of PE, PS and CL , tend to form membranes in the cubic
phase (HII) [75]. Phospholipids with head groups that are slightly wider than their fatty
acid moiety, including non-lyso molecular species of PC, PG and PI, have small
negative curvatures and tend to form in the lamellar phase which corresponds to the
bilayer structure found in cell membranes. Figure 2.7 shows examples of phospholipids
in the HI, HII and lamellar phases. Within stable membranes, mixtures of phospholipids
are likely to be asymmetrically distributed based on class, with the anionic classes such
as PE and CL accumulating on the cytofacial leaflet while PC tends to accumulate in the
exofacial leaflet [24]. This distribution is greatly aided by flippase, floppase, and
scramblase activity [76]. Lipid-protein interactions are more likely to occur at the inner,
negatively charged membrane leaflet, and proteins associated with this leaflet contain
high levels of arginine and lysine [55, 77].

2.3.7 Composition and regulation of phospholipids in mammalian tissues
Although thousands of unique phospholipid structures are possible due to potential
combinations of head groups, bonding motifs and fatty acids, mammalian membranes
generally contain only a few hundred different molecular species of phospholipid. The
composition of these molecular phospholipids may differ between species and tissues
[17, 64], and even organelles within cells [17, 78]. The most common classes of
phospholipids in mammal membranes are PC and PE, and together these two classes
typically account for 60–90% of total phospholipids. CL is unusual amongst the
phospholipid classes in that it accounts for approximately 15% of mitochondrial
phospholipids but 1% or less phospholipids in other cell membranes [17]. The
remaining phospholipid classes of PS, PG, PA and PI are less abundant, with their
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Figure 2.7. Influence of phospholipid structures on membrane structural phases.

distribution differing between membrane types. Plasmalogens and alkyl ethers are
distributed evenly across phospholipid classes, being most abundant in PC and PE of
brain, but are also found in a variety of other tissues [67]. PUFA are also unevenly
distributed across phospholipid classes, with phospholipids of CL commonly containing
multiple PUFA [79] while phospholipids containing more than one PUFA are rare in
other classes [18, 24, 80]. Less is known about the composition of individual
phospholipid species in mammal tissue, but PC 16:0_22:6, PE 18:0_22:6, and PS
18:0_22:6 have been found to be more common in smaller mammals than larger
mammals [18], and more common in short-lived mammals compared to long-lived
mammals [40]. In larger mammals, PC 16:0_18:1 and PE 18:0_18:2 are more common,
possibly serving as replacements for phospholipid containing 22:6n-3.
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The phospholipid composition of cellular membranes is regulated through
synthesis [64], selective transfer between organelles, remodelling, and degradation [81].
The endoplasmic reticulum (ER) is the primary site of PC, PE, and PS synthesis within
cells, mitochondria are the primary site of PG, PA, and CL synthesis and may also
synthesize PE, and peroxisomes are the primary site of plasmalogen production [17, 8285]. These phospholipids are subsequently transported between cellular membranes
where they may undergo remodelling of their acyl content. For example, while
mammalian cells normally produce only four acyl combinations (16:0/18:1, 16:0/18:2,
16:0/22:6 and 18:1/18:2) of PC and PE de novo, a variety of other molecular species of
PC and PE are common suggesting that extensive acyl remodelling occurs [86]. This
remodelling appears to be more common in PE, as PC 16:0_18:1 and PC 16:0_18:2 are
dominant phospholipids in most mammal membranes and PC 16:0_22:6 is extremely
common in small mammals like mice [18].
Phospholipid remodelling occurs by the Land cycle, a series of deacylation and
reacylation reactions named after William E. Lands who conducted the seminal work in
this area [87]. Phospholipid deacylation is initiated by the hydrolysing of a fatty acid at
the sn-1 position for the phospholipase 1 (PLA1) family or at the sn-2 position by
member of the phospholipase 2 (PLA2) family [85]. Acyl transferases, such as those of
the

acylglycerophosphate

acyltransferase

(AGPAT)

and

membrane-bound

O-acyltransferases (MBOAT) families, may then selectively reacylate the free sn
position with a different fatty acid [85]. This selective reacylation can be influenced by
availability of fatty acids substrates, with the types and amount of PUFA of particular
importance in this respect. Unlike plants, mammals lack the desaturases required to
produce n-3 and n-6 PUFA de novo and so must acquire 18:2n-6, 18:3n-3 and other
PUFA from the diet [88]. In the absence of sufficient dietary PUFA, 18:1n-9 will be
converted to mead acid (20:3n-9) in what may be an attempt by the organism to
overcome this deficiency through alternate pathways [72]. This response is insufficient
in the long term as animals that are not fed sufficient dietary PUFA die at an earlier age
than controls [89]. In the presence of sufficient dietary n-3 and n-6 PUFA, the
percentage of total dietary PUFA does not affect membrane composition but the ratio of
n-3 PUFA to n-6 PUFA does as both are substrates for acyltransferases [28, 90, 91].
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Peroxidation: The oxidation of lipids

2.4.1 Background
The term peroxidation refers to the oxidative modification of biological molecules to
form peroxides, with lipids being the most common substrate for this reaction.
Peroxidation was first observed in 1791 by the Swiss scientist Senebier who observed
that the prolonged exposure of olive oil to air caused the oil to turn rancid [92]. This
was followed by numerous investigations into the effect of peroxidation on food taste
and stability (reviewed in Hammond (2011) [93]), including the finding in 1911 by the
Swedish scientist Thunberg who reported that this process was catalysed by iron salts
[94]. Despite this early work, the chemical mechanisms underlying peroxidation were
finally elucidated by workers at the British Rubber Producers’ Association in the 1940s
[11, 93]. In more recent years, interest into the roles of non-enzymatic and enzymatic
peroxidation in biology has greatly expanded.

2.4.2 Chemistry of peroxidation
Initiation, propagation, and termination
Peroxidation proceeds in a classical free radical chain reaction of initiation, propagation
and termination that is most commonly initiated by reactive oxygen species (ROS) [4, 5,
10, 11]. Initiation of peroxidation can occur through the addition of ROS to a lipid
methylene group (LH) (Equation 1) or the abstraction of a hydrogen from a LH by ROS
(Equation 2) [11]. The abstraction of hydrogen is more common than the addition of
ROS, but in either case a carbon radical (L●) is formed. This carbon radicals often
stabilises by re-arranging to form a conjugated diene radical, and this diene may react
with available oxygen to form a peroxyl radical (LOO●) (Equation 3). The LOO●
produced in this manner are sufficiently reactive to abstract hydrogen from another LH
to produce a lipid hydroperoxide (LOOH) and a second L●, propagating the
peroxidation reaction (Equations 4). The structures and progression of peroxidation are
illustrated in Figure 2.8.
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LH + OH● → LHOH● (alternatively written L●)

Equation 1

LH + R● → L● + RH

Equation 2

L● + O2 → LOO●

Equation 3

LOO● + LH → LOOH + L●

Equation 4

Termination of peroxidation may occur when two conjugated diene radicals cross-link
(Equation 5), two lipid peroxide radicals react (Equation 6), or a conjugated diene
radical or lipid peroxide radical reacts with an antioxidant (Equation 7).
L● + L● → L–L

Equation 5

LOO●+ LOO● → LOO–LOO

Equation 6

L● or LOO● + antioxidant → non-radical products

Equation 7

Figure 2.8. Initiation and propagation of peroxidation by hydrogen abstraction. Based on Yin et
al. (2011) and Halliwell and Guetteridge (2007) [5, 11].
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Initiators and targets of peroxidation
The energy required for hydrogen abstraction – and therefore the likelihood of
abstraction occurring – is theoretically determined by difference in reduction potentials
of substrates and oxidizing agents. Theoretically, a molecule can oxidise any compound
with a lower standard reduction potential (V) [5, 11]. Table 2.2 shows standard
reduction potentials of common targets and causes of oxidation in biological systems
[73, 95]. As can be seen from the table, the bis-allylic methylene groups present in
PUFA have a lower reduction potential than SFA, MUFA, proteins or DNA and are
therefore more likely to undergo hydrogen abstraction. While numerous forms of ROS
initiator may be present in cellular environments, in vitro studies of peroxidation
generally use radical clocks such as 2,2'–azobis(2–amidinopropane)–dihydrochloride
(AAPH) to generate ROS at a constant rate to allow the kinetics of peroxidation to be
accurately determined [5, 96], or use iron and copper to initiate peroxidation through the
generation of peroxyl and alkoxyl radicals [11, 96].

Table 2.2. Initiators and substrates of peroxidation
Standard
reduction
potential (V)

Type

Couple

Initiators
Hydroxyl
Alkoxyl
Hydroperoxyl
Peroxyl

OH●, H+ /H2O
RO●, H+ /ROH
HOO●, H+ /H2O2
ROO●, H+ / ROOH

2.31
1.61
1.06
1.00

Targets
SFA
MUFA
PUFA
Protein (Cysteine)
DNA (Guanine)

Methylene●, H+ /methylene–H
Allylic methylene●, H+/ allylic methylene–H
Bis–allylic methylene●, H+/bis–allylic methylene–H
ROS●, H+ / ROS–H
Various product species/guanine

1.90
0.96
0.60
0.92
0.96

Antioxidants
α-Tocopherol (Vitamin E)
Ascorbate (Vitamin C)

TO●, H+/TOH
Ascorbate●, H+/ascorbate monoanion

0.50
0.28

Values are from [72].
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Role of iron and other transition metals
Iron and copper greatly increase the rate of peroxidation, a process most extensively
studied in ferrous (Fe2+) and ferric (Fe3+) iron [11, 97-100]. High concentrations of Fe2+
may react with O2 to form OH• via H2O2 production and decomposition (Equation 4–7)
or may react directly with H2O2 to produce OH● through the Fenton reaction (Equation
6–7).
Fe2+ + O2 ↔ Fe3+ + O2●–

Equation 4

2O2●– + 2H+ → H2O2

Equation 5

Fe2+ + H2O2→ Fe3+ + OH– + OH●
3+

2+

Equation 6

+

Fe + H2O2→ Fe HO2● + H

Equation 7

Although OH● produced in this manner may initiate peroxidation, the presence of
H2O2–scavenging proteins inhibits OH● production but not peroxidation, suggesting that
peroxidation is being initiation by ROS other than OH●. Such ROS may be produced
when Fe2+ and Fe3+ decompose LOOH in a similar way as described for H2O2, with Fe2+
reacting with LOOH to produce LOO● (Equation 8) and Fe3+ reacting with LOOH to
produce alkoxyl radicals (LO•) (Equation 9) [99].
Fe3+ + LOOH → Fe2+ + LOO● + H+

Equation 8

Fe2+ + LOOH → Fe3+ + OH– + LO●

Equation 9

The LOO● and LO● radicals produced during this reaction are sufficiently reactive to
abstract a hydrogen from a second bis-allylic methylene group, therefore initiating and
propagating peroxidation (Equation 1). As Fe2+ and Fe3+ cannot abstract hydrogen
directly, some LOOH must already be present in the lipid for mediation to occur
through LOO● and LO● production. This is normally not a limitation for in vitro
experiments as LOOH is commonly formed during purification, sonication and
exposure to oxygen [101]. An added complexity of iron-mediated peroxidation is that
Fe2+ and Fe3+ can also scavenge radicals under some conditions, terminating
peroxidation (Equations 10–11).

21

2.4 Peroxidation: The oxidation of lipids

Fe2+ + LO● + H+ → Fe3+ + LOH
3+

+

Equation 10

2+

Fe + LOO● + H → Fe + LOOH

Equation 11

A similar mechanism for redox cycling during peroxide decomposition has been
reported for copper [11]. Although the chemistry of initiating peroxidation with iron and
copper is complex [11, 96, 99, 101-103], poorly liganded iron is likely to be a major
cause of peroxidation within cells [104, 105].

2.4.3 Products of peroxidation
It has been estimated that 120–150 different forms of lipid hydroperoxides may be
produced in natural membranes during peroxidation [2], and the decomposition of these
hydroperoxides produces a wide range of highly unstable secondary products including
alkanes, aldehydes, ketones, alcohols and furanes [4]. This variety of products is due to
the diversity off bis-allylic methylene groups position in PUFA, whether peroxidation
occurs at one or multiple bis-allylic methylene groups, and whether cyclization or crossliking occurs. In addition, the products of peroxidation may be produced in racemic
mixtures [5]. Many of these products are highly volatile and can form adducts with
proteins [106] and DNA [42, 107], with aldehydes being particularly reactive in this
regard [4, 106]. Common examples of lipid peroxidation products include
malondialdehyde (MDA) formed from PUFA with three or more double bonds, 4–oxy–
2(E)–nonenal (ONE) produced from the decomposition of 18:2, 4–hydroxy–2(E)–
nonenal (HNE) produced from the peroxidation of n-6 fatty acids, and 4–hydroxy–
2(E)–hexenal (HHE) produced from the peroxidation of n-3 fatty acids [4]. The mixture
of these products is therefore largely determined by the distribution of PUFA present in
membrane phospholipids.

2.4.4 Phases of peroxidation
Peroxidation typically occurs in discrete phases of lag, propagation, and termination
[96]. The phases and possible measures of peroxidation are presented in Figure 2.9.
Following initiation, peroxidation enters a lag phase with a low rate of peroxidation
(RLag). This phase is measured as a period of time (TLag) between the start of
peroxidation and the beginning of the propagation phase. The amount of peroxidative
product produced by the end of this phase is termed the (ALag). The TLag can be
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lengthened and the the ALag increased by antioxidant defences that prevent the build-up
of high levels of ROS. From a biological perspective, the TLag is important as it
represents a window of opportunity for cells to prevent entry into the potentially more
damaging propagation phase. The duration of TLag is therefore considered to be a
measure of the antioxidant status of membranes [108].
The propagation phase begins when the lag phase ends. The peroxidation phase is
when the maximal rate of peroxidation (RMax) occurs. Propagation is likely to be the
most damaging phase of peroxidation, and the RMax of lipids has been studied in both
solvents and liposomes [5, 21, 22, 109, 110]. The RMax increases with the number of
bis-allylic methylene present in PUFA, and this relationship has been reported being
exponential in some studies [21, 109] but linear in others [5, 22, 110]. The termination
phase of peroxidation occurs as the RMax ebbs due to substrate exhaustion, radical
crosslinking, or antioxidant quenching. The time at which this occurs is termed the TMax,
and the maximal amount of peroxidation product that has been produced by this point is
termed the AMax.

Figure 2.9. The progression of peroxidation during the lag, propagation and termination phases.
Measures of peroxidation in each phase are highlighted in red. Based on Pinchuk and
Lichtenberg, 2014 [96].
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2.4.5 Measuring peroxidation
Lipid peroxidation produces conjugated dienes, consumes oxygen and PUFA, forms
lipid hydroperoxides (LOOH), and produces numerous secondary products from LOOH
decomposition. As a result, there are many ways of measuring peroxidation including
substrate loss and product formation [11]. The earliest and simplest method used to
measure peroxidation was to simply expose lipids to oxygen and measure the
subsequent changes in lipid mass over time [94, 111]. Alternatively, the production of
conjugated dienes, LOOH, and MDA can be used to measure peroxidation with various
simple assays and absorbance spectrophotometry [111]. More complex techniques of
measuring peroxidation include determining the loss of PUFA or production of
secondary products measured with gas chromatography (GC), high performance liquid
chromatography (HPLC), mass spectrometry, nuclear magnetic resonance spectroscopy
(NMR), or a combination of these techniques [4, 10]. Much of the literature in this area
has focused on the secondary products of peroxidation in in vivo samples, but in vitro
studies also use more direct and continuous measures of peroxidation. In this thesis,
peroxidation was measured using oxygen consumption and LOOH production.
Oxygen consumption was used as a measure of the reaction of conjugated diene
radicals with oxygen to form a peroxyl radical. This reaction is an early and
fundamental component of the peroxidation reaction. The consumption of oxygen
during the formation of peroxyl radical can be measured using Clark-type oxygen
electrodes [112]. Clark-type electrodes have been used in a large number of
peroxidation studies including recent studies (e.g. [23, 30]). Modern Clark-type
electrodes are extremely sensitive and can detect changes of as little as 500 nmol of
oxygen per 0.5 seconds and produce results that are less variable than most measures of
conjugated diene formation [111]. The continuous nature of oxygen consumption also
has the added advantage of accurately measuring the different phases of peroxidation
and measures within these phases.
The production of LOOH was also used to measure peroxidation in this thesis.
This choice was based on LOOH being a primary product of peroxidation and a
relatively stable molecule in comparison to other products of peroxidation [113]. LOOH
production was measured using the ferrous oxidation-xylenol orange (FOX) method
proposed by Wolff in 1994 [114] and recently updated to the FOX-2 assay by Bou et al.
[113]. The FOX-2 method is considered an improvement on the earlier iodometric assay
in terms of both sensitivity and reproducibility [111]. The FOX-2 method is based on
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the oxidation of Fe2+ to Fe3+ by reaction with hydroperoxides formed during
peroxidation under acid conditions (Equations 12–13). The subsequent reaction of Fe3+
with xylenol orange dye forms a chromophore complex that absorbs in the 540–600 nm
range.
ROOH + Fe2+ → Fe3+ + LO• + OH–

Equation 12

Fe3+ + XO → Fe–XO

Equation 13

The FOX-2 assay measures LOOH regardless of molecule. This is an advantage over
the commonly used thiobarbituric acid reactive substances (TBARS) for MDA, as
MDA does not form from the peroxidation of 18:2n-6. This limitation of the TBARS
method is of particular relevance to the current thesis as 18:2n-6 was the primary PUFA
examined in the peroxidation assays in this thesis.

2.4.6 Peroxidation in biological systems
The chemistry of peroxidation is well understood under controlled conditions, but
conditions of in vivo peroxidation are far more complex and varied [11]. For example,
although the initiation of peroxidation is theoretically determined by thermodynamic
parameters, radicals must also be stable enough to reach a suitable target within the
hydrophobic region of the cell membrane, a requirement that may rule out the most
volatile or hydrophobic radicals [11]. Biological systems also have added complexity in
terms of phospholipid compositions, pH conditions, concentrations of reactants,
antioxidants, and the presence of poorly liganded iron present in haemoproteins such as
complexes II, III and IV of the ETC as well as ferritin, the iron storage protein [105].
These conditions may even vary between organelles within a cell, with mitochondrial
membranes particularly likely to undergo peroxidation as complexes I and III of the
ETC are the main sources of cellular ROS production [14, 36]. To add to this
complexity, organisms have evolved many strategies to use, repair or prevent
peroxidation. Examples of this include the small number of products formed by
enzymatic peroxidation involved in cell signalling activities including modulating
inflammation and apoptosis [6-8], and the repair of peroxidation damage by turnover of
10% of membrane phospholipids over per hour [115]. Adaptations thought to prevent
peroxidation include limiting the availability of iron and other catalysts within cells
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[105], the formation of supercomplexes of potential enzymatic sources of ROS together
in the ETC to limit electron leak, and production of antioxidants [11]. Substrate
availability is also tightly controlled. For example, although the pO2 of air is 21.1%, the
pO2 of human brain, liver and muscle is below 5% [116]. The percentage of PUFA in
cell membranes can also be limited, with the membranes of longer-lived species
generally having a lower degree of unsaturation than shorter-lived species [13]. Despite
these adaptations, peroxidation is still considered a major cause of damage in cells and
has been identified as a possible cause of aging.

2.5

The biological context of peroxidation: Focus on aging

2.5.1 Background
“The reasons for some animals being long-lived and others short-lived and, in a word,
causes of the length and brevity of life call for investigation.”
Aristotle, On Longevity and Shortness of Life, paragraph 1 [1].
How aging occurs – and whether aging can be prevented – has long been of interest to
the scientific community and the general public alike. Due to its universal nature, aging
was identified as an important aspect of biology by the very earliest scientists. The
seminal mechanism of aging was proposed by Aristotle, who wrote that aging was
caused by the damaging “fires of respiration” (and possibly also the soul). Aristotle
based this theory on observations that larger mammals generally have longer lifespans
than smaller mammals, but realised that this trend has many exceptions as “a superior
immunity from decay attaches neither to the largest animals (the horse has shorter life
than man) nor to those that are small” [1]. Modern science has a greater wealth of data
to draw on than was available to Aristotle, and this data supports the early observations
that lifespan shows an association with body mass, but with many exceptions including
humans (Figure 2.10). More recent investigations of aging have replaced Aristotle’s
“fires of respiration” with multiple mechanistic and evolutionary theories of how aging
progresses (reviewed in [117, 118]), yet the causes of aging still remain largely
unresolved.
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Figure 2.10. The association between mammalian longevity and body mass (n=1124). Data
shown is from the AnAge Database.

Aging has been characterised as a universal and progressive accumulation of
deleterious changes that lead to a loss of homeostasis and an increased likelihood of
death [118-120]. One of the leading mechanistic theories of aging that fits this
definition is the “Free Radical Theory of Aging”, which was first proposed by Harman
in 1956 [121]. This theory, which is also known as the “Oxidative Stress Theory of
Aging”, is based on findings that ROS produced during aerobic metabolism can be
mutagenic and toxic. This theory has been updated in recent years by Harman [32, 33]
and other researchers [9, 12, 14, 36, 122, 123], but is also debated by some scientists on
the basis that oxidative damage is not always detrimental to lifespan and is only one
possible form of damage to cells [124-126]. The arguments against the “Free Radical
Theory” often based on comparisons of wild-type and mutant animals within a species
[124-126] while much of the support for this theory has come from comparative animal
studies that have examined aging-related properties across a range of mammals
(reviewed in [12, 14, 127]). This approach, which was first used by Aristotle and his
colleagues, is based on the key finding that longevity may differ more within a class
than within a species. For example, the maximal lifespans (MLS) of mammals varies
100–fold between the short mammal lifespan of the shrew (Myosorex varius, MLS of
2.2) and the long life of the bowhead whale (Balaena mysticetus, estimated MLS of 211
years) (AnAge Database), but concerted efforts by the Methuselah Foundation
(www.mfoundation.org) and other researchers have yet to extend the MLS of mice (Mus
musculus) by more than 2–fold. Somewhat surprisingly, comparative studies of animal
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sspecies have found only two cellular properties to be strongly related to aging: 1) the
mitochondrial production of ROS and 2) the degree of membrane unsaturation [12, 14].
These two factors are related as ROS is both an initiator and product of the peroxidation
of unsaturated fatty acids [5], supporting suggestions that the peroxidation of membrane
phospholipids is a key component in the process of aging

2.5.2 The “Membrane Pacemaker Theory Of Aging.”
In 1978, Gudbjarbason et al. [128] reported a positive correlation between the 22:6n-3
content of membranes and the heart rate of mammals ranging in size from mice to
whales. This was one of the earliest findings linking membrane composition with body
mass and metabolism, and suggested that membrane composition differs greatly
between animals. Couture and Hulbert (1995) continued this work with a report that
MUFA and PUFA contents of mammalian membranes vary with body mass [129]. The
muscle, kidney, and liver of larger mammals were found to contain a higher percentage
of 18:1n-9 and a lower percentage of 22:6n-3 than smaller animals. In contrast to these
tissues, brain was found to contain high levels of 22:6n-3 in animals of all sizes which
may reflect the importance is of 22:6n-3 to neural development and function [130].As
larger mammals tend to live longer than shorter mammals, later work in this area found
a similar relationship between membrane composition and longevity in liver
mitochondria [12, 35, 131, 132]. Based on this work, it was proposed that the lower
percent of PUFA and higher percent of MUFA seen in long-lived mammals than
shorter-living mammals leads to a decrease in membrane susceptibility to peroxidation
while maintaining membrane fluidity in what is termed a homeoviscous-longevity
adaptation [35, 131]. The relationship between membrane composition and aging
caused by lipid peroxidation was formalised by Hulbert as the “Membrane Pacemaker
Theory Of Aging” in 2005 [13].
This theory includes the mechanistic aspects of the “Oxidative Stress Theory Of
Aging” and is influenced by both the homeoviscous-longevity adaptation and the
“Membrane Pacemaker Theory Of Metabolism” [12], and focusses on phospholipid
composition and peroxidation as key determinants of oxidative damage. The key
mechanistic aspects of this theory are based on the self-propagating nature of
peroxidation (described in section 2.4.2), the damage caused by the highly volatile
products of peroxidation (described in section 2.4.3) and the close relationship between
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the membrane-bound enzymes that produce ROS and membrane phospholipids
(described in sections 2.1 and 2.4.6). In order to establish a relationship between
membrane composition and longevity, the “Membrane Pacemaker Theory Of Aging”
and related work commonly distil the peroxidative capacity of complex membranes
down to a simple theoretical measure of relative vulnerability to peroxidation.

2.5.3 Comparing membrane vulnerability to peroxidation
A number of ways to measure the relative susceptibility of membranes to peroxidation
have been proposed by researchers in this area. The earliest measure used to calculate
membrane susceptibility to peroxidation from membrane fatty acid composition was the
number of unsaturated fatty acids (UFA) per 100 fatty acids. This calculation considers
all MUFA and PUFA as UFA regardless of the number of double bonds present, despite
MUFA being far less likely to undergo peroxidation than PUFA. As a result, the UFA is
not a useful measure of membrane susceptibility to peroxidation. An alternative
measure is the double bond index (DBI), also termed the unsaturation index (UI), which
is calculated as the number of double bonds per 100 fatty acids [35]. Although popular
with many researchers in this area, the DBI treats all double bonds as equally likely to
undergo peroxidation regardless of whether they result in allylic or bis-allylic methylene
groups [14, 45]. As a result, a membrane containing 100% 18:1n-9 with no bis-allylic
methylene groups would be given the same DBI value as a membrane containing 50%
18:2n-6 with many bis-allylic methylene groups and therefore a higher susceptibility to
peroxidation.
The “Membrane Pacemaker Theory Of Aging” combines membrane composition
with RMax values for fatty acids reported from experiments in chlorobenzene solution by
Holman (1954) [21] to give a peroxidation index per 100 fatty acids. These rates of
peroxidation increase exponentially with the number of bis-allylic methylene groups so
that 18:2n-6 has a normalised value of 1, 18:3n-3 has a value of 2, 20:4n-6 has a value
of 5 and 22:6n-3 has a value of 8. The peroxidation index of membranes is therefore
calculated as: (% MUFA x 0.025) + (% PUFA with 1 bis-allylic methylene group x 1) +
(% PUFA with 2 bis-allylic methylene groups x 2) + (% PUFA with 3 bis-allylic
methylene groups x 4) + (% PUFA with 4 bis-allylic methylene groups x 6) + (% PUFA
with 5 bis-allylic methylene groups x 8).
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The peroxidation index is widely used in comparative physiology, but the
exponential relationship between RMax and bis-allylic methylene groups reported by
Holman have been contested. Examinations of the peroxidation of fatty acids in
chlorobenzene solution and liposomes have found a linear relationship between
bis-allylic groups and RMax [5, 22, 110], although there is support for an exponential rate
from experiments in in vitro cell cultures [109]. Overall, the relationship between RMax
is widely considered to be linear in relation to bis-allylic methylene groups in
contemporary chemistry. In order to maintain continuity with published physiology
literature, however, the peroxidation index values determined by Holman (1954) [21]
are used in this thesis.

2.5.4 Recent evidence for the “Membrane Pacemaker Theory of Aging”
A strong inverse relationship has been found between peroxidation index and longevity
of mammals and other classes of animals [29, 127]. This relationship is best
characterised for mammals, but relationships have also been found for birds [12],
molluscs [37], bees [38], and strains of the nematode Caenorhabditis elegans [39]. The
relationship between the peroxidation index of mammalian muscle and the maximal
lifespan (MLS) of mammal species is shown in Figure 2.11 using data published in
[29]. Although this is the most extensive dataset available, similar trends have been
found for mammalian liver mitochondria [12]. Recent work in this area generally
supports this relationship, with the membranes of skeletal muscle and liver
mitochondria from naked mole rats (MLS of 28 years) found to have a lower
peroxidation index than those from mice (MLS of 4 years) despite both animals having
a similar body mass [133]. This difference was primarily due to phospholipids
containing 22:6n-3 being less common in naked mole rat tissues than mouse tissues [40,
133]. A lower peroxidation index than predicted by body mass has also been reported
for the echidna (Tachyglossus aculeatu), which lives 3–4 times longer than predicted for
its mass, and the long-lived Ames mutant strain of mice (Mus musculus homozygosis
for Prop1 phenotype) [44, 134, 135]. However, not all recent data support the
“Membrane Pacemaker Theory Of Aging”. The hoary bat (Lasiurus cinereus) has a
predicted MLS of 4.5 years based on body mass and a reported MLS of 14 years, but
contains a high percentage of 22:6n-3 in its muscle membranes and has a higher
peroxidation index than predicted for a mammal of its lifespan [136]. Order Chiroptera
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(bats) generally live longer than predicted for their body mass, but there is insufficient
evidence available to determine if the entire order is an exception to the “Membrane
Pacemaker” theory, or if this exception is limited to the hoary bat alone [29].

Figure 2.11. Correlation of the peroxidation index of mammal muscle and longevity (n=60).
Data is from [29].

Relatively little is known regarding the peroxidation index of membrane phospholipids
in humans (Homo sapiens). Humans have a predicted MLS of ~25 years based on their
body mass (AnAge Database) but an actual MLS of 122 years [137]. This MLS is
extremely long for a mammal, and is only exceeded by estimates for the bowhead
whales. Although data on human membrane composition and peroxidation index is rare,
there is some evidence to suggest human liver membranes contain a low percentage of
PUFA [138, 139], and a recent comparison of mammalian plasma found humans had a
lower DBI, a lower peroxidation index, and a lower level of peroxidation products than
shorter lived mammals [42].
The link between membrane composition and peroxidation with longevity is best
described in mammals, but similar relationships have also been found in other classes of
animals. For birds, the membranes of long-lived petrels (order Procellariiformes) were
less susceptible to peroxidation than those of the of short-lived fowl (order Galliformes)
with comparable body masses [140]. Differences were not seen, however, in a
comparison of long-lived parrots (order Psittaciformes) to fowl with similar body
masses [141]. In invertebrates, membrane susceptibility to peroxidation was found to be
lower in queen bees (MLS of 8 years) than worker bees from the same hive (MLS of 7
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weeks) [38], lower in the Age–1 mutant strain of C. elegans, and lower in long-living
molluscs than shorter-living molluscs with similar body masses and environments [37].
The majority of evidence for the “Membrane Pacemaker Theory Of Aging” comes
from comparative animal studies, but some experimental interventions have been found
to decrease the degree of membrane polyunsaturation and extend lifespan. Calorie
restriction, which has been found to elongate lifespans in mice, rats and primates, has
also been shown to decrease the peroxidation index of rats by increasing membrane
MUFA content and decreasing membrane PUFA, particularly 22:6n-3 [29, 142-144]. In
a recent study by Gómez et al. (2014) [145], the lifelong treatment of mice with
atenolol, a β–blocker, was found to decrease the degree of polyunsaturation in cardiac
and skeletal muscle primarily by decreasing 22:6n-3 and increasing 18:1n-9. This study,
which was the first to examine the link between the peroxidation index and longevity
experimentally in mammals, found that atenolol prevented oxidative modifications to
proteins and decreased the loss of immune and behavioural functions related to aging,
but did not increase lifespan. The authors of the study attributed the lack of an increase
in lifespan to adverse side effects of atenolol itself that have been found to increase the
likelihood of cardiovascular failure in humans. Despite not increasing of animal
lifespan, this finding does provide support for the theory that a decrease in peroxidation
slows the aging process.

2.5.5 Measuring and comparing membrane phospholipid composition
The majority of past investigations into membrane composition and longevity have used
GC to compare relative percentages of fatty acids and peroxidation indexes between
membranes (e.g. [80, 90, 129, 134]). Some studies have used additional purification
steps with thin-layer chromatography (TLC) coupled with GC (e.g. [146-148]) or
HPLC/GC (e.g. [80, 149, 150]) to better understand how fatty acids are distributed
across classes, but these methods are relatively slow and labour intensive. More recent
work has used mass spectrometry to examine the percentage of phospholipid class and
molecular structure in membranes [18, 19, 40-42, 151], with some of the most detailed
membrane studies using shotgun lipidomics techniques [18, 19, 151].
Shotgun lipidomics was first proposed by Han and Gross (1994) [152] as a
method of direct infusion that “exploits the unique chemical and physical properties of
each lipid class to facilitate the high-throughput analysis of a cellular lipidome on a
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large scale directly from organic extracts of biological samples” [50]. This method uses
electrospray ionization and other “soft” ionization methods in which each lipid gives
rise to a single anion or cation depending on its molecular structure [153]. Using a triple
quadrupole mass spectrometer, lipids may then be subjected to collision-induced
dissociation to produce diagnostic fragmentation products, including for head group
class and acyl chain content from which the molecular structure of the lipid can be
deduced [50, 154]. Scan types used in such an analysis include product ion scans,
precursor ion scans, and neutral loss ion scans [153]. Shotgun lipidomics has the
advantage of requiring minimal sample preparation while having high sensitivity and
high throughput in comparison to TLC/GC or HPLC/GC methods [50, 153, 154]. In
addition, the data produced from shotgun lipidomics can be used to calculate total
membrane fatty acid composition to give comparable results as those for GC [18]. The
limitations of shotgun lipidomics include the potential for ion suppression and current
lack of precursor scans to differentiate plasmalogens from alkenyl ethers. Despite these
limitations, shotgun lipidomics is, an improvement on the use of GC and has the
potential to give new insights into the association between membrane composition,
peroxidation, and longevity.

2.6

Conclusion

The peroxidation of membrane phospholipids produces products that may cause cellular
damage and aging. The susceptibility of membrane phospholipids to peroxidation is
primarily determined by PUFA content, but other elements of phospholipid composition
may also influence peroxidation. Many questions remain unanswered regarding the
importance of phospholipid composition to peroxidation and aging. This dissertation
addresses some of these questions through the use of three different methodologies. In
Chapter Three, data is analysed to determine how dietary fatty acids influence the
composition of mitochondrial CL, PC and PE, and the outcomes of this incorporation in
terms of mitochondrial function and susceptibility to peroxidation. Chapter Four
presents an in vitro examination of whether phospholipid class influences peroxidation,
and Chapter Five investigates whether peroxidation is influenced by phospholipids that
do not contain PUFA. This is followed by an examination of mice, pigs and human
membranes using shotgun lipidomics that compares the mitochondrial membrane
between species in Chapter Six, and intra-species differences in mitochondrial and
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microsomal membranes from these animals in Chapter Seven. Chapter Eight provides
an overview of the results of these studies.
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Chapter Three
Dietary docosahexaenoic acid incorporates into cardiolipin at the
expense of linoleic acid: An analysis of published datasets

3.1

Overview

Cardiolipin (CL), the signature phospholipid of mitochondria, is commonly viewed as
having a highly regulated fatty acid content due to its high levels of linoleic acid
(18:2n-6). In contrast to this view, numerous published studies have shown that dietary
docosahexaenoic acid (22:6n-3) increases the percentage of 22:6n-3 present in CL
suggesting that the fatty acid content of CL conforms to diet. This chapter reviews all
previously published articles that examined the influence of dietary fatty acids on the
fatty acid composition of CL, and examines the possible outcomes of changes in the
fatty acid composition of CL in terms of mitochondrial function and susceptibility to
peroxidation. The incorporation of 22:6n-3 into two other mitochondrial phospholipid
classes, phosphatidylcholine and phosphatidylethanolamine, is also reviewed. This
chapter is closely based on the published work ‘Dietary docosahexaenoic acid (22:6)
incorporates into cardiolipin at the expense of linoleic acid (18:2): Analysis and
potential implications’ by Cortie CH and Else PL, International Journal of Molecular
Sciences, (2012). 13(11): p. 15447–15463. The structure of the present chapter differs
slightly from the published work to avoid repetition of material presented in Chapter
Two. CHC proposed the study, collected and analysed the data, and produced the
primary draft of the paper. PLE supervised all aspects of the work.

3.2

Introduction

Cardiolipin (CL) is the only prevalent di-phospholipid present in mammalian
membranes [155-158] and is found almost exclusively in the inner leaflet of the inner
mitochondrial membrane where it is synthesised [155]. CL has been called the signature
phospholipid of mitochondria [156] as it has important roles in binding the
mitochondrial proteins required for oxidative phosphorylation [25, 158] and initiating
mitochondrial-induced apoptosis by reacting with the haem present in cytochrome c
[156, 157, 159, 160]. These roles are related to CL’s unusual di-phospholipid structure
and fatty acid composition. CL possesses four fatty acids rather than the two fatty acids
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present in other phospholipid classes, and while the combination of two PUFAs on the
same phospholipid molecule is rare in other mammalian phospholipid classes [18, 161],
CL containing four linoleic acid (18:2n-6) is highly common in mammalian muscle and
other tissues [26]. Schlame et al. [26] reported that CL 18:2/18:2/18:2/18:2 comprises
80% of all CL in human heart, 70–77% in dog heart, 41–77% in rat heart and 50% in
bovine heart, while Han et al. [162] reported that this same species of CL comprises
42% of CL in rat heart and 52% in rat liver. Other groups have reported the 18:2n-6
content of CL in liver and brain as lower than 60%, meaning that this form of CL may
not be as common in some of these tissues [146, 147, 151]. CL 18:2/18:2/18:2/18:2 has
been found to have a closer association with the mitochondrial ADP/ATP carrier than
CL 16:0/16:0/16:0/16:0 [163], and to have a higher binding affinity for cytochrome c in
comparison to CL molecules with high levels of oleic (18:1n-9), stearic (18:0) and
palmitic acid (16:0) respectively [164].
Although a high 18:2n-6 content is potentially important in CL-protein
interactions, the exposure of CL to free reactive oxygen species (ROS) produced in the
mitochondria put the PUFA present in CL at high risk of oxidative damage [156]. The
peroxidation of CL may decrease its affinity for protein binding and disrupt the
structure of the inner mitochondrial membrane, and has been suggested to be an early
event in the apoptotic cascade [164-168] or even a trigger of apoptosis [159, 169].
Changes in the degree of unsaturation in CL’s PUFA content could therefore be
expected to affect both its interaction with proteins and susceptibility to peroxidation,
modifying its function in mitochondria. Such changes are thought to be unusual, as one
of the widely held beliefs about mammalian CL fatty acid composition is that it is
highly regulated, primarily due to its high levels of 18:2n-6 and the prevalence of a CL
18:2/18:2/18:2/18:2 in cardiac mitochondria, but also due to an apparent resistance to
dietary manipulation [26]. This review examines the evidence that, contrary to popular
belief, CL’s PUFA composition does conform to dietary fatty acid intake in some
circumstances, particularly when diets are rich in 22:6n-3

3.3

Changes in the fatty acid composition of cardiolipin due to diet

3.3.1 Dietary trials investigating cardiolipin in animal models
It has been known for some time that dietary fats affect phospholipid composition
[148], and CL seems to be no exception. The fatty acid composition of CL has been
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reported in numerous studies examining the effects of various dietary fatty acids on the
phospholipid composition of heart and liver mitochondria. Most (~75%) of these studies
have used rats [56, 146-149, 170-182] or mice [150, 183-186], and these studies supply
the raw data used in the present study. The primary focus of many of these studies has
been on n-3 and n-6 PUFA that, unlike SFA and MUFA, mammals cannot form de novo
from basic carbon sources [89]. The sources of dietary SFA, MUFA and PUFA used in
these studies were generally from sources commonly eaten by humans including fish,
linseed, corn, olive, rapeseed and soybean, although one study used crocodile oil [185]
(Table 3.1). The majority of the studies examined predate the use of mass spectrometry,
instead using combinations of thin layer chromatography (TLC) or high-performance
liquid chromatography (HPLC) together with gas chromatography (GC). One limitation
of these techniques (versus a lipidomics approach) is that they cannot readily determine
the abundance of specific phospholipid molecular species within each phospholipid
class. However, these studies did provide the total fatty acid composition of the CL
present in membranes,
The incorporation of dietary fatty acids was found to be a selective process in
these studies, and so this analysis did not include all fatty acids. Although some
researchers reported SFA in very low levels in CL, presumably due to the presence of
immature CL (discussed in section 3.4), SFA content was not examined in this review
as not all work reported SFAs shorter than 18:0. Linolenic acid (18:3n-3) was also not
examined as, although it is consumed at moderate levels in the diet [187], little if any
appears in most phospholipids [18] including CL [26], presumably due to its conversion
through to the longer chained omega-3 fats. Arachidonic acid (20:4n-6) was not
included in the present analysis due to limited data in this area but has been reported in
CL at levels ranging from 0–12% [148, 170, 184]. As eicosapentaenoic acid (EPA,
20:5n-3) can be converted to 22:6n-3, diets containing greater than 10% EPA or diets in
which 20:5n-3 levels exceeded those of 22:6n-3 were excluded to prevent confounding
effects. This review therefore focussed on the influence of dietary 18:1n-9, 18:2n-6 and
22:6n-3 on CL composition.
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Table 3.1 Details of species, sources of fat, measurement method used, and feeding
period of studies examined.
Source of fat

Method

Dietary fat
(w/w)

Feeding
period
(weeks)

Yamaoka et al., 1988 [147]

Corn oil, sardine oil

TLC, GC

20%

4

McGee et al., 1996 [146]

Not stated

TLC, GC

20%

4

Charnock et al., 1986 [148]

Sunflower oil, tuna,
vegetable oil

TLC, GC

4% or 16%

60

Astorg et al., 1991 [149]

Sunflower seed oil,
linseed oil

HPLC/GC

10%

20

Ikeda et al., 1996 [170]

Safflower oil, perilla
oil, palm oil, methyl
20:4
Soya-bean, rapeseed
Palm oil, olive oil,
sunflower oil, linseed
oil, menhaden oil

TLC/GC

10%

3

TLC, GC
HPLC, GC

20%
15%

5
4

Kramer, 1980 [173]

Corn oil, zephyr oil

TLC, GC

20%

16

Novak et al., 2006 [174]

Standard chow diet

TLC, GC

3.5%

9

Coconut oil, olive oil,
safflower oil,
menhaden oil
20:5 and 22:6
methylesters
Corn oil, sardine oil

TLC, GC

2% or 20%

10

TLC, GC

15%

2

TLC,
HPLC, GC

20%

2

Hoy and Holmer, 1990 [179]

Marine oil, olive oil,
sunflower seed oil

TLC, GC

20%

10

Charnock et al., 1984 [180]

Sunflower seed oil,
sheep kidney fat

TLC, GC

4%, 12%

20

Charnock et al., 1991 [181]

Sunflower, fish oil

TLC, GC

16%

44

Robblee and Clandinin, 1984 [182]

Beef tallow, soybean
oil

TLC, GC

7–23%

2

Lee et al., 2006 [188]

Soybean oil and meal,
fish meal, alfalfa meal,
corn meal

TLC, GC

4%

16

7%

13

10%

17

7%

13

10%

17

Reference
Rats

Innis and Clandinin, 1981 [171]
Jahouvey et al., 1990 [172]

Power et al., 1994 [175]

Taniguchi et al., 1993 [177]
Yamaoka et al., 1990 [178]

Mice
Croset and Kinsella, 1989 [183]

Crocodile oil, soybean
TLC, GC
oil
Berger and German, 1990 [184]
Coconut oil, safflower
HPLC, MS
oil, flaxseed oil
Watkins et al., 2001 [185]
Crocodile oil, soybean
TLC, GC
oil
Hussein et al., 2009 [150]
Coconut oil, safflower
HPLC, MS
oil, flaxseed oil
TLC: thin layer chromatography; GC: gas chromatography; HPLC: high
chromatography; MS: mass spectrometry.
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A small number of exclusion criteria were applied for data selection. As 18:2n-6
is the most readily consumed PUFA in the human diet (~42% of PUFA consumed
[187]) and an essential fatty acid in mammals, the analysis excluded any diets
containing less than 2% of 18:2n-6 as a proportion of total dietary fatty acid. Based on
the work of Owen et al. [189], two weeks of dietary intervention is the minimum period
required in order to allow adequate time for phospholipid remodelling to occur, so any
dietary interventions shorter than two weeks were excluded. Where different feeding
periods were used in the same study, the period closest to four months was chosen as it
represented an average common feeding period across studies. In the entire analysis, the
only study excluded as a gross outlier was that of Berger et al. from 1992 [186]. This
study reported that the percentage of 22:6n-3 in mouse heart CL was increased from 12
to 48% of total fatty acids after 18 days on a diet containing 22:6n-3 at 11% of total
fatty acids [186]. This percentage was approximately double that reported by any other
study, and has not been replicated since its original publication.

3.3.2 Conformer-regulator model
The conformer-regulator model was used to examine the relationship between dietary
fatty acid composition and phospholipid fatty acid composition. In this model, the
percent of a fatty acid in the diet (e.g. 18:1n-9, 18:2n-6 or 22:6n-3) is plotted against its
level or that of another fatty acid present in CL. A slope of 1 represents a perfect
conformation between dietary fatty acid composition and phospholipid fatty acid
composition, and a slope of zero suggests that the fatty acid composition of
phospholipids is independent to that of diet and is therefore perfectly regulated [90].
Slopes not significantly different from zero indicate regulation, slopes significantly
greater than zero but below 1 indicate weak conformity, and slopes of 1 or more
represent very strong, active dietary conformity. Previous work using this model has
shown that total membrane SFA, MUFA and PUFA content are likely to show a
regulator pattern with diet, but n-3 and n-6 PUFA show varying levels of dietary
conformity, particularly at low dietary levels where presumably their essential dietary
nature is displayed [28, 190].
Line fit and slopes in all figures presented in this study were determined using
segmental linear regression with an unconstrained line intercept available in GraphPad
Prism 5.04 (GraphPad Software, CA, USA). All statistical analyses were performed
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using the same software package and slope values are reported as slope ±95%
confidence interval.

3.3.3 Modelling fatty acid composition of diet and cardiac cardiolipin
The three fatty acids most commonly reported in CL were 18:1n-9, 18:2n-6 and 22:6n-3
[146, 147, 149, 150, 170-174, 176, 177, 183-185, 188]. Figure 3.1 shows the percentage
of 18:1n-9 and 18:2n-6 in CL against their percentage in the diet in heart and liver. No
significant trend was apparent for 18:1n-9, with a slope of 0.036±0.094 (P= 0.886)
across a wide dietary range (0–78%), indicating a regulated pattern with 18:1n-9
comprising around ~10% of cardiac CL fatty acid content. The incorporation of 18:2n-6
into cardiac CL showed a distinctive biphasic pattern with a rapid rise in CL 18:2n-6
levels from 2–20% of dietary fat indicating a conformer pattern as indicated by a slope
of 1.17±1.10 (P= 0.038). At these lower levels of dietary 18:2n-6 intake, the
incorporation of 18:2n-6 into CL appeared to be an active and selective process as
would be predicted from the high 18:2n-6 content generally reported for CL. At dietary
levels where 18:2n-6 was above 20% (range 21–68%) of dietary fat, the incorporation
of this fatty acid was reduced to a regulated pattern with a slope of 0.036±0.524,
levelling off at ~70% of CL fatty acid being 18:2n-6 (or ~65% when rat and mouse
values are combined), supporting reports that 18:2n-6 levels in CL is largely a regulated
phenomenon
Analysis of 22:6n-3 levels in heart CL showed that a small percentage (2–8%) of
22:6n-3 was present in CL even when 22:6n-3 was absent from the diet (Figure 3.2).
This was presumably due to the elongation and desaturation of shorter chained PUFA
such as 18:3n-3 to 22:6n-3 by the liver [191] and the subsequent incorporation of
22:6n-3 into heart CL. When 22:6n-3 was present in the diet at levels of up to 20% of
total fatty acid, it was readily incorporated into CL in a strong active conformer pattern
with a slope of 1.43±0.58 (P< 0.0001). Although 22:6n-3 was examined over a more
extended range (0–37%) than 18:2n-6, dietary levels of 22:6n-3 above 20% of total
dietary fatty acid indicated some degree of regulation with the plateauing of 22:6n-3
levels at ~20% of fatty acid CL content. Therefore 18:2n-6 and 22:6n-3 seemed to be
readily incorporated into heart CL when their levels in the diet were up to 20% of total
dietary fatty acid, indicating a strong active conformer pattern, but at higher dietary
levels a regulated pattern was suggested.
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3.3.4 Modelling fatty acid composition of diet and liver cardiolipin
Fewer studies have examined CL acyl remodelling in liver compared to heart, but what
was available [149, 175, 177, 184, 185] is presented in Figure 3.1 for 18:1n-9 and
18:2n-6, and in Figure 3.2 for 22:6n-3. Both figures use data for mice and rats. In
general, the percentage of 18:1n-9 was higher (at ~20%) in liver than in heart and the
percentages of 18:2n-6 and 22:6n-3 were lower. Presumably 18:1n-9 was acting as an
alternative for some of the 18:2n-6 and 22:6n-3 fatty acids in liver, with some studies
reporting 18:1n-9 levels of 25% or higher in liver CL [175, 179, 184]. The incorporation
of 18:1n-9 into liver CL was regulated at a low level with a very mild and nonsignificant accrual (slope of 0.237±0.266; P= 0.076) throughout the dietary range
examined (2–70%). Similarly, 18:2n-6 showed little indication of any strong trend to
incorporate into liver CL at either low or high dietary 18:2n-6 intakes (Figure 3.1) with
a slope of 0.164±0.352; (P= 0.33) across a broad dietary range, again indicating that the
incorporation of 18:2n-6 into CL is highly regulated. Although there was little data
available for the influence of dietary 22:6n-3 on the composition of liver CL
(Figure 3.2), what was available suggested a conformer pattern when 22:6n-3 levels
were below 10% of total dietary fatty acid with a slope of 1.04±0.85 (P= 0.02).

3.3.5 The effect of dietary 22:6n-3 on the incorporation of 18:2n-6 into heart and
liver cardiolipin
All studies that incorporated both 22:6n-3 and 18:2n-6 into the same diet and measured
the fatty acid composition of CL were analysed (Figure 3.2) for heart [147, 148, 150,
172, 177, 180, 181, 183, 185, 188] and liver [147, 175, 177, 185, 186]. Owing to the
more limited number of studies available that included both 22:6n-3 and 18:2n-6 in the
same diet, the analysis includes data for both rat and mouse tissues. No statistical
relationship was found between dietary levels of 22:6n-3 and 18:2n-6. For example,
when 22:6n-3 was at its highest level in the diet (37%) the level of 18:2n-6 was also one
of the highest of any of the diets (56%) indicating that changes in 18:2n-6 levels in heart
CL were not simply due to dietary 22:6n-3 displacing dietary 18:2n-6 [183]. Figure 3.2
clearly shows the deposing influence of 22:6n-3 on 18:2n-6 levels in cardiac CL at
22:6n-3 levels of up to 20% of total dietary fatty acid. At dietary levels where 22:6n-3
was less than 20% of total fatty acids, 22:6n-3 was incorporated into cardiac CL (slope
of 1.43±0.58; P= 0.0001) while percentages of 18:2n-6 in CL decreased (slope of
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–2.14±1.24; P= 0.002). At percentages of dietary 22:6n-3 above 20% of fatty acids, the
percentage of 18:2n-6 appeared to plateau at just under 40% of total fatty acids in heart
CL which was below its “normal level” of ~70% (Figure 3.1), whereas 22:6n-3
plateaued at just above ~20% of total fatty acid making up most of the difference
(Figure 3.2).
Liver CL also appeared to accrue 22:6n-3 at the expense of 18:2n-6 (slope of
1.041±0.846; P= 0.022) although less data was available for liver than heart (Figure
3.2). A study that examined the effects of very high levels of dietary 22:6n-3 on CL
composition reported liver CL did not incorporate 22:6n-3 even when dietary 22:6n-3
exceeded 10% of total fatty acid in the diet [177]. At this point 18:2n-6 plateaued at
slightly over ~20% of CL fatty acid content, down from the normal ~30–60% with
22:6n-3 at ~13% of CL fatty acid making up a large proportion of the difference.
Therefore CL in heart and liver maintained 18:2n-6 levels at ~70% and 50%
respectively, and in the case of heart readily accrued 18:2n-6 from the diet when this
fatty acid is at lower levels (<20%). However, when 22:6n-3 was available in the diet it
was incorporated into CL at the expense of 18:2n-6 until 22:6-3 made up ~20% of CL
fatty acid content in heart and ~13% in liver, after which both 18:2-6 and 22:6n-3 levels
seemed to be constant and therefore regulated.

3.3.6 Comparison of 22:6n-3 incorporation into other mitochondrial phospholipids
Although functionally important, CL is not the major phospholipid class in
mitochondria, comprising 5–20% of mitochondrial phospholipids [17, 51]. The two
major mammalian mitochondrial phospholipids classes are phosphatidylcholine (PC)
and phosphatidylethanolamine (PE), which make up ~45% and ~35% of total
mitochondrial phospholipid respectively [192]. Some of the studies examined here [28,
56, 164, 167, 168, 170, 172, 173, 175, 176, 178-185] included data for PC and PE in
addition to CL, and a brief analysis of 18:1n-9, 18:2n-6 and 22:6n-3 incorporation into
PC and PE of heart and liver mitochondria was conducted (Figure 3.3). There were no
significant trends in the incorporation of 18:1n-9 and 18:2n-6 into PC and 18:1n-9 into
PE of cardiac mitochondria across a broad range of dietary supplementation (2–78% of
total fatty acids), indicating a regulated pattern for these fatty acids in heart. In
comparison, the incorporation of 18:2n-6 into heart PE showed a weak but significant
conformer trend with increasing levels across the same dietary range with a slope of
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Figure 3.3. Levels of 18:1n-9, 18:2n-6 and 22:6n-3 as a percentage of total fatty acids in
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) against total dietary fatty acids.
Each figure includes both rat (●) and mouse (○) data. Data used for heart PC was from [147150, 171, 172, 174, 177, 178, 180-185], for heart PE was from [56, 149, 183, 184], for liver PC
and PE were from [147, 149, 170, 175, 177, 184, 185]. Data excluded from the analysis
included diets that contained higher 20:5n-3 than 22:6n-3.
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3.4

Cardiolipin remodelling

This analysis used a comprehensive compilation of studies to show that dietary 18:2n-6
is selectively incorporated into heart and liver CL, but that the incorporation of dietary
22:6n-3 has an even greater selectivity. The analysis indicated a strong conformer
pattern when dietary levels of 18:2n-6 were between 2–20% of total dietary fatty acid,
with higher dietary availability of 18:2n-6 showing regulated levels. In liver, no trend
was evident for 18:2n-6 incorporation into CL across a broad range of dietary 18:2n-6
intakes, indicating a regulated level of 18:2n-6 into CL of liver mitochondria. When
22:6n-3 and 18:2n-6 were present in the same diet and 22:6n-3 was between 0–20% of
total dietary fatty acids, CL preferentially incorporated 22:6n-3 into its structure at the
expense of 18:2n-6. This preference for the incorporation of 22:6n-3 over 18:2n-6
seems to be present in both heart and liver. The replacement of 18:2n-6 by 22:6n-3 has
previously been noted in phospholipids of heart. For example, in a dose-response study
of dietary 22:6n-3 (0–32%) examining myocardial phospholipids, Owen et al. [189]
found that 22:6n-3 replaced 18:2n-6, and to a lesser extent 18:1n-9. Other studies
comparing diets low and high in 22:6n-3 have noted similar trends in cardiac
phospholipids [183, 185] and CL specifically [147, 149, 178, 185]. The present analysis
found that 22:6n-3 will replace 18:2n-6 in CL even when dietary levels of 18:2n-6 are
high, but this replacement will occur at levels of dietary 22:6n-3 of up to 20% in heart
and ~10% in liver.
The selectivity of 22:6n-3 over 18:2n-6 in CL and the preferential incorporation of
these two fatty acids over others is likely due to the complex nature of CL synthesis and
remodelling. CL is synthesised from the condensation of a PG molecule with cytidine
diphosphate diacylglycerol resulting in what is commonly referred to as immature CL
with a mixed acyl content that is then remodelled to produce mature CL with high
18:2n-6 content [156]. The selected incorporation of fatty acids during remodelling was
recently investigated by Kiebish et al. [193], who reported that only 1–5% of the fatty
acids incorporated into CL during the remodelling process come from PC and PE, with
this process having a low acyl selectivity. The majority of fatty acids are drawn from the
pool of acyl-CoA fatty acids and this incorporation is highly selective [193].
Interestingly, heart acyltransferases were reported to have 1.3 times the specificity for
22:6n-3 in comparison to 18:2n-6, which in turn had specificity many times higher than
that of any other fatty acid. In contrast, liver acyltransferases had a far higher specificity
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for 18:2n-6 over 22:6n-3 or any other fatty acid [193]. The specificities of these
acyltransferases and tissue differences are likely to explain the underlying mechanism
by which 22:6n-3 replaces 18:2n-6 in heart CL but does not explain the response in
liver.

3.5

Consequences of the incorporation of 22:6n-3 into cardiolipin

The accrual of 22:6n-3 into phospholipids in a conformer fashion probably reflects the
essential dietary nature of omega-3 fats generally and the readiness of tissues to use
preformed fatty acid if available. Based on the roles CL performs in mitochondria, the
functional consequences of accruing 22:6n-3 into the structure of CL are likely to be
significant. The incorporation of 22:6n-3 in CL might increase the fluidity and
permeability of inner mitochondrial membranes and may adversely affect CL’s
interactions with proteins [163]. These changes would be expected to decrease the
efficiency of oxidative phosphorylation, and the three dietary studies in the analysis that
investigated the effect of 22:6n-3 incorporation into CL on mitochondrial oxidative
phosphorylation found no change [183] or a decrease in activity [147, 182]. More recent
work in this area has shown a similar trend of dietary 22:6n-3 either decreasing or not
affecting mitochondrial respiration [194, 195].
As 18:2n-6 contains only one bis-allylic methylene group but 22:6n-3 contains
five, the incorporation of 22:6n-3 over 18:2n-6 into CL, PC and PE will increase
membrane susceptibility to peroxidation, which is an important mechanism in cellular
health and disease [3-5]. Furthermore, the products formed during peroxidation of n-3
PUFA are proposed to be more reactive than those produced from n-6 PUFA [196]. CL
has been shown to be more susceptible to peroxidation than other phospholipid classes
both in vitro [30] and in vivo [166] due to its high level of 18:2n-6, proximity to ROS
production, and close association with the haem-containing cytochrome c [25, 197,
198]. An increase in CL’s susceptibility to peroxidation due to the incorporation of
22:6n-3 may also increase cell sensitivity to apoptosis as the peroxidation of CL is
thought to be an early event in mitochondrial-induced apoptosis related to cytochrome c
release and disruption of the inner and outer mitochondrial membranes [164-166, 199].
Overall, the replacement of 18:2n-6 with 22:6n-3 has the potential to adversely affect
cell function, but the finding that CL selectively accrues 22:6n-3 in place of 18:2-6
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suggests that the incorporation of 22:6n-3 into CL is not a disadvantageous under
normal dietary circumstances.

3.5.1 Limitations
This chapter shows both the limitations and importance of analysing data from
published works. The incorporation of 22:6n-3 into the CL of mammalian heart and
liver is likely to increase the peroxidation index of these tissues, but the exact changes
in the peroxidation index could not be determined from the available data. In addition,
physiological changes due to increased 22:6n-3 in CL composition were not examined,
and so it could not be determined if the incorporation of 22:6n-3 into the CL of healthy
organisms has an overall positive or negative influence on longevity and health. The
advantage of the present study, however, is that it combines similar findings from
multiple sources to provide the best evidence available that the fatty acid composition of
CL can be influenced by diet, particularly dietary 22:6n-3.

3.6

Conclusions

The high level of 18:2n-6 reported in CL has led to the view that the fatty acid
composition of CL is regulated interdependently of diet [26]. This analysis has,
however, shown that the 18:2n-6 and 22:6n-3 content of CL is influenced by the
percentage of these fatty acids in the diet. The accrual of 18:2n-6 into cardiac CL
increased when 18:2n-6 was present at 2–20% of dietary fatty acids, and was regulated
at ~70% of CL when 18:2n-6 was present at higher percentages in the diet. In
comparison, liver showed no indication of accrual at lower 18:2n-6 dietary levels and
overall levels of 18:2n-6 in liver CL are lower. This analysis also clearly shows that the
incorporation of 22:6n-3 into heart CL is favoured over the incorporation of 18:2-n6
when 22:6n-3 is present at up to 20% of dietary fatty acids, but not at higher
percentages of dietary 22:6n-3. There is less evidence that this is occurring in liver,
suggesting that selectivity may differ between tissues. The replacement of the single
bis-allylic methylene group present in 18:2n-6 with the five bis-allylic methylene
groups in 22:6n-3 may result in changes in cellular respiration, membrane peroxidation
index, and in the initiation of mitochondrial-mediated apoptosis.

47

4

Chapter Four
Comparison of lipid hydroperoxide production between phospholipid
classes matched for linoleic acid: Cardiolipin is not an exception

4.1

Overview

Phospholipid peroxidation is primarily a function of polyunsaturated fatty acid (PUFA)
content, but a number of studies have also found phospholipid class to influence
susceptibility to peroxidation. This chapter presents an in vitro comparison of ironmediated peroxidation of cardiolipin and other phospholipid classes in diffuse solutions
and in liposomes. Unlike many past works, the phospholipids compared in this chapter
all contained linoleic acid at equivalent amounts in order to remove fatty acid
composition as a variable in comparisons.

4.2

Introduction

The oxidative damage of phospholipids by reactive oxygen species (ROS), a process
termed peroxidation, is intrinsic to aerobic organisms [3-5, 200, 201]. Although the
head groups that define phospholipid class do not normally peroxidises, differences in
head group structures have been suggested to influence phospholipid peroxidation [15,
22, 30, 202-204]. Work in this area is limited and has resulted in contradictory findings
due to differences in initiators, phospholipid mixtures, buffers and measurement
technique used [15]. For example, negatively charged phosphatidylethanolamine (PE)
has been reported to increase iron-initiated peroxidation in some conditions but inhibit it
in others [202, 203]. Phosphatidic acid (PA) and phosphatidylglycerol (PG), both small
head groups, have been reported to inhibit peroxidation [204] but the di-phospholipid
cardiolipin (CL), also a small head group in respect to molecule size, has greatly
increased peroxidation in comparison to phosphatidylcholine (PC) or PE [30]. The
peroxidation of CL is of particular interest due to CLs close association with the early
stages of apoptosis involving the release of cytochrome c into the cytosol [30, 197, 205,
206].
CL is the only prevalent di-phospholipid class present in mammalian membranes
and is found almost exclusively in mitochondria where it facilitates oxidative
phosphorylation by binding cytochrome c and other mitochondrial proteins [197, 205,
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206]. Mammalian CL often contains multiple linoleic acids (18:2n-6) and occasionally
also 22:6n-3, as described in Chapter Three, but other phospholipid classes in
mammalian tissue rarely contain more than one polyunsaturated fatty acid [18]. The
presence of multiple PUFA in a single phospholipid, particularly the presence of
22:6n-3, is likely to make CL highly susceptible to peroxidation. The peroxidation of
CL is an early event in apoptosis, and some researchers have suggested that the
peroxidation of CL by cytochrome c is a trigger of apoptosis [156, 157, 159, 160]. This
idea has resonated recently in a number of studies that have reported preferential
peroxidation of CL compared to other phospholipid classes during oxidative stress [30]
and hyperoxia [169], with reports of CL having twice the peroxidisability of comparable
amounts of 18:2n-6 in methyl ester form [207]. However, measurement of CL
peroxidation via its production of lipid hydroperoxides has never been compared to
other phospholipid classes with similar fatty acid compositions.
This chapter examines the influence of the phospholipid head groups by
comparing the auto and iron-mediated peroxidation of CL, of PC, PE, PG and PA
matched for amounts of 18:2n-6. Phospholipids were examined as either diffuse in
solution or as liposomes in mixtures with a carrier phospholipid, PC 16:0/16:0. All
phospholipids contained comparable concentrations of 18:2n-6 to ensure comparable
peroxidation indexes between experiments. Peroxidation was initiated using ferrous iron
(Fe2+) and measured as LOOH levels due to their high level of production and relative
stability products [113, 203, 208-212].

4.3

Methods

4.3.1 Materials
The bovine heart cardiolipin (BHCL) had a purity of >97% and fatty acid composition
of 90% 18:2, 5% 18:1 and 5% unknown. The synthetic phospholipids had a purity of
>99% and included: PC 16:0/16:0, PC 16:0/18:2, PC 18:2/18:2, PE.16:0/18:2,.PE
18:2/18:2, PG 16:0/18:2, PA 16:0/18:2. All phospholipids were purchased from Avanti
Polar Lipids Inc. (Alabama, USA) without any added butylated hydroxytoluene (BHT)
and kept as 5 mg/ml stock solutions maintained under nitrogen in sealed containers at –
20℃. Ammonium ferrous sulfate (NH4)2Fe(SO4)2.6H2O, xylenol orange and butylated
hydroxytoluene (BHT) were purchased from Sigma-Aldrich (USA). Methanol and
chloroform (HPLC grade) were purchased from Crown Scientific (Australia). Sulfuric
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acid (98%) was purchased from Ajax Chemicals (Australia). All chemicals used were of
analytical grade.

4.3.2 Matching the concentration of bis-allylic methylene groups between
phospholipids
Phospholipids were made-up from stock solutions to a final concentration of bis-allylic
methylene of group concentration of 194 mM. This concentration of bis-allylic
methylene groups reflected original work performed using soy PC to ensure a
comparable peroxidative index between phospholipid classes. Based on this
concentration, 54 mM of BHCL (containing 90% 18:2n-6) had an equivalent
peroxidation index of 194 mM of phospholipids composed of 16:0/18:2 or 97 mM of
phospholipids composed of 18:2/18:2.
4.3.3 Sample preparation
Initial methanol experiments were carried out in 250 µM ammonium ferrous sulfate in a
solution of 90% methanol, 10% 2.5 mM sulfuric acid (v/v) [113]. As CL, PE, and PA
do not readily form liposomes in aqueous media [24] it was necessary to stabilise them
in liposomes of PC 16:0/16:0, a non-peroxidisable phospholipid commonly used to
produce liposomes. During initial experiments, a ratio of 1:3 BHCL:PC 16:0/16:0 (w/w)
was found to have low levels of auto peroxidation and high levels of iron initiated
peroxidation. Based on these results, all phospholipids tested were mixed with 0.3
mg/ml of PC 16:0/16:0 and enough peroxidisable phospholipid to yield 194 mM of
bis-allylic methylene groups. To form liposomes, lipid mixtures were dried under
nitrogen for 60 min at 37 ºC and then hydrated with 140 mM NaCl solution (pH 3.4) for
10 min at 45 ºC. The solution was maintained at pH 3.4 to ensure that the iron used to
initiate peroxidation remained in the ferrous form. Following hydration, mixtures were
vortexed for 15 min and sonicated on ice using a Sanyo Soniprep 150 with an
exponential probe. The probe sonicator output frequency was 23 kHz with an amplitude
of 63 microns. Sonication occurred in 3 bouts of 45 seconds separated by 5 second rest
periods. Liposomes were maintained at 45 ºC and used immediately after preparation.
Mixtures of the peroxidisable phospholipids were also tested in solution of 90%
methanol, 10% water without PC 16:0/16:0. Solutions were assessed for particle
formation (e.g. liposomes or micelles) using a Zetasizer APS (Malvern Instruments Ltd,
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UK) but no discernible populations of particles were detected. The pH of methanol and
aqueous solutions was kept at between pH 3–4 [213].

4.3.4 Peroxidation
Peroxidation was initiated by the addition of ferrous iron in the form of ammonium
ferrous sulfate. Peroxidation involved two components: that associated with ferrous iron
and that independent of ferrous iron i.e. auto peroxidation, both occurring in the same
incubations. To separate these contributions, liposomes were incubated both with and
without ferrous iron. Auto peroxidation (without ferrous iron) was then taken away
from total peroxidation (i.e. that with ferrous iron) in order to distinguish peroxidation
initiated by the presence of ferrous iron only.
Lipid hydroperoxide (LOOH) concentration was used as a measure of
peroxidation using the xylenol orange (FOX-2) assay as previously described [203] and
as reviewed by Bou et al. [113]. All results were reported as lipid hydroperoxides
produced per 18:2n-6 (mmol LOOH per mol 18:2n-6). No LOOH was detected in the
concentrated stock solutions (maintained under nitrogen). In order to determine
conditions for maximum LOOH production, liposomes composed of BHCL and PC
16:0/16:0 at a ratio of 1:3 BHCL:PC 16:0/16/0 (w/w) were tested against increasing
concentrations of ferrous iron using an incubation time of ten min. A second series of
incubations was conducted using incubation times of between 5–120 min and 100 M
ferrous iron to ensure the maximum level of product was formed. Based on these results
subsequent experiments using liposomes were carried out over 10 min with 100 M
ferrous iron used to initiate peroxidation. Data was analysed by one-way ANOVA with
Tukey post hoc tests using GraphPad Prism 5.04 (GraphPad Software, San Diego, USA)
and IBM SPSS Statistics 19 (IBM, New York, USA).

4.4

Results

4.4.1 LOOH formation in diffuse solution
In diffuse solution (90% methanol, 10% water), the total lipid hydroperoxide formation
(mmol LOOH per mol 18:2n-6) was higher for BHCL (305.3±13.6) and PA (356.6±9.2)
than PC, PE, or PG phospholipids (all below 200) (Figure 4.1A). PC 18:2/18:2, PE
16:0/18:2 and PE 18:2/18:2 produced significantly higher total LOOH than PC
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16:0/18:2 and PG 16:0/18:2, and neither PC 16:0/18:2 nor PG 16:0/18:2 produced more
total LOOH than PC 16:0/16:0, the negative control. While auto peroxidation (without
added ferrous iron) was below 50 mmol LOOH per mol 18:2n-6 for most
phospholipids, levels of 61.78±17.9 and 100.3±17.7 were reached for PC 18:2/18:2 and
PE 18:2/18:2 respectively, with both values significantly higher than PC 16:0/16:0
(Figure 4.1B). This auto peroxidation accounted for the major component of total
peroxidation of these two phospholipids. Iron-mediated LOOH production (i.e. total
peroxidation minus auto peroxidation) was highest in PA 16:0/18:2 (355.6±8.4),
followed by BHCL (296.4±12.0) and PE 18:2/18:2 (71.6±14.0) (Figure 4.1C).
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Figure 4.1. Lipid hydroperoxide production (mmol LOOH per mol 18:2n-6) of phospholipids
matched for linoleic acid (18:2n-6) content in a solution of 1:9 water to methanol (v/v).
Peroxidation was initiated by the addition of 100 µM ferrous iron in the form of ammonium
ferrous sulfate for total peroxidation (A) or without iron to determine auto peroxidation (B).
Peroxidation due to initiation with ferrous iron alone (C) was calculated as the difference
between total peroxidation minus auto peroxidation. LOOH levels were tested after 60 min of
reaction. Data are presented as mean ±SEM, n=6. Non-identical letters indicate significant
differences within each graph for P<0.05
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4.4.2 Maximizing LOOH formation in liposomes
Initial experiments found that BHCL alone did not readily peroxidise in aqueous
solution, but LOOH production was greatly increased when BHCL was incorporated
into liposomes with PC 16:0/16:0 (Figure 4.2). Auto peroxidation was maximal when
only BHCL was present and reduced with increasing levels of PC 16:0/16:0. The
maximal level of ferrous initiated BHCL peroxidation occurred at a ratio of 1:3 (w:w)
BHCL to PC 16:0/16:0. This ratio produced LOOH levels significant greater 1:1 BHCL
to PC 16:0/16:0. Based on these results, all subsequent comparisons between head
groups and their ability to peroxidise were carried out at a ratio of 1:3 of peroxidisable
phospholipids to PC 16:0/16:0. This ratio was also used to optimise concentration of
ferrous iron and time of incubation necessary to produce maximal LOOH in liposomes
(Figure 4.3). Results from BHCL in diffuse solution are shown for comparison. The
concentration of ferrous iron found to maximise LOOH production of peroxidisable
phospholipids was 100 µM (Figure 4.3A). The maximum rate of LOOH production was
35.3±1.1 (mmol LOOH per mol 18:2n-6 per min), which occurred within the first 5 min
of incubation. The rate then dropped to 3.2±1.2 (mmol LOOH per mol 18:2n-6 per min)
between 5 to 10 min (Figure 4.3B). LOOH amounts were stable after ten min at a ratio
of 1:3 (BCHL:PC 16:0/16:0).
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Figure 4.3. Production of lipid hydroperoxides (mmol LOOH per mol 18:2n-6) from bovine
heart cardiolipin (BHCL) in liposomes containing PC 16:0/16:0 at a ratio of 1:3 (w/w) or BHCL
diffuse in a solution of 1:9 water to methanol (v/v). All experiments contained 194 mM of
18:2n-6. A) values varying concentrations of ammonium ferrous sulfate after 60 min of
incubation and B) values with increased incubation time and with 100 µM ammonium ferrous
sulfate. Values are means ±SEM, n=4.

4.4.3 Comparison of LOOH production of phospholipid classes in liposomes
All phospholipids incorporated into liposomes in aqueous media peroxidised readily
and had significantly higher levels of total LOOH production than the negative control
(Figure 4.4A). There was a more uniform level of auto peroxidation in the liposomes in
comparison to diffuse solutions and PE 16:0/18:2, PE 18:2/18:2, and PG 16:0/18:2 had
higher levels than the negative control, PC 16:0/16:0 (Figure 4.4B). Overall, ironinitiated peroxidation was the dominant contribution to total peroxidation in all
phospholipids tested (Figure 4.4C). Iron-initiated production of LOOH, the primary
outcome of these experiments, was less homogenous in outcome than auto peroxidation.
The phospholipid with the highest level of iron-initiated peroxidation (mmol LOOH per
mol of 18:2n-6) was PC 18:2/18:2, followed by PE 16:0/18:2, PE 18:2/18:2 and PC
16:0/18:2, BHCL, PG 16:0/18:2, and PA 16:/18:2. The amount of iron-initiated LOOH
production ranged from 103.3 to 296.1 (mmol LOOH per mol of 18:2n-6). Although
BHCL had a lower level of iron-initiated production of LOOH (202.5±5.3) than other
phospholipids when normalised for 18:2n-6 content, it was only statistically lower than
PC 18:2/18:2.
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4.5.1 Differences in diffuse solution and liposomes
This chapter compared the iron-initiated peroxidation of cardiolipin (CL) and species of
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG)
and phosphatidic acid (PA) matched for linoleic acid (18:2n-6) content when diffuse in
solution or in liposomes in aqueous medium. Interest in this comparison came from
experiments conducted by Paul Else examining phospholipid peroxidation using the
updated ferrous oxidation-xylenol orange (FOX-2) assay for lipid hydroperoxides
(LOOH). In these experiments very high levels of peroxidation were observed for
bovine heart CL (BHCL) but not for PC or PE phospholipids containing 18:2n-6. Initial
work showed that this peroxidation was taking place in the FOX-2 solution rather than
in prior assays, suggesting that the CL head group influences peroxidation in ways that
PC and PE do not. When phospholipid classes were tested in diffuse solution, the
ranking of iron-mediated lipid hydroperoxide production was PA> BHCL>> PE> PC,
PG. The cause of the retarded peroxidation of PG, PC and PE and much higher
peroxidation for the phospholipids PA and BHCL is not obvious, but may be related to
the potential of the head groups of these classes to hold double
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Figure 4.4 Production of lipid hydroperoxides (mmol LOOH per mol 18:2n-6) by phospholipid
classes matched for 18:2n-6 in liposomes containing PC 16:0/16:0. Peroxidation was initiated
by the addition of 100 µM ferrous iron in the form of ammonium ferrous sulfate for total
peroxidation (A) or without iron to determine auto peroxidation (B). Peroxidation due to
initiation with ferrous iron alone (C) was calculated as the difference between total peroxidation
minus auto peroxidation. LOOH levels were tested after ten min of reaction. Data are presented
as mean±SEM, n=6. Non-identical letter indicate significant differences within each graph for
P<0.05, as determined by Tukey post-hoc tests.

negative charges [24]. Auto peroxidation in methanol did not follow the same trends as
iron-mediated peroxidation, with PC 18:2/18:2 and PE 18:2/18:2 the only phospholipids
to show significantly higher LOOH production.
In contrast, all phospholipid classes showed similar levels of iron-mediated
peroxidation when tested in liposomes. The overall ranking of iron-initiated lipid
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hydroperoxide production in liposomes was PC> PE> CL> PG> PA. PC and PE are the
largest head groups relative to phospholipid size and were uncharged under the
experimental conditions used while the head groups of PG, CL and PA are relatively
smaller and negatively charged. Previous studies have suggested that negatively charged
phospholipid head groups can increase peroxidation by attracting ferrous iron [202], but
this was not strongly supported by the present study. The differences between the
results found in liposomes compared to those produced in methanol highlights the
importance of the models used to test peroxidation.

4.5.2 Cardiolipin and peroxidation
The present results are in contrast to previous reports that CL peroxidises more readily
than other head groups [30, 169, 207]. One reason for this difference is in the use of free
iron rather than cytochrome c, as cytochrome c forms a tight complex with CL but not
with other phospholipids [159, 169]. A second reason is the choice of stabilizing agents
for liposome preparation. In order to maximise iron-initiated peroxidation and ensure
the availability of CL, BHCL and the other phospholipids were incorporated into
liposomes containing a non-peroxidisable ‘carrier’ phospholipid (PC 16:0/16:0). A
recent study by Roginsky [207] reported CL peroxidises at twice the rate of the methyl
ester of 18:2 per bis-allylic methylene group when used with Triton X-100 (a detergent)
to form CL micelles. CL and 18:2 methyl esters were incubated at different
concentrations (0.6–2 mM to 5–20 mM respectively) in the same concentration of
Triton X-100. However, Triton X-100 contains endogenous peroxide (0.22%: see Sigma
MSDS sheet) that can accelerate rates of peroxidation and potentially total product
formation. This factor may have influenced the results. In addition, methyl esters are far
more resistant peroxidation than those in phospholipids containing the same
peroxidisable fatty acids (Else and Kraffe, in preparation).
Another explanation as to why CL may appear to peroxidise more readily and
produce more product is that peroxidation can be measured as oxidation per bis-allylic
methylene group, as in the present study and [207], or per phospholipid. As a
di-phospholipid rich in 18:2n-6, mammalian CL is far more likely to peroxidise on a per
phospholipid basis than other classes that typically contain only up to one PUFA [79,
214]. Wiswedel et al. [30] compared the peroxidation of CL, PC and PE from rat brain
during oxidative stress and reported that CL content of the mitochondria dropped away
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more rapidly than both PE and PC. Using values for the acyl composition of mouse
brain mitochondria for CL, PE and PC [215], the peroxidative index of these
phospholipids can be calculated to be 106, 170 and 76 respectively. This might indicate
that the early peroxidation of CL is disproportionate to its peroxidative potential.
However, peroxidation was measured by the ‘disappearance’ of phospholipids from a
mass spectrum, a process that measures peroxidation per phospholipid rather than per
bis-allylic methylene group. Due to its structure, CL is approximately twice as likely to
‘disappear’ as PE or PC with comparable peroxidative indexes. This re-evaluated
peroxidative potential of the molecule is in-line with the relative disappearance of the
different phospholipids found by Wiswedel et al. [30]. Similarly, the relative early
disappearance of CL from other studies on rat brain mitochondria during oxidative
stress [216] and in lungs during acute hyperoxic lung injury [169] can be similarly
explained without requiring CL to show exceptional peroxidative capacity.

4.5.3 Limitations
The limitation of the FOX-2 assay to measure in vitro peroxidation are due to its slow
sampling speed which cannot accurately be used to measure the phases of peroxidation.
The use of the FOX-2 assay is an accurate measure of the maximum product of
peroxidation but does not record data faster enough to identify distinct lag and
propagation phases of peroxidation (Figure 4.3, [202]). The maximum rate of
peroxidation was measured for BHCL in diffuse solutions and liposomes, but the length
of the lag phase and rate of peroxidation during this phase could not be measured. This
limitation is shared by similar assays including the thiobarbituric acid reactive
substances (TBARS) assay. These limitations are addressed in Chapter Five, which
describes results obtained following the purchase of a six-channel oxygen meter
(Strathkelvin Instruments) that provided a more sensitive and continuous measurement
of peroxidation. A further limitation was the use of iron as an initiator of peroxidation.
The 100 µM ferrous iron used in these experiments is likely to be far in excess of iron
concentrations found in under physiological conditions, and iron is only one of many
possible initiators that may be used to study peroxidation. Future work in this area could
consider physiologically relevant concentrations of iron alongside other initiators such
as radical clocks to ensure heterogeneity of results.
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The experiments presented in this Chapter show that the CL and PA classes increased
peroxidation products in diffuse solution when compared to other phospholipid classes
independently of PUFA composition. In comparison, peroxidation in liposomes was
similar between classes, with the small differences in peroxidation related to head group
size. In contrast to past studies, CL did not have higher peroxidation (as measured by
product formation) compared to other phospholipid classes in liposomes, suggesting
that the CL head group does not have exceptional peroxidative capacity in terms of
product formation.
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Chapter Five
An antioxidant-like action for non-peroxidisable phospholipids using
ferrous iron as a peroxidation initiator

5.1

Overview

Phospholipids with saturated (e.g. PC 16:0/16:0) and monounsaturated fatty acids (e.g.
PC 16:0/18:1) are some of the most common phospholipids found in membranes, and
under normal conditions are generally non-peroxidisable. This chapter presents an in
vitro investigation into an antioxidant-like effect of PC 16:0/16:0 and PC 16:0/18:1
during iron-mediated peroxidation in liposomes. This study used more sophisticated
techniques than Chapter Four to measure multiple aspects of peroxidation including the
period of the lag phase and the associated rates of peroxidation. This chapter is closely
based the article ‘An antioxidant-like action for non-peroxidisable phospholipids using
ferrous iron as a peroxidation initiator’ by Cortie CH and Else PL, BBA Biomembranes,
2015, 1846(6): p. 1303-1307. The structure of the chapter differs from the accepted
article to avoid repetition with earlier chapters. CHC developed the method used in this
study and collected all data except that presented in Figure 5.5. CHC analysed all data
and drafted the work. PLE proposed the study, collected the data for Figure 5.5, and
supervised all aspects of the work.

5.2

Introduction

Peroxidation is a constitutive process in living systems and is part of healthy functions
but also pathology and aging [217, 218]. Peroxidation is a free radical reaction that
typically progresses through three well-recognised phases; i) the lag phase, a duration of
time (TLag) with a slow rate of reaction (RLag) and product formation, ii) the propagation
phase, with a fast rate of reaction (RMax) and product formation and, iii) termination due
to substrate exhausting or antioxidant quenching (Figure 2.9, [96]). From a biological
perspective, the lag phase is important as it offers the opportunity to prevent
peroxidation entering into the more damaging propagation phase. It is within the lag
phase that membrane antioxidants and enzymes can stop the peroxidation reaction, and
the TLag is commonly considered a measure of the antioxidant status of a membrane
[108].
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The chemistry of peroxidation is complex [5, 219], but the peroxidation of cellular
membranes can be mainly attributed to the polyunsaturated fatty acids (PUFA) present
in membrane phospholipids. As a result of the differences in the bond energies of
hydrogen to the carbons of fatty acids, PUFA are far more likely to undergo
peroxidation than saturated fatty acids (SFA) or monounsaturated fatty acids (MUFA)
([73], Table 2.2). As a consequence, phospholipids that contain one or more PUFA are
peroxidisable phospholipids (PPLs) while phospholipids containing only SFA and/or
MUFA are non-peroxidisable phospholipids (non-PPLs). Despite the challenge PUFA
present to living organisms in terms of peroxidation, PPLs are prevalent in membranes.
In mammals, for example, membrane phospholipids typically possess between 30 to
60% of their total fatty acids as PUFA [18, 220], making PPLs a major portion of
membrane phospholipids.
The current research examines if non-PPLs can protect PPLs from peroxidising.
This work examines the separate peroxidation of two PPLs (a natural phospholipid, soy
phosphatidylcholine, and a synthetic phospholipid phosphatidylcholine, PC 16:0/18:2)
in the presence of one of two different non-PPLs (PC 16:0/16:0 and PC 16:0/18:1) to
determine if any protection occurs. Peroxidation was induced by low levels of ferrous
iron rather than the more common high concentrations of azo-initiator such as AAPH in
order to produce a more natural peroxidative stimulus. Although the mechanism by
which iron initiates lipid peroxidation is still under debate [100], poorly-ligated iron is a
problem common to a number of pathologies [105]. The results of this study suggest
that the presence of non-PPLs decreases the rates of peroxidation resulting in the
extension of the duration of the lag phase producing an antioxidant-like action.

5.3

Methods

5.3.1 Materials
The phosphatidylcholines PC 16:0/16:0, PC 16:0/18:1, PC 16:0/18:2 and Soy PC (fatty
acid composition of 14.9% 16:0, 3.7% 18:0, 11.4% 18:1n-9, 63% 18:2-6, 5.7% 18:3n-3
and 1.2% unknown) were purchased from Avanti Polar Lipids (Alabaster, USA)
without added butylated hydroxytoluene (BHT) as antioxidant. Ammonium ferrous
sulfate ((NH4)2Fe(SO4)2.6H2O), sodium sulfate and butylated hydroxytoluene (BHT)
were purchased from Sigma-Aldrich (St Louis, USA). Methanol (HPLC grade) and
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sulfuric acid (98%) were purchased from Crown Scientific (Rowville, Australia). All
chemicals used were of analytical grade.

5.3.2 Liposome preparation
Stock solutions of phospholipids (125 mM) of both peroxidisable (PC 16:0/18:2 and
Soy PC) and non-peroxidisable (PC 16:0/16:0 or PC 16:0/18:1) phosphatidylcholines
were made-up in methanol and stored at –20 oC under nitrogen. Phospholipids from
each stock solution were combined to produce the required phosphatidylcholine
mixtures. Each phospholipid mixture was dried down under a stream of nitrogen for a
minimum of 90 min (or until completely dry) at 42 oC, made-up to 10 mM using
deionised water (42 oC, pH 3), stirred continuously for 45 min (42 oC) then passed nine
times across a 0.1 μm pore polycarbonate membrane (Avanti Polar Lipids) using a
Mini-Extruder (Avanti Polar Lipids) at (42 oC). Following extrusion, samples were
diluted to 2.5 mM. Samples of liposomes were taken from each preparation, before and
after peroxidation, in order to measure liposome size. BHT was added to prevent further
peroxidation. In addition, the lipid hydroperoxide (LOOH) level of each liposomal
preparation was measured prior to initiation of peroxidation and only those preparations
with no measureable levels of LOOH were used.

5.3.3 Measurement of lipid peroxidation and liposome size
Peroxidation was measured using oxygen consumption as a measure of peroxyl
formation. Oxygen consumption was measured using Clarke-type microelectrodes
(Strathkelvin Instruments) with up to six electrodes used simultaneously. Oxygen
consumption measurements were made over 2 hr periods at 37 oC using a RC-650 sixelectrode respirometer. Oxygen consumption data was acquired each second from each
microelectrode using a Six-Channel Oxygen Meter (Strathkelvin Instruments). Oxygen
electrodes were prepared fresh daily using high sensitivity, fast response membranes
(YSI Life Sciences, Morningside, Australia). Care was taken to remove any trace of
lipid hydroperoxides adhering to the respiration wells between experiments. Prior to any
measurement, microelectrodes were allowed to stabilise and thermally equilibrate to
37oC for a minimum period of 30 min. Incubations were stirred continuously during
experimentation. Microelectrode calibration was performed as per manufacturer's
instruction using air saturated, filtered deionised water with sodium sulfate used to
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determine oxygen range. At 37 oC the oxygen concentration used was 6.73 mg or 210.3
µmol of oxygen/L of water at prevailing atmospheric pressure.
Peroxidation was initiated using 10 µM ferrous iron derived from ammonium
ferrous sulfate (pH 3–4). Liposomes were made up to a final concentration of 2.5 mM,
with PPLs present at between 2.5 and 0.5 mM and non-PPLs added from 0.5 to 2.0 mM
(20–80%). Graphs show the decrease in PPL and increase in non-PPL from left to right.
The inset in each figure show the same experiment carried for liposomes composed of
the same amount of PPL only (2.5–0.5 mM). Except for the period of the lag phase
(TLag), all measurements are normalised for the concentration of PPL. Measurements
made during peroxidation included: rate of peroxidation during the lag phase (RLag),
maximum rate of peroxidation during the propagation phase (RMax), duration of the lag
phase (TLag) and total amount of oxygen consumed during the lag phase (ALag), as
shown in Figure 2.9. RLag and RMax were determined using segmental linear regression
analysis GraphPad Prism 5.04 (GraphPad Software, San Diego, USA) where the model
divided the data into RLag and RMax segments for each replicate and using an iterative
process proceeded to determine the best fit for each segment. The duration of the TLag
was taken as the period between the point of ferrous iron addition to the point of
intersection between the derived RLag and RMax segments [96].
Liposome size was determined using a Malvern Zetasizer (Malvern, UK) at a
refractive index of 1.46 at 37 oC. Measurements were taken before and after each
experiment with liposomes found to vary in size between 140 and 155nm. No
significant change in liposome size was detected as a result of time of incubation (120
min), phospholipid composition or peroxidation. All results were analysed using 2-way
ANOVAs with Bonferroni post-hoc tests using GraphPad Prism 5.04.

5.4

Results

5.4.1 Extension of the lag phase
The duration of the lag phases (TLag) of liposomes composed of the peroxidisable
phospholipids (PPLs) Soy PC (Figure 5.1A) and PC 16:0/18:2 (Figure 5.1B) were
extended by the presence of the non-PPLs PC 16:0/16:0 or PC 16:0/18:1. The insets in
each figure show TLag in the absence of non-PPLs at the same concentration of PPL as
in the main graphs (2.5 mM down to 0.5 mM). In the absence of non-PPLs,
concentrations of 2.5 to 0.5 mM of Soy PC and PC 16:0/18:2 showed no change in the
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duration of their lag phases (Figure 5.1 insets). The presence of either non-PPL with
Soy PC or PC 16:0/18:2 increased the TLag significantly when present at 60% and 80%
of liposomal phospholipids. The presence of PC 16:0/16:0 increased the TLag of Soy PC
by up to 4.7–fold and that of PC 16:0/18:2 by up to 2.6–fold. In comparison, the
presence of PC 16:0/18:1 increased the TLag of Soy PC by up to 3.1–fold and that of PC
16:0/18:2 by up to 5.3–fold. One major difference between the two PPLs was the
duration of TLag in the absence of non-PPLs which was approximately 9–fold longer for
Soy PC compared to PC 16:0/18:2 (3.9–7.0 min for Soy PC compared to 0.43–0.79 min
for PC 16:0/18:2).
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Figure 5.1. The period of the lag phase (TLag) during iron-mediated peroxidation of the
peroxidisable phospholipids (PPLs) Soy PC (A) and PC 16:0/18:2 (B) in the presence of the
non-peroxidisable phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1. PPLs were
measured at concentrations between 2.5 and 0.5 mM, with non-PPLs added to make all final
concentrations of phospholipid 2.5 mM. The inset in each figure shows the response of each
PPL in the absence of any non-PPL across the same concentration range (2.5–0.5 mM).
Peroxidation was initiated with 10 µM ammonium ferrous sulphate. Values are averages ±SEM,
n=6. Significant differences between PPLs in the presence (main graph) and absence (inset) of
non-PPLs are indicated with * for P<0.05 and *** for P<0.001.
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5.4.2 Changes in rate
The ability of non-PPLs to increase the duration of the lag phase of PPLs appears to be
due to their capacity to reduce rates of peroxidation (Note: with the exception of TLag all
other parameters were normalised to account for the differences in PPL concentration).
This is shown in the rates of peroxidation during the lag (RLag, Figure 5.2A and B) and
propagation (RMax; Figure 5.3A and B) phases of Soy PC and PC 16:0/18:2 respectively.
The RLag and RMax values remain constant across an increasing percentage of both
non-PPLs. The RLag and RMax were lower for Soy PC than PC 16:0/18:2, and both
non-PPLs had similar effects on the rates. In the absence of non-PPLs, the RLag of Soy
PC increased 2.1–fold (from 1.4 to 3.0 mmol of O2 per mole of Soy PC per minute,
Figure 5.3A inset) and that of PC 16:0/18:2 increased 3.2–fold (from 3.6 to 11.7 mmol
of O2 per mole of PC 16:0/18:2 per minute, Figure 5.3B inset). Similarly, in the absence
of non-PPLs, the RMax of Soy PC increased 2.1–fold (Figure 5.3A inset) and that of PC
16:0/18:2 by 1.3–fold (Figure 5.3B inset).
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Figure 5.3. Rates of iron-initiated peroxidation during the propagation phase (RMax) of the
peroxidisable phospholipids (PPLs) A) Soy PC and B) PC 16:0/18:2 in the presence of the nonperoxidisable phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1. PPLs were measured
at concentrations between 2.5 and 0.5 mM, with non-PPLs added to make all final
concentrations of phospholipid 2.5 mM. The inset in each figure shows the response of each
PPL in the absence of any non-PPL across the same concentration range (2.5–0.5 mM). Rates
were normalised for differences in the concentration of PPL. Peroxidation was initiated with 10
µM ammonium ferrous sulphate. Values are averages ±SEM, n=6. Significant differences
between PPLs in the presence and absence of non-PPLs are indicated with * for P<0.05 and ***
for P<0.001. In the insets, # indicates significant differences at P<0.05 for values in comparison
to the original PPL concentration of 2.5 mM.

The ability of non-PPLs to inhibit the RLag was supported by measurements of the
total amount of oxygen consumed during the lag phase (ALag) by Soy PC and synthetic
PC 16:0/18:2. The presence of non-PPLs increased the total amount of oxygen
consumed during the lag phase of both Soy PC (Figure 5.4A) and PC 16:0/18:2 (Figure
5.4B), being statistically significant when present at 80% of liposomal phospholipid.
This inhibition is likely due to the ability of each PPL to reach a critical level of
peroxidation product (presumably peroxyl radicals) needed to transition into the
propagation phase.
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Figure 5.4. Amount of O2 consumed by the end of the lag phase (ALag) of iron-mediated
peroxidation of the peroxidisable phospholipids (PPLs) A) Soy PC and B) PC 16:0/18:2 in the
presence of the non-peroxidisable phospholipids (non-PPLs) PC 16:0/16:0 and PC 16:0/18:1.
PPLs were measured at concentrations between 2.5 and 0.5 mM, with non-PPLs added to make
all final concentrations of phospholipid 2.5 mM. The inset in each figure shows the response of
each PPL in the absence of any non-PPL across the same concentration range (2.5–0.5 mM). All
parameters measured were normalised for differences in the concentration of PPL. Values are
averages ±SEM, n=6. Significant differences between PPLs in the presence and absence of nonPPLs are indicated with * for P<0.05 and *** for P<0.001. In the insets, # indicates significant
differences at P<0.05 for values in comparison to the original PPL concentration of 2.5 mM.

5.4.3 The importance of the ratio of Fe2+ to PPL
The increases in normalized rates of peroxidation of PPLs seen with decreasing PPL
concentration can be explained by changes in the ratio of Fe2+ to PPL. This presumably
occurs because 10 µM ferrous iron did not produce a maximal peroxidation response,
and as the concentration of each PPL decreased (in the absence of non-PPLs) the ratio
of Fe2+ to PPL increased from 1:250 to 1:50. To test the importance of relative
concentrations of Fe2+ to PPLs, the RMax of Soy PC was measured at both variable
(1:250 to 1:50) and constant (1:250) Fe2+:PPL ratios. The result shows that increases in
the RMax were removed once the ratio of Fe2+ to PPL ratio was held constant (Figure
5.5).
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Figure 5.5. The relative maximal rates of peroxidation (Rmax) of Soy PC at either constant
(1:250) or increasing (1:250 to 1:50) ratios of Fe2+ to Soy PC. Statistical differences show
comparisons between measurements at the same Soy PC concentration but different Fe2+:Soy
PC ratios. Values are averages ±SEM, n=6, *** indicates a significant difference at P<0.001.

5.5

Discussion

5.5.1 Non-peroxidisable phospholipids have an antioxidant-like action
Antioxidant molecules and enzymes are considered key defences in controlling the
radical-generating reactions of peroxidation. These defences act by extending the lag
phase of peroxidation, thus preventing the transition to the more damaging propagation
phase [96, 108], and so the duration of the lag phase is commonly considered to reflect
the antioxidant status of membranes [108]. Many factors influence peroxidation
including both physical and chemical aspects of the lipid and their packing within
membranes, with the polyunsaturated fatty acid (PUFA) content being particularly
important [15, 64]. The role of non-peroxidisable phospholipids (non-PPLs) containing
saturated fatty acids (SFA) or monounsaturated fatty acids (MUFA) in influencing
peroxidation has been only examined in a limited number of studies [16, 221]. The
present work suggests that these non-PPLs can produce an antioxidant-like action that
protects peroxidisable phospholipids (PPLs), therefore preventing the propagation of
peroxidation in membranes. This action appears to be accomplished by decreasing the
overall rate of peroxidation during the lag phase and impeding the build-up of
peroxidation product necessary to enter into propagation phase. As a result, the presence
of non-PPLs extends the duration of the lag phase which is likely to be the most
important antioxidant-like action produced by these phospholipids in membranes. NonPPLS commonly account for about half of the phospholipid molecules found in
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membranes [18], and it is at this level that the significant antioxidant-like activity of
non-PPLs extends the lag phase by 2.5–fold to 5.3–fold.
The antioxidant-like action of non-PPLs was found to have a greater influence on
the extracted Soy PC than the synthetic PC 16:0/18:2 even though these two
phospholipids have a similar acyl composition. Soy lecithin, which is primarily soy PC,
has a high level of antioxidants [222] and so the extended lag phase of Soy PC is likely
due to the presence of antioxidants co-extracted during purification. If this is the case,
the greater influence of non-PPLs on Soy PC than PC 16:0/18:2 suggests a synergistic
action of the antioxidants present in Soy PC with the antioxidant-like action of the nonPPLs. Such an action could reduce the levels of antioxidant needed in membranes to
control peroxidation reactions by providing more time for antioxidants to be recycled or
for damaged phospholipids to be removed.
Indications of some antioxidant-like actions for non-peroxidisable phospholipids
have been previously reported by Lee et al. (1998) [16] who examined liposomes
containing phosphatidylcholines with a constant proportion of 18:2n-6 (37.5%) and
varying amounts of 18:1n-9 and 16:0. This study found that “when 16:0 was replaced
by 18:1 there was a marked increase in the lag time”. The study of Lee et al. did not
vary the concentration of non-PPLs and emphasised the role of 18:1n-9. In the present
work, the concentration of non-PPLs varied and both PC 16:0/16:0 and 16:0/18:1 were
found to be capable of extending the lag phase of Soy PC and PC 16:0/18:2. An
antioxidant-like action for PC 16:0/16:0 has also been shown in the study of
Soto-Arriaza et al. (2008) [221] examining the peroxidation of liposomes made-up of
egg PC and varying amounts of PC 16:0/16:0 (0–60 mol%). This study found that PC
16:0/16:0 inhibited peroxidation “beyond that expected from the unsaturated lipid
dilution”. The antioxidant action was interpreted as being due to a rigidification of the
bilayer and ‘capture’ of initiating radicals. This explanation is slightly contrary to the
result of the present study where PC 16:0/16:0 and PC 16:0/18:1 were both found to
display antioxidant-like activity even though their transition temperatures are quite
different, (41.5 oC for PC 16:0/16:0 and –2 oC for PC 16:0/18:1 [223]). It is therefore
possible that the antioxidant-like action of these non-PPL works by steric hindrance
without requiring rigidification. The peroxidation reaction requires lipid radicals to
come in contact with each other in the plane of the monolayer in order to continue
peroxidation and this requires diffusion as peroxidation appears not to cross monolayers
within the bilayer [23]. The presence of non-PPL may ‘cage’ lipid radicals within the
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monolayer and thus slow rates of peroxidation. The ability of different non-PPLs to
perform this task is likely to depend upon their individual structure and acyl
composition. This mechanism appears not to be a simple linear dilution effect as shown
for PC 16:0/18:2 where a 20% increase in PC 16:0/18:1 (60–80%) increased lag
duration 3–fold.

5.5.2 Methodological considerations
One reason the antioxidant-like action of non-PPL has only been recognised in a small
number of studies is that most peroxidation studies use high levels of initiator (e.g.
AAPH, Cu2+, Fe2+, or radiation) to maximize the peroxidation response. The levels of
ferrous iron needed to produce a maximal peroxidation response (100–1000 µM) would
have overwhelmed any protective effect of the non-PPL. In the present study, the use of
a submaximal ferrous iron concentration (10 µM) added extra complexity due to
variable ratios of Fe2+ to PPLs, but did allow non-PPLs to exhibit their antioxidant
capacity. As even a 10 µM ferrous iron peroxidation stimulus is likely to be extremely
high in vivo, the strength of the antioxidant-like action of non-PPLs in the membrane of
normal working cells is likely to be biological relevant.

5.5.3 Limitations
The use of oxygen consumption to measure peroxidation addresses the limitations of the
methods used in Chapter Four. A general limitation of the in vitro studies presented in
this thesis was the use of a single initiator, iron, in peroxidation assays. Iron-initiated
peroxidation is biologically relevant but chemically complex. Radical clocks such as
AAPH produce ROS at a known rate and could have been used to better determine the
kinetics of the peroxidation reactions [5, 96], but these kinetics are still complex [224]
and initiating peroxidation in this manner may not accurately model physiological
conditions. Future studies of peroxidation would benefit from the use of multiple
initiators including AAPH, iron, copper and haem to ensure that results are not limited
to a single initiator. In addition, future work could also be extended to examine the
importance of other major components of membranes such as proteins to this
antioxidant-like activity.
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5.6

Conclusion

Phospholipids composed of SFA and MUFA are present in cellular membranes at
sufficient concentrations to extend the lag phase of peroxidation. This study shows these
non-PPLs may play an important role in protecting membranes from peroxidation by
extending the lag phase in a newly-described antioxidant-like action. It is suggested that
this antioxidant-like action may assist cells at controlling peroxidation in membranes by
working synergistically with other antioxidant defences. Future would in this area could
test the homogeneity of these results with peroxidation caused by AAPH, and would
also benefit from examining this effect in other phospholipid classes.
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Chapter Six
Of mice, pigs and humans: A lipidomics analysis of mitochondrial
phospholipids from mammals with very different maximal lifespans

6.1

Overview

Maximal lifespan (MLS) has been found to be inversely related to the degree of
membrane unsaturation, particularly of polyunsaturated fatty acids (PUFA). Previous
comparative work in this area has examined membrane composition at the level of fatty
acids, but little is known regarding the influence of phospholipid classes and individual
phospholipid molecules. In addition, data for humans is extremely rare in this area. This
chapter presents a shotgun lipidomics analysis of mitochondrial membranes and the
peroxidation index of skeletal muscle, liver, and brain in three mammals that span the
range of mammalian longevity. This work is closely based on ‘Of mice, pigs and
humans: A lipidomics analysis of mitochondrial phospholipids from mammals with
very different maximal lifespans’ by Cortie CH, Hulbert AJ, Norris SE, Mitchell TW,
McAndrew D, and Else PL, published in Experimental Gerontology, 2015, 70: 135-143.
This chapter differs from the submitted work to avoid repetition with earlier chapters.
CHC collected and analysed the samples, wrote the Excel algorithms used to identify
molecular phospholipids and determine fatty acid composition, and drafted the article.
SEN and TWM assisted in developing the mass spectrometry methods used. PLE and
AJH designed the study, supervised the work, and assisted with drafting the article.

6.2

Introduction

Animal longevity has been inversely correlated with mitochondrial production of
reactive oxygen species (ROS) and the degree of fatty acid unsaturation in membranes
[12, 14]. These factors are closely related as ROS are both a cause and a product of the
peroxidation of polyunsaturated fatty acids (PUFA) [5]. Propagation of peroxidation can
adversely affect cell function by forming adducts with DNA and proteins, disrupting the
structure of cell membranes, and propagating damage to lipids [4, 65]. The peroxidation
of mitochondrial membranes is particularly important as mitochondria are the major
source of ROS within cells [14] and mitochondrial failure is an indicator of aging [118].
Peroxidation primarily occurs at bis-allylic methylene groups as the reduction potential
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of these groups is lower than that of other methylene groups [73]. Bis-allylic methylene
groups are present in PUFA, but saturated fatty acids (SFA) and monounsaturated fatty
acids (MUFA) do not contain these groups and are resistant to peroxidation. The
number of bis-allylic methylene groups present in PUFA, and therefore the relative
susceptibility of membranes to peroxidation, increases with the degree of
polyunsaturation [21, 22]. Common mammalian PUFA include linoleic acid (18:2n-6)
with one bis-allylic methylene group, arachidonic acid (20:4n-6) with three groups, and
docosahexaenoic acid (22:6n-3) with five groups.
The relative susceptibility of cellular membranes to peroxidation, termed a
peroxidation index, can be determined from membrane composition and experimentally
derived rates of peroxidation [12, 35]. A strong inverse correlation has been established
between the peroxidation index and maximal lifespan (MLS) of skeletal muscle and
liver mitochondria for a range of mammals [34, 35]. This relationship is best
characterised for mammals, but similar relationships have also been found for birds
[12], molluscs [37], bees [38], and strains of Caenorhabditis elegans [39]. Despite the
breadth of prior work in this area it is not known 1) whether results for muscle
mitochondrial membranes correspond to whole muscle, 2) if brain mitochondria exhibit
a similar relationship between the peroxidation index and MLS as found in skeletal
muscle and liver and 3) how different phospholipid classes and phospholipid molecules
contribute to the peroxidation index.
To address these questions, an in-depth lipidomics analysis was conducted using
the common mouse (Mus musculus, MLS of 4 years), the domestic pig (Sus scofa, MLS
of 27 years), and humans (Homo sapiens, MLS of 122 years). Mice and humans were
chosen as examples of the extremes of mammal longevity (AnAge Database), and as
data for human mitochondria is extremely rare. Pigs were chosen as they have a similar
body mass to humans but a much shorter maximal lifespan. Shotgun lipidomics was
used to determine phospholipid composition of mitochondrial-enriched fractions of
skeletal muscle, liver and brain of each animal, and calculated the fatty acid
composition and peroxidation index of mitochondrial membranes from phospholipid
values.
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Methods

6.3.1 Materials
Methanol and chloroform (HPLC grade or higher) were supplied by VWR International
(Queensland, Australia). Analytical grade ammonium acetate was obtained from Crown
Scientific (New South Wales, Australia). Sucrose, Tris, and ethylenediaminetetraacetic
acid (EDTA) were supplied by Astral Scientific (New South Wales, Australia). Pierce
BCA Protein Assay Kits were obtained from Thermo Fisher Scientific (Victoria,
Australia). Butylated hydroxytoluene (BHT) was supplied by Sigma-Aldrich, (New
South Wales, Australia). Phospholipid internal standards were purchased from Avanti
Polar Lipids through Auspep (Victoria, Australia) and consisted of 20 µM of PC
19:0_19:0, PE 17:0_17:0, and PS 17:0_17:0 and 10 µM of lyso-PC 17:0 and lyso-PE
14:0. Internal standards were stored in 2:1 chloroform to methanol at –20 °C.

6.3.2 Animals and tissues
Skeletal muscle, liver and brain tissue samples were harvested from six mice (Mus
musculus C57BL6; female) 12 months of age, six domestic pigs (Sus scrofa domesticus;
mixed gender) approximately 6 months of age and six humans (Homo sapiens; mixed
gender) ranging in age from 64 to 104 years. Mouse tissue was harvested immediately
following euthanasia by CO2 inhalation. Pig tissue was harvested immediately following
the death of each animal at the Wollondilly Abattoir (Picton, New South Wales,
Australia). Human tissue was provided by the University of Wollongong body donation
program (ethics number HE12/373). The post-mortem interval for human tissue was
between three to seven days with the bodies maintained at 2–4 oC. Skeletal muscle was
harvested from the intercostal muscle of all three mammals. Human liver was harvest by
percutaneous liver biopsy. Similar regions of mouse and pig liver were taken following
removal of the whole liver. Brain was harvested from humans through a burr hole
approximately 20 mm superior to the external acoustic meatus by means of a surgical
drill and a cutting biopsy needle. A similar region of the brain was harvested from mice
and pigs following decapitation.
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6.3.3 Subcellular fractionation and lipid extraction
Approximately 100 mg of tissue was extracted in 10% homogenising solution
containing 20 mM Tris buffer, 250 mM sucrose and 2 mM EDTA, pH 7.4. The tissue
was homogenated in glass-glass homogenizers and the homogenate was centrifuged (10
min, 1,000 x g) to give a pellet containing nuclei and large cellular debris. Supernatant
was collected and centrifuged (35 min, 10,000 x g) to produce a mitochondria-enriched
pellet. All centrifugation steps were performed at 4°C. Characterization of the
mitochondrial fraction was performed in preliminary work using lamb brain using
cytochrome c as a mitochondrial marker and Na+/K ATPase as a marker for microsomal
membrane. This assessment found a high level of cytochrome c but low levels of Na+/K
ATPase in the mitochondrial fraction but low levels of cytochrome c in the microsomal
fraction. Mitochondrial pellets were resuspended in milliQ H2O and total protein
content was determined. Protein concentrations were determined using a BCA assay.
Aliquots containing 75 µg of total protein and 50 µL of an internal standard mixture
were added to 2 mL chloroform: methanol (2:1 v/v with 0.01% BHT). Phospholipid
internal standards consisted of 20 µM each of PC 19:0/19:0, PE 17:0/17:0, and PS
17:0/17:0: and 10 µM lyso-PC 17:0 and lyso-PE 14:0 in chloroform: methanol were
purchased from Avanti Polar Lipids through Auspep (VIC, Australia). Lipids were
extracted using a modified Folch method as previously described in Deeley et al (2008)
[225]. Lipid extracts were reconstituted in 1 mL chloroform:methanol (1:2 v/v) and
stored at -20°C until analysed.

6.3.4 Mass spectrometry and bioinformatics analysis
Nano-electrospray ionization mass spectrometry of lipid extracts was performed using a
hybrid triple quadrupole linear ion trap mass spectrometer (QTRAP® 5500 AB Sciex,
MA, USA) equipped with an automated chip-based nano-electrospray source (TriVersa
Nanomate™, Advion Biosciences, NY, USA). Samples were diluted to approximately
10 µM for total phospholipid, and 50 µl of diluted sample was spiked with 50 µl of
ammonium acetate in chloroform and methanol (1:2 v/v) for a final concentration of
5 mM of ammonium acetate. Samples were loaded onto 96–well plates. Plates were
centrifuged (10 min, 2200 x g) prior to direct infusion. Spray parameters were set at a
gas pressure of 0.4 psi and a voltage of 1.2 kV and 1.1 kV for positive and negative ion
mode respectively for all acquisitions.
76

6.3 Methods

Phospholipid data was acquired by targeted ion scans using multi-channel
acquisition. All scans used are listed in Appendix A. As a result of the ammonium
acetate, phospholipids of all classes were protonated (M+H)+ in the positive ion mode,
phospholipids of the PC class formed acetate ions (M+OAc)- in the negative ion mode,
and phospholipids of PE, PS, PG and PA formed anions (M-H)- in the negative ion
mode. Target lists for these charged phospholipids were made using the
Glycerophospholipid MS/MS Prediction tool (www.lipidmaps.org) and converted to
targeted ion lists for use in Lipidview™. Phospholipids of the PC, PE and PS classes
were quantified from internal standards using positive ion scans for head groups while
phospholipids in the PG and PA classes were quantified from internal standards using
negative precursor ion scans for fatty acids. Phospholipid molecular species were
determined from positive and negative scans was using custom-written spreadsheets in
Microsoft Excel 2010 (Microsoft Corporation, Redmond, USA). Phospholipids were
first quantified at the sum composition level, e.g. PC 34:1 from head group scans before
the molecular level composition was determined, e.g. PC 16:0_18:1. Negative precursor
ion scans were also used to quantify phospholipid isobaric species within classes.
Isobaric phospholipid species containing either alkyl ethers or vinyl ethers
(plasmalogens) could not be differentiated using this method and therefore the sum of
alkyl ethers and plasmalogens were reported. Processing settings in LipidView™
software were set at a mass tolerance of 0.5 Da, with a minimum intensity of 0.1% and
a minimum signal-to-noise ratio of 10. Phospholipid species that comprised less than
0.5% of each phospholipid class across the tissue were present in less than 66% of the
tissue samples were removed from analysis. Values are normalized relative to total
concentration of phospholipid in each phospholipid class. Phospholipid structure was
reported using the nomenclature proposed by Liebisch et al. [74].

6.3.5 Fatty acid composition
Membrane fatty acid composition was calculated from quantified molecular
phospholipid species using custom Excel calculators. The fatty acid composition of the
combined phospholipid classes (PC, PE, PS, PG, and PA) were calculated, and the fatty
acid composition of PC, PE and PS were calculated for each class. The sum of saturated
fatty acids (SFA) included ether-linked species. As double bond position with fatty
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acids could not be determined using the method of analysis, all fatty acids are reported
without omega-designations.

6.3.6 The peroxidation index
The peroxidation index was calculated from membrane composition as (% MUFA x
0.025) + (% PUFA with 1 bis-allylic methylene group x 1) + (% PUFA with 2 bisallylic methylene groups x 2) + (% PUFA with 3 bis-allylic methylene groups x 4) + (%
PUFA with 4 bis-allylic methylene groups x 6) + (% PUFA with 5 bis-allylic methylene
groups x 8) based on experimental values from [21]. This gives a peroxidation index per
100 fatty acids. The relative contribution of each phospholipid class to the peroxidation
index was calculated as the peroxidation index of each class multiplied by the relative
abundance of each class. This calculation gave the relative contribution of each class as
a percentage of the total peroxidation index. Similarly, the contributions of molecular
phospholipids to the peroxidation index were calculated from he peroxidation index and
relative abundance of molecular phospholipids

6.3.7 Statistical analysis
Two-way ANOVAs (animal x measure) with Bonferroni post-hoc tests were used for all
comparisons. All statistical analyses were completed using GraphPad Prism 5.04
(GraphPad Software, San Diego, USA).

6.4

Results

6.4.1 Phospholipid composition of skeletal muscle mitochondria
Greater than 85% of phospholipids found in the mitochondria of skeletal muscle were
phosphatidylcholines

(PC)

and

phosphatidylethanolamines

(PE),

10%

were

phosphatidylserines (PS) and less than 5% were phosphatidylglycerols (PG) and
phosphatidic acids (PA) (Figure 6.1A). Phosphatidylinositol (PI) was not examined due
to a PI standard not being available for use. Mice and pigs possessed a lower percentage
of PC and a higher percentage of PE than humans. No significant difference was found
in the relative distribution of PS between species. PA was present in mouse muscle
mitochondria but was absent in human and pig muscle. The muscle mitochondria of
mice possessed a much higher percentage of phospholipids containing multiple bis78
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allylic methylene groups than humans or pigs (Figure 6.2A). This occurred throughout
the phospholipid classes and included PC 16:0_20:4 with three bis-allylic methylene
groups, and PC 16:0_22:6, PE 18:0_22:6 and PS 18:0_22:6 which each have five bisallylic methylene groups. In contrast, human and pig mitochondria had much lower
levels of these highly peroxidative phospholipids but had a higher abundance of
phospholipids containing 18:2, the PUFA containing only one bis-allylic methylene
group. These phospholipids included PC 16:0_18:2 and PE 18:0_18:2. Mouse and pig
muscle shared similar levels of phospholipid resistant to peroxidation such as PC
16:0_18:1 with humans having more of these peroxidation resistant phospholipids,
including PC 16:0_18:1 as well as PC 18:1_18:1.

6.4.2 Phospholipid composition of liver mitochondria
The relative distribution of phospholipid classes in liver mitochondria was similar to
that found for muscle mitochondria, with PC, PE and PS accounting for the majority
(>90%) of phospholipids (Figure 6.1B). The percentages of PC, PE and PS did not
differ between mice and humans whereas pigs possessed a lower percentages of PC and
a higher percentage of PE than mice or humans. PS was also significantly higher in
mice than in the pigs. Mice and humans shared a similar high percentage of PE
18:0_20:4, whereas mice and pigs shared a high level of PS 18:0_20:4. Mice tended to
possess phospholipids with more bis-allylic methylene groups than humans (Figure
6.2B). Mice and humans shared similarly high levels of peroxidation-resistant PC
16:0_18:1 compared to pigs. Overall, differences between species were smaller in the
mitochondria of liver than found in skeletal muscle.
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Figure 6.1. Distribution of phospholipid classes in A) skeletal muscle mitochondria, B) liver
mitochondria and C) brain mitochondria of mice (M. musculus), pigs (S. scrofa) and humans (H.
sapiens). Values are presented as mean mol% of total phospholipids ±SEM, n=6. Significant
differences are indicated with *** for P<0.001. PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PS, phosphatidylserine; PG, phosphatidylglycerol PA, phosphatidic
acid.

6.4.3 Phospholipid composition of brain mitochondria
The distribution of PC and PE phospholipids in brain mitochondria was very similar in
mice and pigs, whereas humans had significantly more PC and less PE (Figure 6.1C).
The only other major difference was that PS was statistically lower in the mitochondria
of mice than pigs. The phospholipids with the most bis-allylic methylene groups in
brain mitochondria were species of PE and PS (Figure 6.2C). Of these, mice brain
contained a higher percentage of PE 16:0_22:6 but similar levels of PE 18:0_22:6 to
humans. Pigs had less PE 16:0_22:6 than mice and less PE 18:0_22:6 than mice and
humans. Interestingly, humans had more PS 18:0_22:6 than the other two species. Two
of the most common phospholipids in brain mitochondria were the peroxidation
resistant PC 16:0_16:0 and PC 16:0_18:1, with mice having more PC 16:0_16:0 and
humans more PC 16:0_18:1.
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Figure 6.2. Common phospholipid compositions for A) phosphatidylcholine (PC), B)
phosphatidylethanolamine (PE), and C) phosphatidylserine (PS) of mitochondria isolated from
the tissues of mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). Values are
presented as mean mol% of total phospholipids in each class ±SEM, n=6. Significant
differences are indicated with * for P<0.05, ** for P<0.01 and *** for P<0.001.
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6.4.4 Fatty acid composition by class
The fatty acid composition of total phospholipids (PC, PE, PS, PG, and PA) for muscle,
liver and brain mitochondria of mice, pigs, and humans are shown in Table 6.1. The
most common types of fatty acids in the combined phospholipid fraction were saturated
fatty acids (SFA) including alkenyl ethers and vinyl ethaers (plasmalogens), which
comprised 39–46% of fatty acids in muscle mitochondria, 44–45% in liver
mitochondria, and 50–54% in brain mitochondria. The mitochondria of mice and pigs
contained around 13–20% monounsaturated fatty acids (MUFA), but the mitochondria
of humans had a higher percentage of MUFA. Mouse and pig mitochondria contained
higher percentages of polyunsaturated fatty acids (PUFA) in muscle, liver, and brain
compared to humans. Mouse mitochondria invariably contain higher percentages of
22:6, the fatty acid with the most bis-allylic methylene groups, than either pigs or
humans. For all tissues, mouse mitochondria contained a higher percentage of 22:6. Pig
mitochondria contained more 18:2 in muscle, 22:5 in liver and brain, and 22:4 in brain.
All species possessed high levels of 20:4 in all tissues.
Table 6.2 shows the PUFA composition of the major phospholipid classes (PC,
PE, and PS) in each tissue for each species. In most cases, PE contained the highest
percentage of PUFA and the highest levels of 22:6, with the only exception being PS in
liver. Muscle mitochondria in mice were unique as it was the only tissue in which 22:6
was present at high percentages in PC, PE and PS. Human mitochondria contained a
lower percentage of PUFA than mice or pigs in PC, PE, and PS. Of the tissues
examined, liver mitochondria showed the smallest difference in total PUFA and 22:6
content between the three animals. In most tissues, values for pig mitochondria were
intermediate between values for mouse and human mitochondria. Interestingly, PUFA
was lower in the PC (3.4%) and higher in the PE (54%) of human brain mitochondria
than in any other tissue mitochondria examined.
As alkyl ethers and plasmalogens could not be differentiated and were reported
together. These ethers were most commonly found in the PE phospholipids of
mitochondria, and were lower in the mitochondria of muscle and brain of mice than in
humans and pigs (Table 6.3).). Alkyl ethers and plasmalogens were largely absent in the
PC and PS phospholipids for all tissue (<3%) with the exception of pig muscle.
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Table 6.1. Acyl composition (mol%) of the combined phospholipids of mitochondria from mouse, pig, and human tissues
Skeletal Muscle

Liver

Brain

Mouse

Pig

Human

Mouse

Pig

Human

Mouse

Pig

Human

16:0

26.0±0.7P

19.2±0.4M,H

25.9±2.5P

23.5±1.9P

14.3±0.3M,H

27.8±2.5P

23.9±1.6P

19.6±1.2M,H

23.9 ±1.8P

18:0

19.4±0.9P,H

12.6±0.8M

10.5±1.2M

20.5±1.0P

28.8±0.6M,H

16.6±1.5P

26.3±1H

24.7±0.6

22.5 ±1.4M

18:1

10.9±0.7P,H

15.2±0.9M,H

25.5±1.3M,P

18.0±0.9

15.0±0.7H

21.0±2P

18.5±0.4H

19.1±0.9H

24.5±1.0M,P

18:2

7.8±0.8P,H

30.5±1M,H

20.4±1.2M,P

12.7±1.8

13.2±0.5

12.3±1.6

0.3±0.1

0.6±0.2

0.3±0.1

7.0±0.7

4.3±0.2M

Fatty acid

20:4

8.3±0.8

7.2±0.6

6.5±1.3

16.9±2.5

16.9±0.8

13.2±1.9

8.2±0.1

22:4

0.9±0.4

1.4±0.2

0.8±0.2

0.7±0.2

0.9±0.1

0.5±0.1

1.9±0.1P

6.3±0.6M

5.1±0.5

1.8±0.4

P

6.2±0.6

M

2.5±0.4

8.2±0.4

M

9.9±0.9M

22:5
22:6

3.8±0.6
19.6±1.4

1.3±0.3
P,H

0.6±0.1

M

1.6±0.5
1.4±0.2

0.1±0.0

2.7±0.2

M

5.3±0.5

3.0±0.3

2.9±0.4

1.6±0.3
14.3±0.3

P,H
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ΣSFA

46.2±0.8P,H

39.7±0.4M

39.2±1.4M

44.5±1.7

44.0±0.4

45.6±1.3

54.4±0.4P

50.1±0.9M

ΣMUFA

13.0±0.5H

15.5±0.8H

28.4±1.3M,P

18.5±1.0

16.5±0.8H

23.2±1.9P

18.6±0.4H

20.0±0.9H

26±1.2M,P

ΣPUFA

40.4±0.7H

41.0±0.9H

30.7±2.0M,P

35.6±1.8

36.7±0.7H

30.7±2.9P

26.2±0.4H

28.4±0.7H

22.1±1.2M,P

51.3±0.8

Values are mean mol% of the combined phospholipid fraction ±SEM, n=6. Superscript indicates significant differences of mean within the
corresponding tissue at P<0.05: M, mouse (M. musculus); P, pig (S. scrofa) and; H, human (H. sapiens). Combined acyl composition was calculated from
quantified molecular species of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, and phosphatidic acid of
mitochondria. Acyls less than 3 mol% of all tissues are not listed but have been included in all calculations. ∑SFA, total saturated fatty acids including
acyl ethers; ∑MUFA, total monounsaturated fatty acids; ∑PUFA, total polyunsaturated fatty acids.
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Table 6.2. Polyunsaturated fatty acid composition (mol% of total fatty acids) in mitochondrial phosphatidylcholine,
phosphatidylethanolamine, and phosphatidylserine.
Skeletal muscle
Pig

Liver
Pig

Human

21.8±1.2M,P
4.1±0.9M
0.4±0.2
0.9±0.3
0.1±0.0M
39.8±1.5M
31.4±1.2M,P
27.4±2.1P

18.7±2.2
8.2±1.0
0.0±0.0
0.0±0.0
2.0±0.5
45.2±2.8
24.0±2.9
28.9±2.1

16.3±0.4
9.8±0.6H
0.2±0.0
1.9±0.2
1.6±0.2
46.0±0.3
21.0±0.9
29.7±0.7

16.9±2.7
4.5±1.3P
0.0±0.0
0.8±0.2
1.0±0.3
46.7±2.0
29.6±2.9
23.1±2.7

0.6±0.1
5.4±0.2H
0.0±0.0P
0.0±0.0
4.1±0.2P,H
64.6±0.4P,H
24.1±0.4P,H
10.0±0.0H

0.5±0.2
2.8±0.8
1.6±0.6M,H
0.0±0.0
2.3±0.3M,H
61.5±0.7M,H
30.8±0.7M,H
7.1±0.5H

0.5±0.1
2.8±0.2M
0.0±0.0P
0.0±0.0
0.0±0.0M,P
57.4±1.3M,P
38.4±1.0M,P
3.4±0.3M,P

28.3±1.5 M
13.6±1.4
3.5±0.5
3.3±0.6
0.4±0.1 M
33.3±1.6 M
10.0±0.7
49.2±0.8

19.3±3.0
16.5±1.7
3.3±0.8
4.0±1.2
1.1±0.4M
36.4±1.2M
15.5±2.5M
44.2±2.2

0.0±0.0
38.2±3.7
2.6±0.8
0.0±0.0
9.3±2.9
41.7±1.8H
8.4±1.8H
50.0±0.0P

10.1±0.5
25.8±0.6
2.0±0.2
3.6±0.2
4.4±0.5
43.6±0.4
7.7±0.5H
45.9±0.2M

0.0±0.0
38.6±3.1
1.4±0.6
4.3±1.2
5.2±1.4
47.0±0.8M
2.5±0.8P,H
49.5±0.2

0.0±0.0
12.4±0.3
3.4±0.3
3.8±0.7
26.8±0.5
43.6±0.5
9.6±0.6H
46.2±0.9H

1.0±0.5
12.8±1.3
10.2±0.7
9.7±0.9
15.6±1.0
39.8±1.5H
7.8±1.5H
49.3±0.9H

0.0±0.0
7.6±0.9
14.8±1.6
6.8±1.1
24.8±1.3
43.8±0.7P
2.1±0.6M,P
53.9±1.0M,P

0.0±0.0
20.0±0.7
4.8±1.1
4.2±1.3
3.3±0.8 M
17.0±2.6 M
68.9±5.1 M,H
14.2±2.5 M

0.0±0.0
3.4±0.8
5.3±0.6
7.9±1.6
7.7±1.1M
27.7±3.0M
48.1±6.1M,P
24.2±3.1M

0.0±0.0
27.1±1.1H
1.8±0.5
1.5±0.5
16.6±0.7P
50.0±0H
3.0±0.4H
47.0±0.4

0.0±0.0
27.2±1.6H
2.6±0.5
6.3±0.5
10.1±1.6M
49.3±0.1
4.6±0.4H
46.1±0.3

0.0±0.0
15.5±3.4P,M
3.8±0.4
6.6±1.2
14.1±1.7
43.6±1.5M
16.4±3.7M,P
40.0±2.2P

0.0±0.0
5.2±0.2
5.3±0.4P
0.0±0P,H
8.9±0.7P,H
39.8±0.8
40.9±0.7P,H
19.3±0.9P,H

0.0±0.0
2.6±0.5
10.3±1.3M,P
9.3±1.7M,H
4.5±0.5M,H
4.9±0.5H
28.4±2.6M
26.6±2.4M,H

0.0±0.0
2.9±0.2
5.1±0.4P
3.3±0.2M,P
21.8±1.3M,P
39.4±0.4P
27.6±1.2M
33.1±0.9M,P

32.1±1.0 M,H
4.1±0.2 M
0.5±0.2
0.4±0.1
0.2±0.1 M
42.5±0.4 M
18.0±0.9H
37.3±1.0H

Phosphatidylethanolamine
18:2
6.7±2.1P
20:4
9.6±4.7
22:4
1.7±0.7
22:5
7.6±1.7
22:6
23.4±5P,H
ΣSFA
43.0±1.6P,H
ΣMUFA
7.6±1.7H
ΣPUFA
49.0±0.6
Phosphatidylserine
18:2
0.0±0.0
20:4
2.7±0.9
22:4
2.7±0.5
22:5
5.5±0.6
22:6
30.3±2.6P,H
ΣSFA
45.3±1.1P,H
ΣMUFA
13.4±2.5P,H
ΣPUFA
41.2±1.5P,H

Human

Mouse

Brain
Pig

Human

Values are mean mol% of the phospholipid classes, ±SEM, n=6. Superscript indicates significant differences of mean within the corresponding tissue at
P<0.05: M, mouse (M. musculus); P, pig (S. scrofa), and; H, human (H. sapiens). ∑SFA, total saturated fatty acids including acyl ethers; ∑MUFA, total
monounsaturated fatty acids; ∑ PUFA, total polyunsaturated fatty acids.
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Mouse

Mouse
Phosphatidylcholine
18:2
10.9±1.0P,H
20:4
10.8±0.9P,H
22:4
0.5±0.2
22:5
0.9±0.2
22:6
11.2±1.1P,H
ΣSFA
49.5±0.5P,H
ΣMUFA
15.9±0.5H
ΣPUFA
34.2±0.6

Table 6.3. Alkenyl ether and vinyl ether composition (mol% of total acyls, alkenyl ethers, and vinyl ehters) present in the combined
phospholipids, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine fractions of mitochondria.

Liver mitochondria
Mouse
Pig
Human

Mouse

0.4±0.1P,H
0.0±0.0P,H
1.0±0.3P,H
0.7±0.3

0.5±0.2
0.0±.0.0
2.6±0.8
0.0±0.0

0.4±0.2P,H
0.0±0.0H
0.9±0.4P,H
0.0±0.0

7.8±0.6M,H
10.0±0.7M,H
3.6±0.4M
0.0±0.0

2.1±0.3M,P
2.2±0.3M,P
2.8±0.5M
0.0±0.0

0.8±0.1
0.4±0.0
1.3±0.1
1.5±0.2

1.1±0.3
0.9±0.3
2.3±0.7
0.0±0.0

Brain mitochondria
Pig
Human
3.2±0.4M
0.0±0.0H
6.9±0.7M
1.4±0.4

3.2±0.6M
2.6±0.7M,P
5.3±1.0M
0.0±0.0
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Values are mean mol% of acyls of the phospholipid fraction, ±SEM, n=6. Superscript indicates significant differences of mean within the corresponding
tissue at P<0.05: M, mouse (M. musculus); P, pig (S. scrofa), and; H, human (H. sapiens). Acyl ethers represents the sum of acyls identified as
plasmalogens and alkyl ethers, but may also include odd-chain fatty acids. Combined phospholipid composition (combined PL) was calculated from
quantified molecular species of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, and phosphatidic acid
fractions of mitochondria.
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Combined PL
Phosphatidylcholine
Phosphatidylethanolamine
Phosphatidylserine

Skeletal muscle mitochondria
Mouse
Pig
Human

6.4 Results

6.4.5 The contributions of phospholipid class to peroxidation index
The peroxidation index of muscle, liver and brain mitochondria was higher in mice than
in humans, with this difference greater in muscle than liver and brain (Figure 6.3A). The
muscle mitochondria of mice had a peroxidation index 3 times that of humans, and the
peroxidation index of liver and brain mitochondria was higher in mice than humans.
The peroxidation index for pigs were more similar to those of humans for muscle, but
more similar to mice for liver and brain. Tissue-dependent differences in the
peroxidation index were not consistent between mice, humans and pigs. The
peroxidation index of mouse muscle mitochondria was nearly two times that of mouse
liver and brain mitochondria. In contrast, the peroxidation index of humans muscle was
lower than liver or brain. Overall, the peroxidation index of pigs was more similar to
humans than mice.
The relative contributions of PC, PE and PS to the peroxidation index were more
similar between animals than between tissues (Figure 6.3B). The relative contributions
of PC and PE phospholipids to the total peroxidation index were comparable in muscle
mitochondria, but PE was a larger contributor in liver mitochondria and the dominant
contributor in brain mitochondria where it accounts for over 80% of the total
peroxidation index. Interestingly, the relative contribution of PC to the total
peroxidation index of brain mitochondria decreased with MLS while the relative
contribution of PS increased.
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A) Peroxidation index of combined phospholipids
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Figure 6.3. The peroxidation index of A) the total phospholipid fractions and B) the contribution
of phospholipid class as a percentage of the peroxidation index in muscle, liver and brain
mitochondria of mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). The
contributions of each phospholipid class to peroxidation index was calculated as the
peroxidation index of each class multiplied by the percentage of each class (Figure 6.1). Values
are means ±SEM, n=6. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS,
phosphatidylserine. Significant differences are indicated with * for P<0.05, ** for P<0.01 and
*** for P<0.001.

6.5

Discussion

6.5.1 Peroxidation, membrane composition, and maximum life span
An inverse relationship has been found between maximal lifespan (MLS) and
membrane peroxidation index for mammals and other animal classes [12, 37-39]. In this
study, shotgun lipidomics was used to examine this relationship at the level of
molecular phospholipids and fatty acid composition in the mitochondria of muscle,
liver, and brain. This chapter is one of the most in-depth studies of the phospholipid
composition of mammalian mitochondrial membranes published to date. The
peroxidation index of muscle mitochondria of mice and humans was found to fit the
trends for whole skeletal muscle [29], and the peroxidation indexes for liver
mitochondria were similar to published trends [45]. The peroxidation index of brain
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mitochondria from mice and humans has not been previously described, but would seem
to fit with the differences found in other tissues of mice and humans with high values
for mice and lower values for humans. The peroxidation values of pig mitochondria
were similar to mice for liver and brain mitochondria but more similar to humans for
skeletal muscle mitochondria. Overall, the peroxidation index of pigs was lower than
expected for muscle and liver [29, 34], but the membrane composition of pig
mitochondria is consistent with past studies of membrane composition in pig muscle
that used gas chromatography to determine membrane composition [226].
The higher peroxidation values of mice mitochondria were due to both a higher
percentage of PUFA and a higher number of bis-allylic methylene groups per PUFA
than for humans. Muscle mitochondria of mice contained a high percentage of 22:6, the
PUFA with the most bis-allylic methylene groups and therefore the PUFA most
vulnerable to peroxidation. In comparison, human muscle mitochondria contained a
high percentage of 18:2, the PUFA with the least number of bis-allylic methylene
groups and therefore less susceptible to peroxidation. A similar difference was found in
brain mitochondria, but not in liver. No difference in PUFA profile was seen between
liver mitochondria of mice and humans, and differences in the peroxidation index were
due to the higher percentage of total PUFA in mice than humans. In contrast, pig
mitochondria had a higher percentage of total PUFA but a similar PUFA profile to
human mitochondria. These results support past findings that the percentage of 22:6 is
lower in the muscle and liver of longer-lived mammals [40, 220].
Differences in the peroxidation indexes of each tissue varied by species. Mice had
a higher peroxidation index in the muscle mitochondria than liver or brain mitochondria
while humans and pigs had a lower peroxidation index in muscle and liver mitochondria
than brain mitochondria. The primary PUFA in muscle mitochondria was 22:6 in mice
but 18:2 in humans and pigs, which partly explained the large differences seen in the
peroxidation indexes of muscle mitochondria. The primary PUFA in liver was 20:4, but
22:6 was also found at low levels in all animals. This contrasts to the only previous
investigation of human liver mitochondria which reported no 22:6 [138], but supports
the finding that membrane composition varies less between species in liver than muscle
[220]. This may be explained by the ability of liver to regenerate liver, and it is possible
that the peroxidation of membrane lipids has less long-term ramifications to cell health
in liver compared to post-mitotic tissues such as skeletal muscle and brain.
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The primary PUFA in brain mitochondria was 22:6, which has previously been
found to be at similar levels in a range of mammalian species [220] suggesting that
peroxidation index of brain is high and comparable in mammals. In this study, however,
the peroxidation index of mitochondria in the mouse brain was greater than that of
humans. As peroxidation is associated with numerous pathologies, including neuronal
diseases [227], the high 22:6 content found in brain has the potential to be detrimental
to long-term survival. An alternative view proposed by Yavin et al. (2002) suggests that
22:6 may not be as susceptible to peroxidation might be expect from its structure [228].
It is also possible that 22:6 may protect the brain from inflammation by serving as a
precursor for resolvins [229]. In the current study, a negative association was found
between the 22:6 content of brain mitochondria and lifespan for the combined
phospholipid, PC, and PE. Brain PS was found to contain more 22:6 in humans than
mice or pigs, suggesting a possible positive correlation in PS, but overall these results
support the view that the 22:6 content of brain is inversely correlated with MLS. The
enzymatic peroxidation of PUFA, however, is involved in a broad range of cell
signalling pathways and is required for healthy brain function [8]. For example, the loss
of 22:6 in brain is associated with severe brain anomalies including Zellweger
syndrome [230] and Alzheimer’s disease [231]. As a speculative hypothesis for the
difference in the peroxidation indexes of muscle and brain mitochondria, I propose that
that muscle membranes are exposed to more ROS than brain membranes, and that
oxidative damage to muscle is more detrimental to organism survival than oxidative
damage to the central nervous system.

6.5.2 Contributions of phospholipids to the peroxidation index
For all three mammals, PC and PE had relatively equal contributions to the peroxidation
index of muscle mitochondria, but the relative contribution of PE was the dominant
contributor in liver and brain mitochondria. PUFA are generally less common in the PC
classes than the PE or PS classes [20], and the high ratio of PC to PE present in the
mitochondria of human muscle and brain may represent an adaptation to limiting
membrane peroxidation independently of fatty acid composition. The significance of the
distribution of PUFA across phospholipid to peroxidation remains to be established as
data in this area is uncommon and often contradictory due to differences in methods
used [15, 202].
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The peroxidation index was largely determined by a surprisingly low number of
molecular phospholipids (Figure 6.4). The greatest difference between animal species
was the contributions of PC 16:0_22:6 and PE 18:0_22:6 in mice muscle mitochondria
and the contributions of PC 16:0_18:2 and PC 18:0_18:2 in pig and humans
mitochondria. The higher percentages of PC 16:0_22:6 and PE 18:0_22:6 found in the
muscle of mice in comparison to pigs or humans supports is similar to comparisons
between mice and naked mole rats (Heterocephalus glaber, MLS of 28 years) [40, 44].
As PC 16:0_22:6 is synthesized de novo by mammals but PE 18:0_22:6 is not [86],
mammals with longer lifespans may have adapted to decrease the peroxidation index of
muscle membranes by decreasing the de novo synthesis of PC 16:0_22:6, increase
remodelling of PC 16:0_22:6 to other molecular species of PC, and limiting the
synthesis of PE 18:0_22:6 during remodelling.
This replacement of PUFA susceptible to peroxidation with the less susceptible
18:2 seen in muscle was not found in liver mitochondria where the phospholipids with
the largest contribution to the peroxidation index was PE 18:0_20:4 in all species, or in
brain mitochondria where the greatest contributor was PE 18:0_22:6 for all three
species. The high contribution of PE to the peroxidation index in brain has been
previously identified as being due to high levels of 22:6, but had not previously been
identified as being due to the presence of a single molecular species [80]. Despite
having a potentially high risk of undergoing peroxidation, the percentage of PE
18:0_22:6 in the mitochondria of healthy adult human brain remains relatively constant
during normal adult aging [232] and 22:6 has been even been identified as having a
possible role in protecting brain from ROS damage by some researches [228].
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Figure 6.4. Molecular phospholipids with the largest contribution to the peroxidation index of
mitochondria from mouse (M. musculus), pig (S. scrofa) and human (H. sapiens) tissues. The
percentage of peroxidation index is determined from the peroxidation index and relative
abundance of molecular phospholipids.

6.5.3 Importance of non-peroxidising phospholipids
The most abundant peroxidation-resistant phospholipid found in mitochondria was
PC 16:0_18:1 in all tissues, suggesting that this phospholipid may be important to
membrane function. As PC 16:0_18:1 is one of the few molecular phospholipids that
mammalian cells can assemble de novo, high levels may indicate that comparatively
limited phospholipid remodelling of this phospholipid is taking place [86]. The
advantages of PC 16:0_18:1 include a lower melting point than phospholipids
containing SFA [24] and an increased resistance to peroxidation in comparison to
phospholipids containing PUFA [21, 73]. These benefits are similar to those of
non-methylene interrupted PUFA associated with long-lived molluscs [37]. Another
interesting feature of PC 16:0_18:1 is its apparent capacity to delay the onset of
peroxidation by extending the lag phase of peroxidation as described in Chapter Five. It
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is likely that PC 16:0_18:1 serves as a substitute for phospholipids containing PUFA
and therefore may be a useful biomarker of membrane resistance to oxidative damage.
Phospholipids with vinyl-ethers at the sn-1 position (commonly termed
plasmalogens) may also increase membrane resistance by acting as a sacrificial target
for ROS [233, 234]. Plasmalogens have been positively associated with longevity in
mammals [40] but not in consistently in molluscs [37], suggesting that the link between
longevity and the presence of plasmalogens in membranes remains unclear. In the
current study, isobaric alkyl ethers and plasmalogens could not be differentiated as the
method used cannot identify the position of bonds and therefore the vinyl ether of
plasmalogens cannot be differentiated from an alkyl ether that contains a double bond
elsewhere along it’s chain. This is an important distinction as only the vinyl ether
inhibits the loss of the phosphoethanolamine head group, and therefore the method
underestimated PE-plasmalogens when using a neutral loss of 141 to identify PE
phospholipids [235]. The present study used the conservative approach of reporting the
sum of alkyl ethers and plasmalogens together without using a correction factor for
plasmalogens [40, 236]. The sum of alkyl ethers and plasmalogens comprised <3% of
the PE fraction of mitochondria and were largely absent from the PC and PS fractions.
An exception to this finding was the high percentage of alkyl ethers in the PC fraction
of pig muscle mitochondria. This is possibly a case of incorrect identification because
odd-chain fatty acids cannot be distinguished from alkyl ethers or plasmalogens with
the present mass spectrometry method with complete certainty. However, odd-chain
fatty acids were not reported in a review of studies of pig tissues [226]. Overall, the
mitochondria of muscle and brain contained a lower percentage of alkyl ethers and
plasmalogens in mice than in pigs or humans, suggesting that alkyl ethers and
plasmalogens may be positively associated with MLS in mammals.

6.5.4 Limitations
Although the use of human tissues is very valuable, working with human tissues
presents several difficulties including the precious nature of the samples and the
inevitable post-mortem interval prior to lipid extraction. The average post-mortem
interval of the present study was four days. Lipid composition has been reported to
show only minor changes with post-mortem intervals of three days [237] and five days
[238]. We are not aware of any studies examining lipid degradation over longer-post92
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mortem intervals, although such a study would be useful. The relative stability of
membrane lipids during the post-mortem interval suggests that the post-mortem interval
of the human tissue used in this study was unlikely to greatly affect the overall
conclusions. The inclusion of human tissue in this study also limited the amount of
sample available to approximately 100 mg per sample, resulting in mitochondrial yield
that was sufficient for the analysis but did not allow for extensive purification steps.
A further limitation of the present study is that cardiolipin (CL), a phospholipid
class that comprises 10-15% of mitochondrial phospholipids [17], was not able to be
measured with the methods used. CL is a di-phospholipid with a highly conserved fatty
acid composition of CL 18:2/18:2/18:2/18:2 in mammalian tissues [79] that is
considered to be important in lipid-proteins interactions with proteins of the eletron
transport (ETC) chain and early apoptotic evens [165, 166, 169, 239]. CL as been
reporeted to have a similar contribution to the peroxidation index across a range of
mammal species [80, 138], and although the composition of CL can be influenced by
dietary fatty acids and may therefore differ between species (Chapter Three) this is not
expected to be the case for mice or pigs and is unlikely in humans. The absence of CL
from the analysis underestimates the peroxidation index of each animal, and the values
presented may be lower than reported values generated with alternative methods for
mammalian muscle and liver [12, 29]. This underestimation is unlikely to greatly affect
the large differences in peroxidation index between species.
An additional consideration of this study (and many aging studies) is the
comparison of animals at very different stages of their MLS. The mice examined in the
present study had reached 25% of the MLS, the pigs examined had reached only around
2% of their MLS, and humans varied from 50-80% of their MLS. The phospholipid
composition of mammalian membranes does appear to change gradually over the adult
lifespan. In human brain, small increases in phospholipids containing 22:6 and small
decreases in phospholipids containing 20:4 were found with increasing age, but the
percentage of mitochondrial PE 18:0_22:6 was found to be consistent across a wide
range of ages [232]. An increase in the 22:6 content and peroxidation index with age has
also been reported for mouse muscle membranes [145], but overall differences in the
membrane PUFA composition and peroxidation index across a species lifespan seem
minor in comparison to differences between species with very different lifespans.
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6.6

Conclusion

This work has shown that the mitochondria of muscle, liver and brain of mice are highly
susceptible to peroxidation while the tissues of pigs and humans are less susceptible to
peroxidation. Human membranes differed from mouse and pig membranes by
containing a lower percentage of PUFA, suggesting that this may be a protective form
of lipid remodelling. Somewhat surprisingly, a relatively small number of molecular
phospholipids that contributed the majority of the peroxidation index in each tissue. The
differences in these molecular species varied across tissues and suggests that differences
in lipid remodelling in muscle may be particularly important for lifespan. Overall, this
study shows that the link between membrane susceptibility and peroxidation is more
complex than PUFA content and the peroxidation index. Other elements of membrane
composition found to be associated with lifespan were the percentages of alkenyl ethers
and plasmalogens, the ratio of PC to PE, and the percentage of peroxidation resistantphospholipids such as PC 16:0_18:1. These findings supported the ‘membranepacemaker’ theory of aging and the importance of peroxidation as a mechanism of
aging. Future work in this area would benefit from examining these measures across a
wider range of mammals and other animal classes.
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Chapter Seven
Is human longevity due to a unique ability to limit the peroxidation of
mitochondrial membranes?

7.1

Overview

The damage to mitochondria caused by peroxidation is associated with aging, and it
has been suggested that humans have the unusual ability to exclude highly
peroxidisable phospholipids from their mitochondrial membranes. Past comparisons of
the peroxidation index of mitochondrial and microsomal membranes of human tissues
has shown high variability, and no single study has examined both fractions using the
same methods. This chapter presents a shotgun lipidomics analysis of mitochondrial
and microsomal membranes from skeletal muscle, liver, and brain from humans. Mice
and pig tissues were also examined to determine if differences in mitochondrial and
microsomal fractions were unique to humans.

7.2

Introduction

The maximal lifespan (MLS) of humans (Homo sapiens) is 122 years, which is 3–4 fold
longer than other mammal species with similar body masses (AnAge database, Figure
2.10). No single explanation for human longevity has yet been universally accepted, but
one possible explanation is that human membranes are resistant to the damage of
cellular components caused by peroxidation [4, 65]. Peroxidation is initiated by reactive
oxygen species (ROS) and primarily affects the bis-allylic methylene groups found in
polyunsaturated fatty acids (PUFA) present in membranes [14, 36, 240]. The relative
vulnerability of membranes to peroxidation, termed a peroxidation index, can be
calculated from the percentage of membrane PUFA, the number of bis-allylic methylene
groups present in this PUFA, and experimentally derived rates of peroxidation [35].
Chapter Six of this thesis found that the mitochondrial membranes of skeletal muscle,
liver and brain contained a lower percentage of PUFA in humans than in mice (Mus
musculus, MLS of 4 years) or pigs (Sus scrofa, MLS of 27 years). As a result, the
mitochondria of these organs had a lower peroxidation index in humans than in mice or
pigs, suggesting that human mitochondria are less susceptible to peroxidation than
mouse or pig mitochondria. An inverse relationship between MLS and the peroxidation
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index has also been reported in a variety of other mammals [29], birds [12], molluscs
[37], bees [38], and strains of Caenorhabditis elegans [39] suggesting a strong link
between longevity and membrane composition.
The composition of mitochondrial phospholipid is of particular importance to
age-related peroxidation as mitochondria are a major source of ROS within cells [14,
36] and mitochondrial failure is an indicator of aging [118]. Based on differences in the
membrane fatty acid composition reported for whole liver [241-243] and liver
mitochondria [138], Hulbert (2010) suggested that humans exclude highly peroxidisable
fatty acids from their mitochondrial membranes to prevent peroxidation damage and
extend longevity [45, 240]. Unfortunately, human data in this area is rare and highly
variable due to the differences in methods used by different laboratory groups. In the
few studies available, the peroxidation indexes calculated for whole cell membranes
were 110 [241], 170 [242] and 280 [243], while the peroxidation index calculated for
mitochondria was 50 [138]. If these findings are correct, mitochondria are far less
susceptible to peroxidation than other cellular membranes in humans, but not in other
exceptionally long-lived mammals or in mammals with MLS close to those predicted
for their mass, [45, 134, 244, 245]. On this basis, it was hypothesized that 1)
mitochondrial membranes have a lower peroxidation index than other cellular
membranes in human tissues and 2) there is no difference in the peroxidation index
between mitochondrial membranes and other cellular membranes in other mammals.
To test these hypotheses, this chapter used shotgun-lipidomics to compare the
membrane composition and peroxidation index of mitochondrial and microsomal
fractions from humans, mice (Mus musculus, MLS of 4 years) and pigs (Sus scrofa,
MLS of 27 years). Microsomal fractions, which contain the phospholipids from the
plasma membrane, endoplasmic reticulum (ER), Golgi apparatus, secretory vesicles and
endosomes [246], represent an average cell membrane in the absence of mitochondria.
Mice and pigs were chosen as examples of mammals that have lifespans similar to other
mammals of their mass (AnAge Database) and therefore serve as control species for
exceptionally long-lived humans.

7.3

Methods

The samples and methods used in this chapter are described in Chapter Six (6.3.
Methods). In addition to these methods, a microsomal pellet and supernatant were
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isolated from the supernatant by centrifuging at 100,000 x g for 40 min at 4 oC [246]. In
the present study, two-way ANOVAs (tissue x fraction) with Bonferroni post-hoc tests
were used to compare mitochondrial and microsomal fractions within each species for
each tissue GraphPad Prism 5.04 (GraphPad Software, San Diego, USA).

7.4

Results

7.4.1 Phospholipid composition
The distribution of phospholipid classes in the mitochondrial and microsomal
membranes of skeletal muscle, liver and brain are shown for mice, pigs and humans in
Table 7.1. In skeletal muscle, the percentage of phosphatidylcholine (PC) was higher in
the mitochondrial fraction than the microsomal fraction for humans and mice but lower
in the mitochondrial fractions than the microsomal fraction for pigs. The percentage of
phosphatidylethanolamine (PE) did not differ significantly between the mitochondrial
and microsomal fractions for humans and mice, but was higher in the mitochondrial
fraction than the microsomal fraction for pigs. No significant differences were found
between the mitochondrial and microsomal fractions for phosphatidylserine (PS),
phosphatidylglycerol (PG) or phosphatidic acid (PA). Phospholipid composition did not
differ greatly between the mitochondrial and microsomal fractions of mouse or pig
skeletal muscle, but some differences were seen for human muscle (Table 7.2). The
percentage of PC 16:0_16:0 was higher in the mitochondrial fraction than the
microsomal fraction in mice and the percentage of PE 18:0_18:2 was higher in the
mitochondrial fraction than the microsomal fraction of pigs, but no other significant
differences were observed. In humans, the percentages of PC 16:0_18:1, PC 18:0_18:2
and PE 18:0_18:2 were lower in the mitochondrial fraction than the microsomal
fraction. The full list of phospholipids identified in the mitochondrial and microsomal
fraction of skeletal muscle is presented in Appendix Table B1.
In liver, the only difference in the percentages of phospholipid classes was a
statistically higher level of PE in pig mitochondrial membranes (Table 7.1). Within
classes, however, liver contained more differences in the relative amounts of molecular
phospholipids between fractions than seen for muscle (Table 7.2). For mice, higher
percentages of PC 16:0_16:0, PC 16:0_18:1, PE 18:0_20:4 and PS 18:1_18:1 were seen
in mitochondria compared to microsomes, but a far lower percentage of PE 16:0_22:6
was seen in mitochondria. Similarly, pigs were found to have a higher percentage of PE
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16:0_20:4 but a lower percentage of PE 18:0_18:2 in their mitochondria than their
microsomes, and human mitochondria contained a higher percentage of PE 18:0_20:4
than human microsomes. The full list of phospholipids identified in the mitochondrial
and microsomal fraction of liver is presented in Appendix Table B12.
For the brain mitochondrial and microsomal fractions, PE was higher in the
mitochondrial fraction of both mice and pigs, PC was higher in the mitochondrial
fraction of humans, and PA was lower in the mitochondrial fraction for all three animals
(Table 7.1). No significant differences were seen for the other phospholipid classes.
Multiple differences were seen in the relative abundance of molecular phospholipids of
brain (Table 7.2). A higher percentage of PC 16:0_16:0 was found in the mitochondrial
fraction than the microsomal fraction of mouse brain while the percentages of both PE
18:0_22:5 and PE 18:0_22:6 were higher in the mitochondrial fraction than the
microsomal fraction of human brain. The percentage of PS 18:0_18:1 was higher in the
mitochondrial fraction than the microsomal fraction of mice and pigs, and the
percentage of PS 18:1_18:1 was higher in the mitochondrial fraction than the
microsomal fraction of pigs and humans. Differences in the distribution of peroxidisable
species of PS were mixed, with the percentage of PS 18:0_20:4 higher in the
mitochondrial fraction of mouse, the percentage of PS 18:0_22:5 higher in the
mitochondrial fraction of pigs but the percentage of PS 18:0_22:6 lower in the
mitochondrial fraction of pigs. The full list of phospholipids identified in the
mitochondrial and microsomal fraction of brain is presented in Appendix Table B13.
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Table 7.1. Distribution of phospholipid classes in the mitochondrial and microsomal fractions of mouse, pig, and human tissues.
Pig
Mitochondrial

Microsomal

Human
Mitochondrial
Microsomal

PC
PE
PS
PG
PA

62.1±0.4
27.7±0.5
6.1±0.5
1.2±0.2
3.0±0.2

53.6±2.7*
31.3±5.2
8.0±1.8
2.9±0.5
4.3±0.8

61.5±0.7
32.6±0.6
5.8±0.6
0.2±0.0
0.0±0.0

68.6±2.8**
18.6±2.1***
7.4±2.4
0.4±0.1
5.1±2.1

73.8±3.0
16.3±3.1
8.7±0.2
1.2±0.2
0.0±0.0

65.4±2.7**
21.0±2.1
12.5±0.7
0.8±0.3
0.3±0.2

Liver

PC
PE
PS
PG
PA

64.6±5.0
24.2±3.6
9.1±1.6
2.2±0.2
0.0±0.0

65.3±1.7
27.8±1.9
4.1±0.3
0.9±0.1
2.0±0.2

57.1±2.2
35.8±1.6
2.1±0.6
2.7±0.7
1.7±0.4

60.4±2.0
30.3±1.4*
2.9±0.2
4.5±1.3
2.0±0.2

67.5±3.8
22.7±3.4
5.9±0.4
3.6±0.6
0.4±0.1

66.5±2.4
23.9±1.2
5.3±0.7
4.0±0.8
0.3±0.1

99
99

Muscle

Brain

PC
43.0±1.6
43.9±2.6
41.0±1.8
39.1±1.0
58.0±2.3
37.4±2.8***
PE
45.6±0.9
34.0±1.4***
45.4±2.3
29.3±2.1***
32.7±2.2
36.2±1.5
PS
6.7±0.3
4.8±0.5
11.4±1.2
15.3±1.0
9.3±0.7
14.8±1.5
PG
1.5±0.4
5.6±0.9
0.8±0.3
4.4±0.8
0.0±0.0
0.0±0.0
PA
3.2±0.6
11.7±2.7***
1.5±0.7
1.9±3.4***
0.0±0.0
1.6±1.3***
Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). Values are presented as mean mol% of total phospholipids
±SEM, n=6. Significant differences between mitochondrial and microsomal fractions are indicated with * for P<0.05, ** for P<0.01, and *** for
P<0.001. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; PG, phosphatidylglycerol PA, phosphatidic acid.
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Mouse
Mitochondrial
Microsomal
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Table 7.2. Significant differences in the acyl composition of phosphatidylcholine (PC),
phosphatidylethanolamine (PE) and phosphatidylserine (PS) between the mitochondrial
and microsomal membranes of mouse, pig, and human tissue.
Mol%
Tissue

Animal

Class

Phospholipid

Mitochondrial

Microsomal

P

Muscle

Mouse

PC
PE
PS
PC
PE
PS
PC

PC 16:0_16:0
None
None
None
PE 18:0_18:2
None
PC 16:0_18:1
PC 18:0_18:2
PE 18:0_18:2
None

6.4±0. 3
–
–
–
28.0±2.1
–
22.4±1.8
20.7±2.7
0.0±0.0
–

0.0±0.0
–
–
–
16.2±3.5
–
29.4±1.9
26.9±2.7
7.1±0.6
–

P< 0.0001
–
–
–
P< 0.05
–
P< 0.05
P< 0.05
P< 0.05
–

PC 16:0_16:0
PC 16:0_18:1
PE 16:0_22:6
PE 18:0_20:4
PS 18:0_18:1
None
PE 16:0_20:4
PE 18:0_18:2
None
None
PE 18:0_20:4
None

9.5±2.3
32.0±6.7
0.0±0.0
64.4±8.3
6.0±0.8
–
4.7±0.2
15.6±0.6
–
–
69.5±7.8
–

0.0±0.0
14.1±0.8
31.5±1.3
20.8±0.6
0.1±0.1
–
0.0±0.0
19.5±1.9
–
–
50.6±5.7
–

P< 0.05
P< 0.0001
P< 0.0001
P< 0.0001
–
–
P< 0.001
P< 0.01
–
–
P< 0.05
–

PC 16:0_16:0
None
PS 18:0_18:1
PS 18:0_20:4
PS 18:1_18:1
None
None
PS 18:0_18:1
PS 18:0_22:6
PS 18:0_22:5
None
PE 18:0_20:4
PE 18:0_22:6
PS 18:1_18:1

15±2.8
–
41.0±3.1
10.4±0.4
20.4±1.6
–
–
33.7±4.2
8.9±1.1
18.5±3.4
–
13.9±1.8
38.5±2.8
12.7±1.3

4.9±2.1
–
30.8±3.0
0.0±0.0
12.1±3.0
–
–
4.7±0.6
47.1±3.9
9.1±0.9
–
6.9±0.9
25.3±1.3
8.4±1.1

P< 0.0001
–
P< 0.01
P< 0.01
P< 0.05
–
–
P< 0.0001
P< 0.0001
P< 0.05

Pig

Human

PE
PS

Liver

Mouse

PC
PE

Pig

Human

Brain

PS
PC
PE
PS
PC
PE
PS

Mouse

PC
PE
PS

Pig

PC
PE
PS

Human

PC
PE
PS

P< 0.05
P< 0.001
P< 0.05

Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). Values
are presented as mean mol% of total phospholipids in each class ±SEM, n=6. Significant
differences between fractions are indicated with * for P<0.05, ** for P<0.01 and *** for
P<0.001.
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7.4.2 Fatty acid composition
Although phospholipid composition varied between tissues and between species, the
fatty acid compositions of the mitochondrial and microsomal fractions within tissues
were generally similar (Table 7.3). In skeletal muscle, small but significant differences
were seen in the 18:0 content of mice and the 16:0 content of pigs, but no differences
were seen for humans. In liver, the mitochondrial fraction of mice contained a higher
percentage of 18:1, a lower percentage of 22:6, but a higher percentage of PUFA
overall. Similar patterns were not seen in the mitochondrial fraction of pigs or humans,
although pig mitochondria had a slightly higher percentage of 20:4. In brain, 16:0 was
higher in the mitochondrial fraction of all three animals, 18:0 was higher in the
mitochondrial fraction of pigs, and 18:1 was higher in the mitochondrial fraction of
mice. Overall, MUFA was lower in the mitochondrial fraction of pig brain, but higher in
the mitochondrial fraction of human brain. Acyl ethers were also not found to differ
significantly between mitochondrial and microsomal membranes in any tissue.
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Table 7.3. Acyl composition (mol%) of the combined phospholipids of mitochondrial and microsomal fractions of mouse, pig, and human tissue.
Mouse

Liver
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Brain

Mitochondrial
26.0±0.7
19.4±0.9
10.9±0.7
7.8±0.8
8.3±0.8
19.6±1.4
1.0±.0.2
46.2±0.8
13.0±0.5
40.4±0.7
23.5±1.9
20.5±1.0
18.0±0.9
12.7±1.8
16.9±2.5
0.1±0.0
5.3±0.5
0.8±0.1
44.5±1.7
18.5±1.0
35.6±1.8
23.9±1.6
26.3±1.0
18.5±0.4
8.2±0.1
1.6±0.3
14.3±0.3
1.5±0.4
54.4±0.4
18.6±0.4
26.2±0.4

Pig
Microsomal
27.7±0.5
16.3±0.4**
12.2±0.2
9.0±0.5
9.1±0.4
18.5±0.8
0.4±.1
45.5±0.4
13.3±0.2
40.1±0.5
26.4±1.3
16.3±0.9
13.1±0.8*
11.3±0.8
13.9±0.6
1.1±0.2
12.4±0.6**
0.5±0.2
43.5±0.8
13.8±0.9*
40.5±0.5**
18.1±1.4**
29.9±0.8*
14.2±1.1**
7.8±1.4
3.6±0.7
14.3±0.9
0.4±.02
55.1±2.0
14.7±1.2
27.3±1.2

Mitochondrial
19.2±0.4
12.6±0.8
15.2±0.9
30.5±1.0
7.2±0.6
0.6±0.1
7.3±0.7
39.7±0.4
15.5±0.8
41.0±0.9
14.3±0.3
28.8±0.6
15.0±0.7
13.2±0.5
16.9±0.8
2.7±0.2
3.0±0.3
0.8±0.1
44.0±0.4
16.5±0.8
36.7±0.7
19.6±1.2
24.7±0.6
19.1±0.9
7.0±0.7
6.2±0.6
8.2±0.4
1.5±0.3
50.1±0.9
20.0±0.9
28.4±0.7

Microsomal
23.0±2.1*
11.6±0.6
12.7±1.4
32.6±0.9
6.4±0.3
0.9±0.4
7.8±0.6
41.8±1.1
13.0±1.5
42.1±0.8
13.9±0.5
29.4±0.7
17.2±0.7
13.6±0.7
14.2±1.0*
2.5±0.2
4.7±0.5
0.7±0.1
44.2±0.6
17.9±0.7
35.8±0.8
15.2±1.7*
25.1±0.9*
21.6±1.1
7.8±0.3
5.5±1.3
9.9±1.2
3.2±0.4
43.7±1.5
26.7±1.5*
28.4±0.5

Human
Mitochondrial
Microsomal
25.9±2.5
26.3±1.2
10.5±1.2
9.7±0.6
25.5±1.3
26.3±2.0
20.4±1.2
23.5±1.4
6.5±1.3
5.4±0.6
1.4±0.2
1.5±0.2
0.5±0.1
2.1±0.3
39.2±1.4
36.8±1.0
28.4±1.3
29.7±2.1
30.7±2.5
32.5±1.8
27.8±2.5
29.5±2.4
16.6±1.5
15.6±1.5
21.0±2.0
18.6±2.4
12.3±1.6
12.6±1.4
13.2±1.9
14.8±2.2
1.8±0.4
1.5±0.4
2.9±0.4
3.4±0.8
0.0±0.0
1.1±0.3
45.6±1.3
45.1±1.2
23.2±1.9
20.8±2.2
30.7±2.9
34.1±3.0
23.9±1.8
15.0±1.3**
22.5±1.4
25.7±1.3
24.5±1.0
22.2±1.2
4.3±0.2
4.0±0.3
2.5±0.4
6.0±1.7
9.9±0.9
7.9±0.9
4.5±0.8
3.2±0.6
51.3±0.8
48.9±0.6
26.0±1.2
23.0±1.1**
22.1±1.2
23.8±1.9

Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens). s double bond positon could not be ascertained with the method used, fatty acids
are reported as carbon: double bonds without omega position Values are mean mol% of the combined phospholipid fraction ±SEM, n=6. Significant differences
between fractions are indicated with * for P<0.05, ** for P<0.01 and *** for P<0.001. Combined acyl composition was calculated from quantified molecular species
of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, and phosphatidic acid of mitochondria. Acyls less than 3 mol% of all
tissues are not listed but have been included in all calculations. ∑SFA, total saturated fatty acids including acyl ethers; ∑MUFA, total monounsaturated fatty acids;
∑PUFA, total polyunsaturated fatty acids.
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Muscle

Fatty acid
16:0
18:0
18:1
18:2
20:4
22:6
Acyl ethers
∑SFA
∑MUFA
∑PUFA
16:0
18:0
18:1
18:2
20:4
22:5
22:6
Acyl ethers
∑SFA
∑MUFA
∑PUFA
16:0
18:0
18:1
20:4
22:5
22:6
Acyl ethers
∑SFA
∑MUFA
∑PUFA
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7.4.3 Susceptibility to peroxidation
The peroxidation index of combined phospholipids did not differ greatly between
mitochondrial and microsomal fractions of skeletal muscle, liver and brain for humans
mice, or pigs (Figure 7.1). The only exception was mouse liver in which the
peroxidation index was significantly lower in the mitochondrial fraction than the
microsomal fraction. The contributions of phospholipid classes to the peroxidation
index of the mitochondrial and microsomal fractions showed numerous but inconsistent
differences (Figure 7.2). A higher contribution of PE was found in pig mitochondria for
muscle, liver and brain, but this was the only difference that was consistent across
tissues. For muscle, human had a higher contribution for PC but a lower contribution for
PS in the mitochondrial the microsomal fraction and no differences were seen for mice
(Figure 7.2A). In liver, no difference was seen for humans but a lower contribution of
PC and a higher contribution of PS was seen in the mitochondrial that the microsomal
fraction of mice (Figure 7.2B). Differences between the contributions to the
peroxidation index of mitochondrial and microsomal fractions were most common in
brain (Figure 7.2C). The relative contribution of PC to the peroxidation index was
higher in the mitochondrial fraction than the microsomal fraction of brain for humans
and pigs, but lower in the mitochondrial fraction of mice. The relative contribution of
PE was higher in the mitochondrial fraction than the microsomal fraction of pig brain,
and the contribution of PS was higher in the microsomal fraction of pig and human
brain.

Mitochondrial fraction
Microsomal fraction

A) Muscle

C) Brain

B) Liver
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Human
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Figure 7.1. The peroxidation index of the in microsomal fraction and mitochondrial-enriched
fraction of the
A) skeletal
muscle, B) liver, and C) brain of mouse (M. musculus), pigs (S.
Mitochondrial
fraction
Microsomal
fraction
scrofa), and humans (H. sapiens). The peroxidation index is calculated using values from
PSof P<0.001 are indicated
A) Holman
Muscle [21].PC
Values are means ±SEM,PE
n=6. Significant differences
with ***.
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Figure 7.2. Relative contributions of the major phospholipid classes to the peroxidation index of
the microsomal fraction and mitochondrial fraction of A) skeletal muscle, B) liver, and C) brain
of mouse (M. Musculus), pigs (S. scrofa), and humans (H. sapiens). Values are means ±SEM,
n=6. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine.
Significant differences are indicated with * for P<0.05, ** for P<0.01 and *** for P<0.001.
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7.5.1 Composition of mitochondrial and microsomal membranes
Humans (Homo sapiens) have a maximal lifespans (MLS) of 122 years, which is far
higher than the MLS of mammals with similar body masses (AnAge Database). The
peroxidation of mitochondrial membranes is considered a major cause of aging [4, 65,
118], and one possible explanation for human longevity is that human mitochondria are
less susceptible to peroxidation damage than expected for a mammal of their mass
(Chapter Six). It has also been suggested that human mitochondria are less susceptible
to peroxidation-related aging than other cellular membranes in humans [45, 240] and
that this may be an evolutionary mechanism to extend longevity that is unique to
humans [45, 134, 244, 245]. Unfortunately human data is rare in this area and only a
limited number of studies from different laboratory groups have reported the fatty acid
composition of whole liver [241-243] and liver mitochondria [138]. Unlike comparisons
of this past work that found differences between the fatty acid composition and
peroxidation index of liver mitochondria to whole liver cells [45, 240], the present study
found few differences between the mitochondrial and microsomal fractions of muscle,
liver and brain in humans. The peroxidation indexes of the mitochondrial and
microsomal fractions did not differ significantly, with the peroxidation index of human
liver mitochondria lower than previously reported [138] but the peroxidation index of
human liver microsomes higher than previous reports for whole liver [241-243] (Figure
7.3.). Unlike humans, mice (Mus musculus, MLS of 4 years) and pigs (Sus scrofa, MLS
of 27 years) are examples of mammals with MLS similar to those of other mammals of
their body mass. Comparisons of the mitochondrial and microsomal membranes of,
found similar peroxidation indexes between mitochondrial and microsomal fractions of
skeletal muscle, liver, and brain for each animal. Overall, mammalian mitochondria and
microsomal membranes were found to be similar in their susceptibility to peroxidation
for humans, mice and pigs.
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Figure 7.3. Comparison of the peroxidation index of human (H. sapiens) liver from this chapter
with published values for humans.

A notable exception was mouse liver, where a higher peroxidation index was
found for the microsomal fraction than the mitochondrial fraction. This difference was
primarily due to the higher percentage of 22:6, a highly peroxidisable PUFA, in the
microsomal fraction and may be related to 22:6n-3 synthesis. Standard mouse diets are
generally low in long chain omega-3 fatty acids including 22:6n-3, and the primary
source of 22:6 present in mouse tissues is 22:6n-3 synthesized in liver [247] by the fatty
acid elongase ‘elongation of very long-chain fatty acids type 2’ (ELOVL–2) [248].
ELOVL–2 is highly expressed in mouse liver [248] where it is located in the
endoplasmic reticulum (ER) [83], [88]. The ER is a major component of the microsomal
fraction, and so high levels of 22:6n-3 synthesis in liver are likely to be reflected in a
higher percentage of 22:6 and a higher peroxidation index found in the microsomal
fraction than the mitochondrial fraction. A high level of 22:6n-3 synthesis in the
microsomal fraction may also account for the higher percentage of PE 16:0_22:6 in
mouse liver mitochondria as PE 16:0_22:6 is one of only four fatty acid compositions of
PE that are synthesized de novo in mammals [86]. In comparison to mice, no difference
was seen in the peroxidation index or percentage of 22:6 in liver mitochondrial and
microsomal fractions for pigs or humans, suggesting that 22:6 synthesis is more
common in mice liver than pig or human liver. This difference in 22:6 synthesis is
likely to be related to the requirements of higher percentages of 22:6 in the tissues of
mice than in the tissues of pigs or humans (Chapter Six).
The relative abundance of phospholipid classes did not differ significantly
between the mitochondrial and microsomal fractions. The similarities found for
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mitochondrial and microsomal PC and PS may reflect the common origin of these
classes in the ER [82, 83]. The PC and PS produced in the ER are transported to
mitochondrial and other cellular membranes either through vesicular pathways
involving endosomal compartments and the Golgi apparatus or non-vesicular pathways
using lipid transporter proteins [68]. Differences in the levels of PC found in muscle
suggest some variation in how PC is imported into cellular membranes. Unlike PC and
PS that must be imported into mitochondria, PE may be either imported from the ER or
synthesised in mitochondria by the decarboxylation of PS [83]. The ability of
mitochondria to synthesise PE independently of the ER may explain the high PE found
in the mitochondrial fraction of all pig tissues and in mouse brain. This increase could
also be associated with a higher importation of PE into mitochondria as no significant
decrease in mitochondrial PS was observed. No difference in the levels of mitochondrial
and microsomal PE was observed in other mouse or human tissues, suggesting pigs
might be unusual in their regulation of PE levels. Mitochondria also synthesise
phosphatidic acid (PA) and phosphatidylglycerol (PG) [83], but the only consistent
finding in all three animals was a lower percentage of PA in the mitochondrial fraction
of brain, which contrasts with a past report that phospholipid class was similar in the
mitochondrial and microsomal fractions of rat brain [249]. The low amount of PA in
mitochondria may be due a high degree of export to the microsomal membranes, or may
be related to the role of PA as a substrate in the mitochondrial synthesis of PG and
cardiolipin (CL) [83].
The mitochondrial and microsomal membranes of muscle, liver and brain
generally contained similar molecular species of phospholipid. This is perhaps
surprising considering that mitochondria possess different isoforms of enzymes for both
fatty acid synthesis and phospholipid remodelling than the cytosol [17, 84]. The
similarities between the phospholipid composition of the mitochondria suggest that
fraction-specific enzyme isoforms do not greatly differ in their selectivity or function.
Interestingly, in the few instances where molecular species of PC did differ between
fractions, there was a trend for PC 16:0_16:0 and PC 16:0_18:1 to be higher in the
mitochondrial fraction. As these phospholipids are synthesized de novo, this finding
suggests that slightly less remodelling of PC is occurring in the mitochondria than in the
microsomes [86]. No significant differences in percentages of PS as a class were found
for any tissue, but the percentage of molecular species of PS did differ significantly in
the mitochondrial and microsomal fractions of brain. The result of this asymmetrical
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distribution was an increase in the percentage of two non-peroxidisable phospholipids,
PS 18:0_18:1 in mice and pigs and PS 18:1_18:1 in humans. The increase in the
percentages of PS 18:0_20:4 in mice and humans and PS 18:0_22:5 in pigs may be
related to the role of PS oxidation in plasma membranes during pro-apoptotic signalling
[250].

7.5.2 Phospholipid contributions to the peroxidation index
With the exception of mouse liver, the peroxidation indexes of mitochondrial and
microsomal membranes did not differ greatly in mice, pig or human tissues. Greater
differences between fractions were seen in the relative contribution of phospholipid
classes to the peroxidation index, but these differences were not generally consistent
within species or tissues. The relative contribution of phospholipid classes to the
peroxidation index was determined by both the relative abundance of phospholipid class
and distribution of molecular phospholipids within that class (Table 7.4). The largest
differences in phospholipid distribution were higher levels of non-peroxidisable
phospholipids such as PC 16:0_16:0 , PC 16:0_18:1, PS 18:0_18:1 and PS 18:1_18:1 in
mitochondrial membranes compared to microsomal membranes. In addition to replacing
phospholipids containing PUFA, two non-peroxidisable phospholipids, PC 16:0_16:0
and PC 6:0_18:1, have been found to exhibit an antioxidant-like activity (Chapter Five).
It has yet to be determined if a similar antioxidant-like effect is caused by
non-peroxidisable phospholipids such as PS 18:0_18:1 or PS 18:1_18:1.
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Table 7.4. Contributions of phospholipid classes and molecular phospholipids to the
peroxidation index in the mitochondrial fraction relative to the microsomal fraction of
mouse, pig, and human tissues.
Tissue

Animal

Muscle Mouse

Pig

Human

Liver

Mouse

Pig

Human

Brain

Mouse

Pig

Human

Class

PC

Contribution relative
to microsomal
fraction
–

Reason
Class

Phospholipid species

PE

–

PS

–

PC

–

PE

Increased

Higher PE

Higher PE 18:0_18:2

PS

–

PC

Increased

Higher PC

None

PE

Decreased

Lower PE*

None

PS

Decreased

Lower PS*

None

PC

Decreased

PE

–

PS

Increased

PC

–

PE

Increased

PS

Decreased

PC

–

PE

–

PS

–

PC

–

PE

Increased

PS

–

PC

Increased

Lower PE,PS*

PE

Decreased

Lower PE,

None

PS

Decreased

Lower PS*

Higher PS 18:0_18:1

PC

Increased

Higher PC

None

PE

–

PS

Decreased

Lower PS*

Higher PS 18:1_18:1

Higher PC 16:0_16:0,
Higher PC 16:0_18:1
Higher PS*

None

Higher PE

Higher PE 16:0_20:4

Higher PE

None

Species examined were mice (M. musculus), pigs (S. scrofa) and humans (H. sapiens).
Notes: *Not significant differences.
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A difference in the percentages of phospholipid with alkenyl ethers and vinyl
ethers (plasmalogens)between membranes may also indicate an adaptation to decrease
peroxidation. Plasmalogens are phospholipids with vinyl-ether bonds at the sn-1
position, and this vinyl bond has been suggested to have an antioxidant-like action by
acting as a sacrificial target for ROS [233]. Unlike other phospholipids, plasmalogens
are synthesised in peroxisomes [83], and PE plasmalogens are transported into cellular
membranes via a non-vesicular, ATP dependent pathway. The majority of alkenyl
ethers and plasmalogens are present in the PE class. Plasmalogens in this class inhibit
the loss of the phosphoethanolamine head group, and therefore the method used
underestimated PE-plasmalogens when using a neutral loss of 141 to identify PE
phospholipids [235]. A correction factor of 3.45 can be used to correct for this, but only
if the plasmalogens can be differentiated from alkenyl ethers. This differentiation is not
possible in the present study due to the methodology used, and so the present study took
the conservative approach of reporting the sum of alkyl ethers and plasmalogens
together without using a correction factor for plasmalogens [40, 236]. If a correction
factor was used, the percentages of plasmalogens in human brain would be comparable
to past findings [251]. In the present study, the percentage of alkenyl ethers and
plasmalogens did not differ between mitochondrial and microsomal fractions of any
tissue, and the high levels reported in the membranes of pig muscle mitochondria
(Chapter Six) were also found in the membranes of pig muscle microsomes. These
results suggest that acyl ethers do not confer additional protection to mammal
mitochondria. This work contrasts to a previous finding of higher percentages of
plasmalogens in mitochondrial membranes compared to other cell membranes of
molluscs [37].

7.5.3 Limitations
This chapter shares the limitations addressed in Chapter Six (Section 6.5.4) with regards
to the post-mortem interval of the human tissue used, the absence of cardiolipin (CL)
from the present analysis, and the comparison of species from different stages of their
MLS. As a result of CL not being included in the analysis, the peroxidation indexes of
mitochondrial membranes presented in this study are an underestimation. This
underestimation does not, however, affect the conclusion of this study as the data did
not support the hypothesis that the peroxidation index of mitochondrial membranes is
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lower than that of microsomal membranes in humans. In addition, the analysis shows
the high degree of similarity in mitochondrial and microsomal membranes (with the
exception of CL) and suggests that the inclusion of CL into mitochondria does not
influence the composition of molecular phospholipids present in other classes within the
membrane. This work is also limited to a small number of species, which prevents the
use of linear slopes to compare trends in cellular fractions. Future work could address
this limitation by extending the number of species examined. A number of caveats
should also be applied to the isolation techniques used to separate the mitochondrial and
microsomal fractions of tissues. The techniques used were not tissue specific, and it is
possible that synapsosomes may have co-sedimented out with brain mitochondria.
These membranes would not have been as abundant as mitochondrial membranes and
are unlikely to have greatly affected mitochondrial purity but should still be considered
in future studies.
7.6

Conclusion

The present study used shotgun lipidomics to compare the membrane composition and
peroxidation index of mitochondrial and microsomal membranes of skeletal muscle,
liver and brain from humans, mice and pigs. The membrane composition of both
fractions were similar for all three species, which does not support the hypothesis that
humans prevent mitochondrial damage by excluding highly peroxidisable phospholipids
form mitochondria. This one of the first lipidomics studies of the membrane
composition and peroxidation index of cellular fractions, and suggests that membrane
composition differs more between tissues that cellular fractions in mammals. Future
work in this area could examine other cellular fractions within mammal tissues or in
long-lived animals of other classes.
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Chapter Eight
Conclusion and outlook

8.1

Membrane composition, peroxidation and longevity

“It remains for us to discuss youth and age, life and death. To come to a definite
understanding of these things would complete our study on animals.”
Aristotle [1], ‘On Longevity and Shortness of Life’, Part 6.
Aristotle may have been optimistic in his belief that a “definite understanding” of life
could ever be reached, and continuing work in this area has shown biological systems to
be some of the most complex systems yet encountered. This thesis has focussed on one
fundamental element of cellular structure, membrane glycerophospholipids, in an
attempt to better understand the importance of peroxidation of membrane phospholipids
to oxidative stress, cellular damage, and aging. This thesis contains three studies that
used different methodologies. The first study examined the relationship between dietary
fats and mitochondrial membrane composition in Chapter Three, the second study
investigated the importance of phospholipid composition to peroxidation in Chapter
Four and Chapter Five, and third study examined the relationship between the
susceptibility of membrane phospholipids to peroxidation and species longevity in
Chapter Six and Chapter Seven. This chapter summarises the outcomes and significance
of these findings and suggests future directions for this work.

8.1.1 Cardiolipin composition is influenced by dietary fats
Cardiolipin (CL) is widely considered to be primarily composed of linoleic acid
(18:2n-6). This is probably due the persistent citation of early reports that found a high
content of 18:2n-6 in CL (reviewed in [20, 51]), and a high percentage of
CL 18:2/18:2/18:2/18:2 in mammalian muscle [79]. Numerous published studies have
reported that docosahexaenoic acid (22:6n-3) is selectively incorporated into CL, but
these studies are frequently overlooked. The analysis of dietary data presented in
Chapter Three reviews all available studies that have examined the influence of dietary
fatty acids on CL composition in mice and rats. Interestingly, this review showed that
when both 18:2n-6 and 22:6n-3 were present in the same diet, 22:6n-3 was incorporated
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into heart CL at the expense of 18:2n-6. This occurred in heart when 22:6n-3 was up to
~20% of dietary fatty acids and in liver when 22:6n-3 is up to 10% of total dietary fatty
acids, suggesting that the regulation of CL composition may differ between tissues. This
finding contrasts to the general view that CL has a highly regulated 18:2n-6 content that
is not influenced by diet, and suggests that molecular species of CL containing 22:6n-3
may be more common than previously considered. The incorporation of 22:6n-3 into
CL and mitochondrial phosphatidylcholine (PC) and phosphatidylethanolamine (PE)
reported in this analysis would greatly increase the peroxidation index of mitochondrial
membranes, and may make mitochondria more susceptible to apoptosis induced by
peroxidation [199].

8.1.2 The importance of phospholipid composition to peroxidation
Most in vivo studies of peroxidation have focused on the role of the PUFA content of
phospholipids, but other elements of phospholipid composition may also influence
peroxidation. Chapter Four presents a comparison of the amount of peroxidation
product produced by phospholipids of the CL, PC, PE, phosphatidic acid (PA) and
phosphatidylglycerol (PG) classes that were matched for PUFA content. This
comparison arose from observations made in the Else laboratory that bovine heart CL
readily undergoes peroxidation in methanol, but that phospholipid of PC and PE do not
despite have a similar peroxidation index. Upon further investigation, the ranking of
iron-mediated lipid hydroperoxide production was found to be greater in CL and PA
when tested in diffuse solutions (1:9 water to methanol v/v), but this was not found for
CL and PA tested in liposomes in aqueous solutions. The order of lipid hydroperoxide
production from highest to lowest for the phospholipid classes tested was PA> CL>>
PE> PC, PG in methanol but PC> PE> CL> PG> PA in liposomes. These differences in
class suggest that head group charge may influence peroxidation in methanol, but
relative head group size appears to have a greater influence on peroxidation in
liposomal bilayers. It was concluded that whatever properties make phospholipids of the
CL and PA classes readily susceptible to peroxidation in methanol did not influence
peroxidation in liposomes, and therefore may not be physiologically relevant. Past
comparisons of phospholipid classes have had similar difficulties in establishing a
relationship between phospholipid class and peroxidation, with some studies reporting
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an influence of class due to charge, others due to phospholipid shape, and a few due to
protein interactions [15].
A more sophisticated study of peroxidation was carried out in Chapter Five using
oxygen consumption as a measure of peroxidation. This chapter examined the ability of
non-peroxidisable phospholipids (non-PPL) to extend the lag phase through an
antioxidant-like action. While most in vitro studies of peroxidation focus on either the
maximal rate of peroxidation or the products of peroxidation, Chapter Five contained
multiple measures of peroxidation as proposed by Pinchuk and Lichtenberg (2014) [96]
including rates of peroxidation during the lag phase, the length of the lag phase, and
rates of peroxidation during the propagation phase. The length of the lag phase is a
particularly important measure of peroxidation as the lag phase is a period of limited
oxidative stress where cells can nullify oxidative damage in order to maintain a healthy
physiological state [108]. It is possible that healthy cells exist in this phase indefinitely
by limiting reactive oxygen species (ROS) production with lipid-soluble antioxidants
such as α–tocopherol. The antioxidant-like ability of non-PPLs to delay peroxidation
through steric hindrance or ‘caging’ of ROS may be particularly efficient in maintaining
the lag phase as non-PPLs are unlikely to be damaged or consumed in the same manner
as other antioxidants. This effect may also be widespread as non-PPLs are major
component of most cells. In addition, the antioxidant-like action of non-PPL is
predicted to work synergistically with other antioxidant systems to greatly enhance their

O2 consumed (Mols)

effectiveness as shown in Figure 8.1.
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Figure 8.1. Oxygen consumption as a measure of the iron-mediated peroxidation of
peroxidisable phospholipids (PPL) alone, with non-PPLs, with antioxidants, and with both
non-PPL and antioxidants. Lines are typical examples of oxygen consumption curves measured
experimentally.
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8.1.3 Membrane composition and lifespan
Chapter Six and Chapter Seven of this thesis investigated the relationship between
membrane susceptibility to peroxidation and the maximal lifespan (MLS) of three
mammals. Skeletal muscle, liver and brain from mice (Mus musculus, MLS of 4 years),
pigs (Sus scrofa, MLS of 27 years) and humans (Homo sapiens, MLS of 122 years)
were examined using shotgun lipidomics. In Chapter Six, an interspecies comparison
found a link between mitochondrial membrane composition and longevity, with mouse
mitochondria containing high percentages of highly unsaturated PUFA in all
phospholipid classes, human mitochondria containing low percentages of PUFA content
with a low degree of unsaturation, and pig mitochondria sharing characteristics of both
mice and human. The results for the peroxidation indexes calculated for skeletal muscle
mitochondria are compared with published values for mammal species in Figure 8.2. As
can be seen from the figure, the values of Chapter Six, particularly for pigs, are slightly
lower than the published trend for mammals. This low value may be a result of using
shotgun lipidomics as this method has been found to report a lower percentage of
membrane PUFA than the gas chromatography (GC) methods used in the majority of
work in this area [18]. This difference may be due to the lipidomics analysis not
including phosphatidylinositol and CL, which are both classes of phospholipid with
high PUFA content [20]. Despite these small differences to past work, however, the
comparison of membrane composition between mice, pigs and humans supports the link
between membrane composition and longevity proposed in the “Membrane Pacemaker
Theory Of Aging” and similar theories.
This thesis also presents one of the first investigations into how phospholipid
classes and individual species of molecular phospholipids contribute to the peroxidation
index. Somewhat surprisingly, the peroxidation index of membranes was primarily
determined by a limited number of molecular phospholipids species (Figure 6.4).
Molecular species of both PC and PE were large contributors to the peroxidation index
in skeletal muscle, PE 18:0_20:4 was the major contributor in liver, and PE 18:0_22:6
was the major contributor in brain. Another molecular phospholipid species of
particular interest was PC 16:0_18:1, a non-PPL found to increase the lag phase of
peroxidation in Chapter Five that was far more common in the tissues of human than of
mice or pigs. This finding suggests that human membranes are more likely to be
protected by the antioxidant-like action of this phospholipid in comparison to the
membranes of mice or pigs.
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Figure 8.2. Comparison of the peroxidation index of mitochondria from mice, pig and human
skeletal muscle values from Chapter Six, (red crosses) to published values for mammal muscle
from [29] (grey circles).

Chapter Seven used the same methods and samples as Chapter Six to investigate
whether humans are capable of excluding highly peroxidisable fatty acids from their
mitochondrial membranes. If this were the case, it would represent an ability to decrease
the rate of aging caused by mitochondrial damage and may explain why humans have
exceptionally long lifespans in comparison to others mammals. This ability was thought
to be unique to humans, and was not be expected to be present in mammals such as
mice or pigs that have lifespans close to those predicted for their body mass. An intraspecies comparison of the mitochondrial and microsomal membranes in humans, mice,
and pigs found a high degree of similarity between organelle membrane composition
within the tissues of each species, although some small differences were seen for
individual phospholipid classes. Mouse liver had a higher peroxidation index in the
microsomal fraction, possibly due to to 22:6n-3 synthesis. With the exception of this
tissue, however, no differences were found in the peroxidation indexes of mitochondrial
and microsomal fractions of tissues of human, mice or pigs. This finding suggests that
the exceptionally longevity of humans is not due to a unique ability to decrease the
susceptibility of their mitochondria membranes to peroxidation, and that humans are
typical mammals in this regard.
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A significant outcome of this thesis was the lipidomics profiling of human tissues
to a level of detail not previously described. To the best of my knowledge, the work
presented in this thesis is one of the most comprehensive examinations of the membrane
composition and peroxidation index of humans and other mammals to date. Working
with human tissues has many challenges, but results for human tissues are of particular
relevance both to the understanding of human physiology and studies of mammalian
longevity and aging. Overall, the finding that the membranes of human tissues
contained a low percentage of PUFA and a high percentage of non-PPLs suggests that
human longevity may be due to an ability to prevent the propagation of peroxidation in
all cellular membranes, and thereby limit oxidative stress and damage.

8.2

Outlook and future directions
The work presented in this thesis supports the association between membrane

susceptibility to peroxidation and lifespan, but emphasise the need for caveats on the
traditional measures of the peroxidation index. Traditional calculations of the
peroxidation index are based on GC measures of fatty acid composition and do not take
into account the potential other elements of phospholipid composition such as class,
non-PPLs, and plasmalogens to influence peroxidation. This thesis has shown the
importance of measuring the contribution of such elements to peroxidation using in
vitro peroxidation studies in addition to the distribution of these elements in animal
tissues using a lipidomics analysis. It would also be valuable to identify how
components of membranes such sterols, proteins, and lipophilic antioxidants may
influence peroxidation. Future work in this area could incorporate the importance of
these elements into the traditional measure of the peroxidation index to reach a better
understanding of the interaction between membrane composition and oxidative stress in
natural systems. My suggestions for such future work include:
1)

Examining how the incorporation of dietary 22:6n-3 into CL affects membrane
susceptibility to peroxidation and animal longevity.

2)

Investigations of whether CL and other phospholipid classes influence the rates
and lag phases of peroxidation in liposomal systems.

3)

Replicating the antioxidant-like effect of non-PPLs using different combinations
of phospholipid classes, fatty acid compositions, and initiators of peroxidation to
clarify the underlying mechanism.
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4)

Proving experimentally that the antioxidant-like effect of non-PPLs affect works
synergistically with lipophilic antioxidants present in cellular membranes.

5)

Comparative studies of tissues from humans and mammals of similar sizes but
shorter lifespans to determine membrane composition using shotgun lipidomics
and membrane susceptibility to peroxidation using in vitro assays to test the lag
phase of membrane peroxidation.
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Appendix A – Scans used in shotgun lipidomics analysis.
Appendix Table A. Targeted ion scans used to acquired phospholipid data
Ion Mode

Scan

DP

EP

CE

CXP

Mass Range

Da/ second

Fatty acid chain scans
PC

Positive

PI 184.1

100

10

47

8

640–1000

200

Lyso–PC

Positive

PI 184.1

100

10

47

8

450–600

200

PE

Positive

NL 141

100

10

30

8

685–950

200

Lyso–PE

Positive

NL 141

100

10

30

8

400–600

200

PS

Positive

NL 185

100

10

30

8

755–965

200

Fatty acid chain scans
14:0

Negative

PI 227.2

-100

-10

-55

-11

580–900

1000

16:1

Negative

PI 253.2

-100

-10

-55

-11

600–900

1000

16:0

Negative

PI 255.2

-100

-10

-55

-11

600–900

1000

17:0

Negative

PI 269.3

-100

-10

-55

-11

560–900

1000

18:3

Negative

PI 277.2

-100

-10

-40

-11

600–900

1000

18:2

Negative

PI 279.2

-100

-10

-40

-11

600–900

1000

18:1

Negative

PI 281.3

-100

-10

-55

-11

600–900

1000

18:0

Negative

PI 283.3

-100

-10

-55

-11

600–900

1000

19:0

Negative

PI 297.3

-100

-10

-55

-11

600–900

1000

20:5

Negative

PI 301.2

-100

-10

-40

-11

500–1000

1000

20:4

Negative

PI 303.2

-100

-10

-40

-11

600–1000

1000

20:3

Negative

PI 305.2

-100

-10

-40

-11

600–1000

1000

20:2

Negative

PI 307.2

-100

-10

-40

-11

600–1000

1000

20:1

Negative

PI 309.2

-100

-10

-55

-11

600–1000

1000

20:0

Negative

PI 311.2

-100

-10

-55

-11

600–1000

1000

22:6

Negative

PI 327.2

-100

-10

-40

-11

700–1000

1000

22:5

Negative

PI 329.2

-100

-10

-40

-11

700–1000

1000

22:4

Negative

PI 331.2

-100

-10

-40

-11

700–1000

1000

22:3

Negative

PI 333.3

-100

-10

-40

-11

600–1000

1000

22:2

Negative

PI 335.2

-100

-10

-40

-11

700–1000

1000

22:1

Negative

PI 337.3

-100

-10

-55

-11

700–1000

1000

22:0

Negative

PI 339.3

-100

-10

-55

-11

600–1000

1000

24:1

Negative

PI 365.3

-100

-10

-55

-11

700–1000

1000

Mass shifting was prevented in negative ion mode by increasing number of summed scans. PI precursor
ion, NL neutral loss, DP declustering potential, EP entrance potential, CE collision energy, CXP collision
cell exit potential, PC phosphatidylcholine; PE phosphatidylethanolamine; PS phosphatidylserine.
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Appendix B – Distribution of phospholipids in mitochondrial
and microsomal fractions of mouse, pig and human tissues.
Appendix Table B1. Distribution of phospholipid classes in the mitochondrial and
microsomal fractions of mouse, pig, and human skeletal muscle
Human
Mitochondria

Mouse

Pig

Microsomal

Mitochondria

Microsomal

Mitochondria

Microsomal

Phosphatidylcholine
PC 16:0_16:0

0.0±0.0

0.0±0.0

6.4±0.3

0.0±0.0

0.0±0.0

0.0±0.0

PC 16:0_18:1

22.4±1.8

29.4±1.9

17.4±0.9

16.8±0.6

16.3±1.5

14.8±1.5

PC 16:0_18:2

20.7±2.7

26.9±2.7

11.0±1.0

11.9±0.5

29.0±0.8

31.8±2.2

PC 16:0_20:4

0.0±0.0

0.0±0.0

14.6±1.4

13.8±0.6

0.0±0.0

0.0±0.0

PC 16:0_22:6

0.0±0.0

0.0±0.0

16.9±1.5

15.3±1.0

0.0±0.0

0.0±0.0

PC 18:0_18:2

0.0±0.0

7.1±0.6

0.0±0.0

0.0±0.0

4.8±1.6

0.0±0.0

PC 18:1_18:1

8.1±1.5

9.1±1.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

PC 8:1_18:2

0.0±0.0

3.4±1.6

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

Phosphatidylethanolamine
PE 16:0_20:4

0.0±0.0

0.0±0.0

2.3±1.9

1.6±0.5

0.0±0.0

0.0±0.0

PE 16:0_22:6

0.0±0.0

0.0±0.0

13.5±3.1

17.3±1.5

0.0±0.0

0.0±0.0

PE 18:0_18:2

23.9±6.1

14.8±1.9

9.5±5.0

4.4±0.4

20.8±2.1

16.2±3.5

PE 18:0_20:4

20.7±2.3

11.9±2.1

14.5±8.0

7.3±0.9

10.2±1.5

18.8±11.7

PE 18:0_22:4

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

PE 18:0_22:6

1.9±0.8

0.0±0.0

28.0±5.9

29.6±2.3

0.0±0.0

0.0±0.0

PE 18:1_18:1

2.5±0.6

1.9±0.9

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

PE 18:1_18:2

5.7±0.9

4.9±0.5

0.0±0.0

0.0±0.0

4.3±0.5

3.2±0.8

PE 18:1_22:6

0.0±0.0

0.0±0.0

2.4±0.5

2.7±0.6

0.0±0.0

0.0±0.0

PS 18:0_18:1

6.9±1.2

6.8±1.3

7.0±0.6

3.1±0.3

5.5±0.6

5.1±0.5

PS 18:0_20:4

8.1±0.9

8.5±0.5

6.6±1.8

5.6±1.1

4.5±1.6

5.4±0.6

PS 18:0_22:6

15.4±2.2

18.4±5

60.6±5.1

65±3.6

7.8±1.2

6.4±0.8

PS 18:0_22:5

15.8±3.2

16.6±2.2

11.1±1.1

14.7±2.0

9.9±2.6

9.5±2.2

PS 18:0:_22:4

10.5±1.2

15.1±3.5

5.3±1.0

8.1±0.8

9.6±2.1

8.7±1.1

PS 18:1_18:1

44.7±6.0

43.2±7.1

9.3±2.2

5.2±1.0

66.1±5.2

65.1±3.7

Phosphatidylserine

Values are means ±SEM, n=6.
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Appendix Table B2. Distribution of phospholipid classes in the mitochondrial and
microsomal fractions of mouse, pig, and human liver
Human
Mitochondria

Mouse

Pig

Microsomal

Mitochondria

Microsomal

Mitochondria

Microsomal

Phosphatidylcholine
PC 16:0_16:0

0.0±0.0

0.0±0.0

9.5±2.3

0.0±0.0

0.0±0.0

0.0±0.0

PC 16:0_18:1

31.2±1.8

33.9±3.3

32±6.7

14.1±0.8

18.1±1.0

19.1±0.9

PC 16:0_18:2

25.5±6.2

23.7±3.5

9.8±3.2

16.3±1

11.0±0.5

11.2±0.6

PC 16:0_20:4

5.8±1.7

10.5±1.3

6.4±2.4

11.1±0.8

0.0±0.0

0.0±0.0

PC 16:0_22:6

0.0±0.0

0.0±0.0

0.0±0.0

9±0.1

0.0±0.0

0.0±0.0

PC 18:0_18:1

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

9.2±0.4

9.9±0.5

PC 18:0_18:2

4.4±1.8

5.3±1.8

9.3±2

10.5±1.2

16.4±0.7

17.1±0.4

PC 18:0_20:4

0.0±0.0

0.0±0.0

0.0±0.0

7.9±1.6

13.3±0.9

12.9±1.5

Phosphatidylethanolamine
PE 16:0_20:4

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

4.7±0.2

0.0±0.0

PE 16:0_22:5

5.2±1.7

9.0±2.6

0.0±0.0

2.8±0.7

0.0±0.0

2.8±0.6

PE 16:0_22:6

0.0±0.0

0.0±0.0

0.0±0.0

31.5±1.3

3.2±0.3

3.8±0.2

PE 18:0_18:2

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

15.6±0.6

19.5±1.9

PE 18:0_20:4

69.5±7.8

50.6±5.7

64.4±8.3

20.8±0.6

38.8±1.1

40.9±1.8

PE 18:0_22:4

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

PE 18:0_22:6

10.4±2.8

0.0±0.0

13.7±4.3

8.9±0.2

4.2±0.6

5.1±0.5

PE 18:1_18:2

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

2.3±0.5

2.0±0.4

PE 18:1_20:4

0.0±0.0

0.0±0.0

12.0±3.1

10.1±0.8

2.7±0.2

3.3±0.2

PE 18:1_22:6

0.0±0.0

0.0±0.0

4.7±1.5

5.1±0.1

0.0±0.0

0.0±0.0

PS 18:0_18:1

7.3±2.0

5.6±0.9

6.0±0.8

0.1±0.1

4.8±0.5

5.9±1.0

PS 18:0_20:4

31.0±6.9

25.2±8

54.3±2.1

55.7±1.5

54.4±3.2

54.3±2.4

PS 18:0_22:6

28.1±3.4

32.0±5.5

33.3±1.4

34.4±2.4

18.7±3.2

18.5±3.0

PS 18:0_22:5

13.2±2.4

9.6±0.7

3±1.1

3.1±1.2

12.6±1

12.7±1.1

PS 18:0:_22:4

7.7±0.7

7.8±0.9

3.6±1.1

4.8±0.4

5.1±1.0

5.1±1.0

PS 18:1_18:1

12.7±3.1

7.8±0.9

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

Phosphatidylserine

Values are means ±SEM, n=6.
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Appendix Table B3. Distribution of phospholipid classes in the mitochondrial and
microsomal fractions of mouse, pig, and human brain
Human
Mitochondria

Microsomal

Mouse
Mitochondria

Pig
Microsomal

Mitochondria

Microsomal

Phosphatidylcholine
PC 16:0_16:0

8.8±2.0

5.5±1.8

15.0±2.8

4.9±2.1

13.7±1.2

0.0±0.0

PC 16:0_18:1

45.7±2.2

41.3±2.1

35.9±0.6

34.8±1.5

38.8±0.6

42.1±13.9

PC 16:0_18:2

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

12.2±7.3

PC 16:0_20:4

2.7±0.2

2.8±0.2

4.5±0.1

5.9±0.5

2.1±0.6

3.4±1.4

PC 16:0_22:6

0.0±0.0

0.0±0.0

4.9±0.2

6.7±0.6

0.0±0.0

0.0±0.0

PC 16:1_18:1

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.5±0.5

12.4±6.3

PC 18:0_18:2

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

PC 18:0_20:4

1.9±0.6

2.3±0.6

4.8±0.2

7.4±0.5

2.2±1.0

4.6±1.5

PC 18:0_22:6

0.0±0.0

0.0±0.0

3.2±0.2

0.0±0.0

0.0±0.0

0.0±0.0

PC 18:1_18:1

3.8±0.8

3.4±0.9

0.0±0.0

0.0±0.0

3.3±0.2

11.0±3.1

PC 18:1_18:2

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

Phosphatidylethanolamine
PE 18:1_18:1

0.0±0.0

0.0±0.0

4.4±0.3

0.0±0.0

0.0±0.0

0.0±0.0

PE 18:0_22:6

38.5±2.8

25.3±1.3

36.6±0.9

38.3±3.2

19.4±1.9

20.5±2.0

PE 18:0_22:4

4.5±2.1

5.3±0.3

2.4±0.8

2.4±1.6

5.7±1.0

7.5±0.8

PE 18:0_20:4

13.9±1.8

6.9±0.9

16.2±0.3

13.1±2.3

13.8±3.9

14.8±3.7

PE 16:0_22:6

0.0±0.0

0.0±0.0

10.2±0.5

10.1±2.7

0.0±0.0

0.0±0.0

PS 18:0_18:1

12.7±1.3

8.4±1.1

41.0±3.1

30.8±3.0

33.7±4.2

4.7±0.6

PS 18:0_20:4

5.8±0.5

7.9±1.1

10.4±0.4

0.0±0.0

5.3±1.1

5.5±0.6

PS 18:0_22:6

43.5±2.7

44.0±3.5

17.7±1.4

21.2±2.3

8.9±1.1

47.1±3.9

PS 18:0_22:5

6.6±0.4

8.0±1.0

0.0±0.0

0.0±0.0

18.5±3.4

9.1±0.9

PS 18:1_18:1

21.2±0.9

14.6±1.3

20.4±1.6

12.1±3.0

10.2±1.1

12.5±1.1

Phosphatidylserine

Values are means ±SEM, n=6.
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